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Abstract
The entire adult central nervous system (CNS) derives from an initially small population 
of apparently homogeneous neuroepithelial precursor cells (NEPs) which produce 
specific differentiating cell types in a highly organised fashion with respect to both the 
time and place at which they are generated. A unifying phenomenon throughout the 
CNS is that neurons are always generated before glia. To better understand what 
mechanisms might be involved, the dynamics of precursor lineages need to be described. 
Here, single NEPs from the murine dorsal embryonic neocortex were cultured at clonal 
density and filmed using time-lapse microscopy to monitor their divisions over time. 
The progeny they gave rise to were identified by immunocytochemical methods and 
expression of the oligodendrocyte lineage-affiliated transcription factor, oUg2 was 
directly observed by using a transgenic mouse that expressed enhanced green fluorescent 
protein (EGFP) in o//g2-expressing cells. (The transgenic mouse line was created by 
phage artificial chromosome (PAC) transgenesis). This data enabled lineage trees for 
individual clones to be retrospectively drawn to include the timing of oHg2 expression 
alongside the final identification of the daughter cells produced. In this way, the effects 
of different growth factors with respect to the induction of glial in preference to neuronal 
phenotypes were assessed.
Using this system it was possible to determine what cell types could be derived from a 
single precursor and with what pattern within a lineage oUg2 might be expressed under 
different culture conditions. Both FGF-2 and a Sonic Hedgehog agonist were seen to 
produce mixed clones in which oUg2 was transcribed at early branch points within a 
lineage and later down-regulated in a selection of daughter cells. This means that oUg2 
expression does not denote commitment to the oligodendrocyte lineage and, 
furthermore, that induction is a sporadic event which seems to be dictated at the level of 
the individual progenitor cells rather than by an intrinsic cell-timer dictated within the 
original NEP.
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Chapter 1
Introduction
1.1 Development of the Central Nervous System
The specification of neural tissue begins at a relatively late stage of embryogenesis, after 
gastrulation, wben the zygote has already multiplied and differentiated into the three 
‘germ layers’ of the embryo - the endoderm, mesoderm and ectoderm, which represent
the inner, middle and outer layers respectively (Figure 1.1).
8-cell
zygote
Blastula Blastula
invaginates
Primitive Streak
O Ectoderm 
O  Endoderm 
@  Mesoderm
Figure 1.1 Schematic representation o f gastrulation. From the fertilized zygote, the early 
blastula is formed -  a hollow ball made up o f a layer o f cells surrounding a central cavity. 
Gastrulation is the process by which cells o f the blastula invaginate to form a long furrow called 
the primitive streak. During the course o f  invagination, cell-cell contact and intercellular 
communication induce cell differentiation, resulting in the formation o f three germ cell layers; 
the outer layer becomes ectoderm, the lining o f the primitive streak (the inner layer) becomes 
endoderm and the cells in between the ectoderm and endoderm become mesoderm. From these 
three layers, all o f  the tissues o f the body are generated; ectoderm produces skin, nervous 
system, cornea and lens; endoderm produces digestive tract, lung epithelium, liver and many 
endocrine glands; mesoderm produces notochord, skeleton, muscles and circulatory system.
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Neural tissue is specified from a region of the ectoderm layer and from this layer of cells 
the early central nervous system (CNS) develops in four principal stages:
1) Neurulation (specification of the neural plate within the ectoderm and formation of 
the neural tube)
2) Régionalisation (early patterning of the neural tube)
3) Neurogenesis (formation of differentiated neurons and glia)
4) Axon path-finding and synaptogenesis (generation of neural networks)
My thesis work focussed on elements of neurogenesis, with particular emphasis on the 
generation of neurons and glia from neuroepithelial precursor cells (NEPs) that express 
the basic helix-loop-helix (bHLH) transcription factor oHg2 {oligodendrocyte lineage 
transcription factor I).
1.2 Neurulation
The neural plate is thought to derive from ectoderm that escapes signalling from bone 
morphogenic proteins (BMPs) and transforming growth factor-/^ (TGFjS). This is 
achieved by the release of specific antagonists to BMPs from early organising centres; 
the primitive node in mouse and chick, the blastopore in Xenopus and the embryonic 
shield in Zebrafish. The antagonists include foilistatin, noggin, and chordin (Hemmati- 
Brivanlou et al., 1994;Lamb et al., 1993;Sasai and De Robertis, 1997). A role for 
BMP/TGF/3 antagonism in neural induction is supported by the finding that absence of 
functional Bmp2b (a specific alternative splice isoform of Bmp2), in bmpb2/swirl 
Zebrafish mutants, results in the expansion of the neural plate at the expense of 
non-neural ectoderm (Nguyen et al., 1998). Antagonistic interactions between fibroblast 
growth factor (FGF), retinoic acid (RA) and Wnt (mammalian homologues of the 
wingless/int family) signalling are also thought to be involved in neural specification, 
particularly with respect to defining anterior/posterior fate (Altmann and Brivanlou, 
2001;Molotkova et al., 2005;Sasai and De Robertis, 1997). Once the neural plate has 
been established, it begins to fold, forming the neural groove (Figure 1.2). As the 
flanking ectoderm moves towards the midline, the neural groove, pivoted at the medial
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hinge point cells which are anchored to the underlying notochord, subsequently closes at 
the dorsal aspect, thus creating the neural tube (Figure 1.2).
Figure 1.2 Neurulation. After the neural plate has been specified, it begins to invaginate. This 
is facilitated by the medial hinge point cells o f the neural plate attaching and anchoring to the 
underlying notochord and changing shape, while the flanking non-neural ectoderm migrates 
inwards towards the midline. This causes the flanking neural plate to rise into the neural folds 
and the neural groove is established. The groove finally closes at the dorsal aspect, thus creating 
the neural tube. Non-neural ectoderm entirely covers the dorsal neural tube and becomes 
epidermis. The remnants o f the neural folds break away and become neural crest cells (adapted 
from Scott F. Gilbert, Developmental Biology 7‘*' edition).
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Figure 1.3 Vesicle formation in the developing brain. After neural tube closure, the anterior 
neural tube balloons into 3 vesicles; the prosencephalon (forebrain), mesencephalon (midbrain) 
and rhombencephalon (hindbrain). These then subdivide further to generate 5 vesicles; the 
forebrain subdivides to form the telencephalon and diencephalon, the hindbrain subdivides to 
form the metencephalon and the myelencephalon and the midbrain remains as it is (the 
mesencephalon). The main structures o f the brain derive from these 5 vesicles as labeled 
(adapted from images from the Department o f Zoology, University o f Guelph, Guelph, Ontario, 
Canada NIG 2W1).
1.3 Régionalisation of the neural tube
Follow ing neural tube closure, the anterior neural tube expands and forms a series o f  
vesicles which prefigure the forebrain (prosencephalon), midbrain (m esencephalon) and 
hindbrain (rhombencephalon). The forebrain fiuther subdivides to form the 
telencephalon and diencephalon and the hindbrain subdivides into the metencephalon  
and myelencephalon. The midbrain undergoes no further subdivision (Figure 1.3). 
Thereafter, a dramatic period o f  cell division com m ences so the tube changes from being  
one cell thick to being multi-layered. This is a tightly controlled process that generates a 
sufficient pool o f  neuroepithelial precursor cells (NEPs) from which neural cells are
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specified. Cell specification is, in turn, a tightly temporally and spatially regulated 
process involving many transcription factor interactions.
By the time of neural tube closure, adjacent mesodermal tissue along the 
anterior/posterior (A/P) and dorsal/ventral (D/V) axes secrete signalling molecules that 
engage early signalling processes for cell specification throughout the tube. The axial 
mesoderm forms the notochord which underlies the length of the CNS at its ventral-most 
aspect (excluding the anterior forebrain and prechordal plate) and secretes the 
morphogen sonic hedgehog (SHH), which is largely responsible for ventral cell type 
specification (Echelard et al., 1993). Simultaneously, BMPs are released from overlying 
non-neural dorsal ectoderm which assist in the dorsalisation of the spinal cord in the 
absence of secretion of antagonists at this stage (Chesnutt et al., 2004;Gross et al., 
1996;Vallstedt et al., 2005). Thus, the neural tube is polarised along the D/V axis. With 
respect to A/P specification, surrounding paraxial mesoderm condenses into blocks to 
form laterally flanking somites which generate muscle and vertebrae. Somitic 
mesoderm is also thought to synthesise and secrete retinoic acid (Niederreither et al., 
1997) which, in combination with FGF signalling, is important in the posteriorisation of 
the neural tube (Molotkova et al., 2005;Moreno and Kintner, 2004). Thus, early 
differentiation of spinal cord cell types is initiated by signals fix>m surrounding 
mesodermal tissue. Régionalisation of the brain is more complex due to the 
invaginations and dynamic cell movements that occur. Nevertheless, the factors that 
have been identified as being involved in dorsal and ventral cell type specification in the 
brain are largely the same as those in the spinal cord; SHH is principally important in 
ventral specification and Wnts, in combination with FGF-8 signalling, in dorsal 
specification (Gunhaga et al., 2003).
Mechanisms of cell specification are more easily studied in the spinal cord since it is a 
relatively simple structure. SHH signalling is critical for D/V patterning of the CNS 
(Echelard et al,, 1993;Hammerschmidt et al., 1997;Roelink et al., 1995) and this role is 
particularly well described in the spinal cord where it is initially released from the 
notochord and diffuses dorsally, thus establishing a ventral-to-dorsal morphogenetic
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gradient of SHH signalling. Different genes are induced or repressed in cells according 
to the concentration of SHH that they are exposed to, which is largely determined by 
their distance from the ventral midline where SHH is secreted (Figure 1.4). Genes 
whose expression are affected by SHH signalling are classified as being Class I or Class 
II according to whether they are repressed or activated by SHH, respectively (Figure 1.4; 
Jacob and Briscoe., 2003). Class I genes include transcription factors such as pax6^ 
pax7, irx3 and dbxl which are expressed in dorsal domains and repressed ventrally. 
Class II genes include nkx6.I, nkx2.2 and oUg2 and they are activated in ventral cells 
where SHH is present at its highest concentrations. SHH signalling thus initiates broad 
domains of transcription factor expression which are spatio-temporally integrated. 
Interactions between transcription factors at the boundaries of these broad domains 
subsequently establish a series of smaller, refined domains of transcription factor 
expression along the D/V axis of the spinal cord, largely via co-repression between the 
proteins that share a boundary (Figure 1.5). Similarly, BMPs released from dorsal 
epidermal ectoderm and roof plate cells form a concentration gradient opposite and 
antagonistic to that of SHH. Thus, BMP signalling both contributes to the dorsalisation 
of the spinal cord as well as refining SHH signalling in more intermediate and ventral 
domains (Chesnutt et al., 2004;Gross et al., 1996;Mekki-Dauriac et al., 2002;Vallstedt et 
al., 2005). In total, six dorsal domains (dPl-dP6) and five ventral domains (pO, p i, p2, 
pMN and p3 domains) are established according to their unique compliment of 
transcription factor expression and the different neuronal and glial subtypes that they 
consequently generate (Figures 1.4 and 1,5). The motor neuron progenitor (pMN) 
domain, for example, is found in the ventral half of the spinal cord, between p2 and p3 
(Figures 1.4 and 1.5), and is defined by the exclusive expression of oUg2 and the 
exclusion of irx3 and nkx2.2. The pMN domain generates motor neurons (MNs) and 
oligodendrocyte progenitor cells (OLPs) (Figure 1.5).
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F igu re  1.4 Domains o f transcription factor expression in the spinal cord. Sonic Hedgehog 
(SHH) released from the underlying notochord at the ventral-most aspect o f the spinal cord 
represses Class I genes (which are therefore expressed more dorsally) and activates Class II 
genes (which are therefore expressed more ventrally). Different homeodomain (HD) and basic 
helix-loop-helix (bHLH) proteins are therefore expressed at different positions relative to their 
distance from the notochord and SHH-secreting floorplate (FP). Domains o f combinatorial 
transcription factor expression are thus established; pO-p3 and the motor neuron precursor 
(pMN) domain are the 5 ventral domains and dPl-dP6 are the 6 dorsal domains. Dorsal domain 
specification is also assisted by the release o f BMPs from ectoderm overlying the dorsal-most 
aspect o f the spinal cord. Co-repression between transcription factors facilitates the refining of 
these domains so distinct boundaries o f homeodomain and basic helix-loop-helix protein 
expression are established (adapted from Kessaris et al., 2001). FP = floor plate, RP = roof 
plate.
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F igu re 1.5 Formation o f discrete spinal cord domains defined by SHH-regulated transcription 
factor expression. The morphogenetic gradient o f SHH released from the ventral notochord and 
floorplate cells establishes a series o f broad domains of gene expression (A) according to the 
concentration o f SHH the receptive cells are exposed to. Class I genes are repressed by SHH 
and Class II genes are activated. These broad domains o f gene expression are refined by cross- 
regulatory interactions between them at expression boundaries (B). Nkx2.2 and Pax6 are two 
homeodomain (HD) proteins that are mutually exclusive, as are Nkx6.1 and Dbx2. Such co- 
repressive interactions generate distinct boundaries between refined domains o f unique 
combinations o f Class I and Class II gene expression (C). These domains subsequently give rise 
to unique neuronal cell types and glia. The basic helix-loop-helix (bHLH) transcription factor 
01ig2 is co-repressive with the HD protein Irx3 and these form the dorsal boundary o f the motor 
neuron progenitor (pMN) domain from which motor neurons and oligodendrocyte progenitors 
are derived (Adapted from Jacob and Briscoe., 2003).
1.4 The Neuron/Glia Switch
Throughout the CN S, neurons are generated before glia, but it is not yet known how  this 
tim ing is regulated. One school o f  thought is that NEPs within the ventricular zone (VZ) 
segregate early in developm ent to becom e either neuron-restricted or glial-restricted  
precursors (NRPs or GRPs) which produce differentiating neurons or glia respectively at 
different times (N oble et al., 2004). Alternatively, neurons and glia (or NRPs and 
GRPs) m ay derive from a com m on precursor that generates neurons or NRPs first and 
then switches to produce glia or GRPs (Figure 1.6). These have been termed the 
‘segregating’ and ‘sw itching’ models, respectively (Richardson et al., 2000). In favour 
o f  the segregating m odel, both NRPs and GRPs have been identified throughout the 
neuroepithelium at different developmental ages. Putative GRPs (including  
oligodendrocyte type-2 astrocyte precursors identified by R aff et al (R aff et al., 1983))
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have been isolated from the full extent of the neuroectoderm by several groups. Most 
GRPs express the marker A2B5 and generate only glia and never neurons in vitro (even 
over weeks of expansion) and after transplantation in vivo (Gregori et al., 2002;Rao et 
al., 1998;Rao and Mayer-Proschel, 1997). PSA-NCAM-positive (poly-sialated neural 
cell adhesion molecule) NRPs have also been isolated which can give rise to multiple 
neuronal phenotypes, but no glia (Mayer-Proschel et al., 1997). The discovery of such 
lineage-restricted precursors in vertebrates has been predated by experimental analysis 
in Drosophila. An example of this is the early asymmetric division of precursors in the 
thoracic segment which generates separate neuron- and glial-restricted progenitors 
(kiyama-Oda et al., 1999). The discovery of NRPs and GRPs does not exclude the 
switching model as a possibility since one precursor cell could give rise to both NRPs 
and GRPs. However, the question remains regarding at what point are NRPs and GRPs 
lineally segregated.
In support of the ‘switching’ model, Temple and co-workers showed that not only can 
both neurons and glia derive from a single, multipotent cortical neuroepithelial precursor 
cell (NEP) in vitro (Davis and Temple, 1994), but that they do so sequentially -  neurons 
first, followed by glia (Qian et al., 2000). This was demonstrated with the use of long 
term time-lapse microscopy and will be discussed in more detail later. Experiments by 
Park and Appel (Park and Appel, 2003) indicate that OLPs and Motor Neuron 
Precursors (MNPs) derive from a common oHg2+ precursor since alteration in the 
numbers of one class of precursor has a reciprocal effect on the other (e.g increasing 
numbers of MNPs sees a decrease in the number of OLPs). Notch signalling in the pMN 
domain supports the maintenance of proliferative NEPs in the ventricular zone (VZ), 
promoting the production of OLPs by preventing oUg2+ NEPs from differentiating into 
MNs. Deficiencies in Notch signalling result in the production of excess MNs at the 
expense of OLPs and vice versa in the presence of excess Notch signalling (Park and 
Appel, 2003). This indicates that a common progenitor pool in the pMN might support 
the generation of both MNs and OLPs and when generation of one cell type is 
encouraged, the other is consequently reduced. Alternatively, the numbers of MNPs and 
OLPs could depend upon feedback between the two precursor populations which is
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disrupted when one or other precursor type is disrupted. Changes in the expression o f  
the pro-neural bHLH factor ngn2  also alters the relative proportions o f  M NPs and OLPs 
that are generated; precocious expression o f  ngn2 promotes neuronal differentiation at 
the expense o f  dividing cells which may be OLPs in the pMN domain (M izuguchi et al., 
2001) w hile ngnl/n gn2  double mutants generate no M Ns, but OLP production is 
increased (Sugim ori et al., 2007). MN specification is coincident with up-regulation o f  
ngn2  in concert with down-regulation o f  oHg2 (Lee et al., 2005). It is possib le that MNs 
and OLPs derive from a com m on oHg2+  progenitor and that specific com binations o f  
oUg2 with other cell-specific transcription factors in daughter cells might determine 
whether they becom e M Ns or OLPs and changes in the expression o f  these transcription 
factors may therefore alter the proportions o f  M Ns and OLPs produced.
Time
GRPNRP
Multipotent NEP
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Figure 1.6 (above) Segregating (A) versus switching (B) models o f neuronal and glial 
generation in the developing CNS. The two principal schools of thought regarding the temporal 
succession o f neuronogenesis followed by gliogenesis are; the segregating model whereby 
neuroepithelial precursor cells (NEPs) segregate early in development to be committed to 
making only neurons (neuron-restricted precursors (NRPs)) or only glia (glial-restricted 
precursors (GRPs)) and that GRPs are activated at a later time than NRPs; and the switching 
model whereby neurons and glia derive from a common precursor that first produces neurons 
and then switches to make glia at a later time point.
1.5 T he o ligodend rocyte lineage
O ligodendrocytes are the myelinating cells o f  the CNS. They spirally enwrap the axons 
o f  CNS neurons with a fatty m yelin membrane, thus enabling fast, saltatory conduction  
o f  action potentials. One oligodendrocyte usually myelinates several axons 
sim ultaneously (Figure 1.7).
Myelin sheatir
Axons
Oligodendrocyte
Nodes of Ranvier
Figure 1.7 Schematic o f a myelinating oligodendrocyte. One oligodendrocyte enwraps several 
axons with a myelin sheath. Myelination is intermittent; the nodes o f Ranvier (small nude 
lengths o f axon in between myelinated portions) are where saltatory conduction o f action 
potentials takes place.
The importance o f  this role becom es evident when dysmyelination or demyelination  
occurs. In m ultiple sclerosis, for exam ple, where axons becom e denuded, action 
potentials are blocked resulting in patient mal-coordination when motor neurons are 
affected, loss o f  sight when visual system  neurons are affected and dementia when
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cortical neurons are affected. A great deal of research has gone into the characterization 
of the oligodendrocyte lineage and the investigation of mechanisms involved in their 
development and differentiation in the hope that understanding their normal 
development will give us clues to how to stimulate regeneration of oligodendrocytes and 
myelin during demyelinating diseases.
In both the spinal cord and the brain, the first OLPs are found in ventral domains; in the 
pMN domain of the spinal cord (Pringle and Richardson, 1993) and the medial 
Ganglionic eminence (MGE) and the anterior entopeduncular area (AEP) of the ventral 
forebrain (Pringle and Richardson, 1993;Tekki-Kessaris et al., 2001;Zhou et al., 2000). 
OLPs from these domains migrate to populate the dorsal regions as well, but along with 
the ventral origins of OLPs in the CNS, there has more recently been identified some 
indigenous dorsal sources of OLPs which emerge at around E l6.5 in the mouse. 
Transgenic labeling of dorsally-derived c/Ax/-expressing precursors has shown that 
OLPs from dorsal sources constitute ~20% of all OLPs in the spinal cord (Fogarty et al., 
2005)(Fogarty unpublished, Kessaris et al 2006). In the perinatal brain, 
oligodendrogenesis also occurs in the cortex itself (Kessaris et al., 2006). Consequently, 
by E19 OLPs throughout both the spinal cord and the brain are derived from a variety of 
sources (Figure 1.8). Most OLPs go on to become myelinating oligodendrocytes 
postnatally, but a significant population persists in the adult CNS. The function of these 
‘adult OLPs’ is not known; they contact the Nodes of Ranvier and also receive synaptic 
input from neurons so they conceivably play a role in adult physiology as well as 
providing a potential new source of oligodendrocytes.
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Figure 1.8 Schematic representation o f ‘waves’ of oligodendrogenesis in the spinal cord (A) and brain (B). In the spinal cord, the first (and 
principal) source of OLPs is from oHg2+ precursors in the pMN domain. These first appear around El 2 and migrate to disperse throughout 
the cord. From around E16 onwards, a second source o f OLPs is generated fi’om dbx+ precursors in dorsal domains of the cord. These, along 
with other dorsal sources of OLPs finally constitute about 10-15% of all OLPs in the spinal cord. In the brain, the first wave of 
oligodendrogenesis originates from the anterior entopeduncular area (AEP) and medial ganglionic eminence (MGE) from El 1.5, followed by a 
second wave from the lateral and caudal ganglionic eminences (LGE and CGE) at around E l5, finally a third wave is generated within the 
cortex itself postnatally. Each wave of oligodendrogenesis can be sourced to precursor cells expressing different transcription factors, unique 
to their domains of origin, as shown (Adapted from Fogarty et al., 2005 and Kessaris et al., 2006).
1.6 OLPs to Oligodendrocytes
Early OLPs are proliferative and highly migratory cells. They can be identified by the 
expression o ï platelet-derived growth factor receptor ot (pdgfro^ (Hall et al., 1996), SRY- 
box-containing gene 10 (soxIO) (Stolt et al., 2002) and oUg2 (Lu et al., 2000;Zhou et al., 
2000). Once they reach their destination they undergo a limited proliferation and start to 
differentiate into pro-myelinating oligodendrocytes (Fro-OLs) characterised by 
expression of 0 4  and downregulation of PDGFRof. Pro-OLs have a highly processed 
morphology and although they are still proliferative (less so than OLPs), they are no 
longer migratory and form small, localised groups of cells (Bansal and Pfeiffer, 1997). 
The final stages of differentiation involve withdrawal from the cell cycle and extension 
of processes to enwrap axons and generate myelin sheaths. These terminally
differentiated myelinating oligodendrocytes express structural components of myelin 
such as myelin basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte 
protein (MOG), galactocerebroside (GC) etc (Bansal and Pfeiffer, 1997).
There are evident morphological changes from OLPs to mature oligodendrocytes along 
with their different proliferative and migratory activities and immunogenic profiles. The 
transition from one phase to the next could conceivably be mediated by FGF-2 since 
expression of different FGF receptor (FGFR) isoforms also changes at different stages of 
the oligodendrocyte lineage (Bansal et al., 1996). The different stages of the 
oligodendrocyte lineage can be defined by the expression profile of FGFRs and by their 
responses to FGF-2 (Figure 1.9). FGFRl is expressed in early progenitors with 
increasing levels of expression as the cells progress to mature oligodendrocytes. FGF-2 
signalling through FGFRl promotes proliferation and migration which are typical 
features of early OLPs. FGFR3 has low levels of expression up until a peak at the 
Pro-OL stage; signalling through FGFR3 promotes proliferation and is thought to be 
involved in the arrest of differentiation in late progenitors in response to FGF-2. FGFR2 
is expressed only in mature oligodendroeytes and is thought to be involved in signaling 
terminal differentiation (Fortin et al., 2005). How the timely expression of these 
different receptors is controlled and regulated is unknown, but FGF-2 signalling has 
been shown to regulate the expression of some FGFR isoforms so may itself be involved
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in regulating the responses of cells of the oligodendrocyte lineage. How OLPs are first 
specified is not yet fully known, but, along with SHH signalling, FGF-2 could also be 
involved.
NEP O LP
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FGFRl FGFR2FGFR3
Figure 1.9 Stages o f the oligodendrocyte lineage and corresponding profiles o f FGFR isoform 
expression. Oligodendrocyte precursors (OLPs) are derived from neuroepithelial cells (NEPs) 
and express FGFRl, which increases in levels as the lineage progresses with peaking levels at 
the pre-myelinating and mature oligodendrocyte stage. FGFR3 has a brief period of expression 
at the pre-myelinating stage and is thought to assist transition to the mature, differentiated 
oligodendrocyte via FGF-2 signal transduction. FGFR2 is only expressed in mature, 
myelinating oligodendrocytes.
1.7 Control of oligodendrogenesis
The principle factor involved in pMN domain oligodendrogenesis is SHH (as outlined 
above) via signaling at a particular range of concentrations (Orentas et al., 1999;Pringle 
et al., 1996;Roelink et al., 1995). Ectopic expression of SHH in the dorsal part of the 
spinal cord results in ectopic generation of MNs and OLPs (Pringle et al., 1996), while, 
in shh-/- mutants, oligodendrocytes and motor neurons are absent (Lu et al., 2000). 
SHH signaling is required over an extended period for OLPs to be generated (Orentas et 
al., 1999), transient exposure not being sufficient. There may be some functional 
redundancy between SHH and other members of the hedgehog (HH) family however, 
since shh-/- mutants have a less severe phenotype than smo-/- mutants in which all HH 
signalling (i.e. from Sonic, Desert and Indian Hedgehogs) is prevented (Wijgerde et al., 
2002).
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Oligodendrogenesis and the involvement of SHH in the brain are less well defined than 
in the spinal cord, but similar principles apply. Zones of SHH expression coincide with 
oligodendrogenic domains and CLP production in the forebrain is delayed or abolished 
in nkx2. /-/- mutant mice in which there is no (or very reduced) SHH expression in the 
ventral forebrain (Tekki-Kessaris et al., 2001). Although OLPs are eventually generated 
in basal forebrain cultures of nkx2.l~/~ mice, this is blocked by the addition of 
cyclopamine, a HH inhibitor, thus indicating that HH signalling is required for 
oligodendrogenesis in the brain as well as in the spinal cord as described above. 
Furthermore, when SHH is misexpressed in the embryonic telencephalon, ectopic, 
supernumerary oligodendrocytes are identified (Nery et al., 2001). It is contentious 
however, as to whether SHH works in a graded fashion in the brain. When SHH is 
applied to telencephalic explants at an early stage (E9 or earlier in rat), ventral medial 
ganglionic eminence (MGE)-like features are identified (Kohtz et al., 1998). However, 
when SHH is added to slightly older explants (El0-El 1.5 in rat), a lateral ganglionic 
eminence (LGE)-like phenotype is generated, which is a more dorsal feature of the 
telencephalon, regardless of the level of SHH that is applied (Kohtz et al., 1998). Thus, 
responsiveness to SHH signalling is demonstrated to change over time.
1.8 SHH-independent OLP specification
Dorsal NEPs presumably do not receive the same level of SHH signalling as those in the 
ventral CNS (if they are exposed to SHH at all), suggesting that a SHH-independent 
mechanism of OLP specification might exist. This has been supported by the finding 
that NEPs from shh-/~ null mice can still generate OLPs in vitro (Chandran et al., 2003) 
although this could be attributed to signalling by other HH proteins as described above. 
Chandran et al demonstrated that FGF-2 induces oligodendrocytes from MEPs derived 
from the dorsal spinal cord, in the absence of SHH signalling. They therefore proposed 
that FGF-2 could be a candidate molecule for SHH-independent oligodendrogenesis 
(Chandran et al., 2003). Dorsal cortical NEPs from E l3.5 mouse embryos have also 
been induced to generate OLPs in vitro in the presence of FGF-2 (Kessaris et al., 
2004;Qian et al., 1997). Both Chandran et al (Chandran et al., 2003) and Kessaris et al
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(Kessaris et al., 2004) showed that FGF-2 still was able to induce OLPs in the presence 
of cyclopamine, which blocks all HH signaling, indicating that it acted independently of 
SHH. Kessaris et al also showed that SHH-mediated induction of OLPs in vitro was 
abolished in the presence of the FGFR inhibitor PD173074, indicating that FGF-2 
signalling is necessary for SHH-induced oligodendrogenesis, possibly by activating the 
MAP kinase pathway (Kessaris et al., 2004). More recent experiments have 
demonstrated that FGF-2 is capable of inducing OLPs in the brain in vivo (Naruse et al., 
2006).
1.9 01îg2 and the oligodendrocyte lineage
OUg2 expression defines OLP and MN precursors in the pMN domain and is a marker 
and transcription factor throughout the oligodendrocyte lineage. It was identified along 
with oligi and oUg3 by three independent research groups; Zhou et al 2000 (Zhou et al.,
2000), Lu et ai 2000 (Lu et al., 2000) and Takebayashi et al (Takebayashi et a l, 2000). 
Zhou et al identified the olig genes while screening for previously uncharacterised 
bHLH factors that may fimction as mediators of glial cell fate in the central nervous 
system (CNS). bHLH transcription factors were already well known to be key 
regulators of many cell types in various tissues across a variety of organisms (Garrell 
and Campuzano, 1991), but in the CNS were implicated in neuronal rather than glial 
specification (Lee et a l, 1995;Ma et a l, 1994). However, given that there were many 
bHLH transcription factors at the time that still remained uncharacterised it was 
postulated that some of these may be involved in glial fate determination.
Concurrent with the discovery of oligJ and oHg2 by Zhou et al, Lu et al cloned rat oligl 
ando/zgZ after identifying them as genes up-regulated in E14.5 rat neuroepithelial cell 
cultures upon induction of OLPs by FGF (Lee et a l, 1995;Lu et a l, 2000). They further 
showed, by in situ hybridisation analysis, that the pattern of oUg2 expression has a 
profile matching that of oligodendrogenic zones in the early embryo. OUg2 was also 
found to be expressed at E13.5 in the retina and in the olfactory epithelium by E l l .5 
where no OLPs develop, suggesting that it may also be involved in developing sensory 
organs. In the spinal cord, oHg2 is not only common to motor neuron progenitors and
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OLPs, but is also required for their generation since oHg2-l- knock-outs have no OLPs 
or MNs in the spinal cord (Lu et al., 2000). Co-expression of oUg2 with other 
transcription factors is thought to promote the generation of different cell types. For 
example, co-expression of ngn2 with oHg2 is thought to promote MN differentiation in 
the pMN domain (Mizuguchi et al., 2001), although oHg2 is then rapidly down-regulated 
in post-mitotic MNs (Lee et al., 2005). Ngnî and ngn2 are down-regulated in the pMN 
domain after the period of motor neuron production. In the chick spinal cord there is 
then a dorsal expansion of nkx2.2 expression from the p3 domain into the pMN domain 
in (Fu et al., 2002) and the consequent overlap of oHg2 and nkx2.2 expression has been 
proposed to assist the onset of oligodendrogenesis (Zhou et al., 2001). This story is 
complicated, however, because in the mouse spinal cord, expression domains of oUg2 
and nkx2.2 remain separate (restricted to pMN and p3 domains respectively) at the onset 
of oligodendrogenesis. Dorsal expansion of nkx2.2 expression into the pMN domain 
occurs about two days after OLPs begin to migrate from the pMN domain (Fu et al., 
2002), indicating that nkx2,2 is not necessary for the onset of oligodendrogenesis in the 
mouse. The idea that nkx2.2 expression alone is not sufficient to induce OLPs (Zhou et 
al., 2001) is supported by the finding that mutations in the nkx2.2 gene cause a reduction 
in MBP and PLP expression, but not in earlier OLP markers (Qi et al., 2001). However, 
oHg2 may co-operate with nkx2.2 for the specification and differentiation of 
oligodendrocytes in vivo since ectopic co-expression of these two transcription factors 
can result in ectopic oligodendrocyte differentiation in the embryonic chicken spinal 
cord (Zhou et al., 2001). Furthermore, all differentiating oligodendrocytes in the white 
matter co-express oUg2 and nkx2.2 in both mouse and chick (Fu et al,, 2002). In the 
brain things are even more complex. Despite a huge reduction in OLPs in the 
embryonic brains of oHg2-/- mutants, there is still generation of OLPs in small regions 
of the forebrain and normal numbers of OLPs are seen in the midbrain (Zhou and 
Anderson, 2002). All oUg2-/- OLPs express oligl however, suggesting a level of 
redundancy between these transcription factors in the brain. Co-expression of nkx2.2 
and oHg2 seems to be important in the specification of OLPs in the brain since Vallstedt 
et al (Vallstedt et al., 2005) showed that oligl/2+  cells in the anterior hindbrain appear 
to be derived from nkx2.2+ progenitors. Nkx2.2 is expressed early in a ventral domain
33
of the anterior hindbrain and its dorsal boundary is maintained by Nkx6-mediated 
repression. In nkx6-/~ mutants, the region of nkx2.2 expression expands dorsally and 
ectopic oligodendrocyte differentiation occurs in register with this (Richardson et al., 
2006;Vallstedt et al., 2005).
In both the brain and spinal cord, oUg2 clearly has an important, instructive role in OLP 
specification. Induction of oHg2 expression in vivo is largely dependent on SHH 
signaling, although SHH-independent mechanisms are now also being suggested; FGF-2 
being a prime candidate. In culture, the addition of a sonic agonist to preparations of 
primary neocortical NEPs results in the up-regulation of the oUg2 within 24 hours of 
treatment (Kessaris et al., 2004). In the absence of SHH, FGF-2 induces oHg2, and 
OLPs are derived thereafter (Chandran et al., 2003;Kessaris et al., 2004). The 
mechanisms of signaling of these two molecules will be described further.
1.10 SHH signalling
Sonic Hedgehog is a 45 kDa protein that undergoes auto-catalytic cleavage to yield a 
20 kDa N-terminal domain and a 25 kDa C-terminal domain. The N-terminal domain is 
thought to carry all of the signalling properties of SHH and it is modified by the addition 
of a cholesterol and a palmitate moiety which converts it to a soluble form that can be 
released extracellularly. It is this soluble form of the N-terminal SHH fragment that is 
freely diffusible and is able to form the concentration gradient in the spinal cord. 
Diffusion gradients are one means of regulating the potency of SHH signalling; 
alternatively, SHH can act at different potencies if  recipient cells alter the density of its 
receptor, Patched 1 (Ptcl) at their surface. In line with this idea, there has been found to 
be a ventral to dorsal gradient of p tc l mRNA in cells of the spinal cord (Pearse et al.,
2001). This may have been established via the initial gradient of diffusing SHH since it 
has been demonstrated that SHH signalling can increase p tcl expression (Marigo and 
Tabin, 1996). The intracellular context of a cell also determines how it interprets the 
concentration of SHH signalling it receives. The main transcriptional regulators of SHH 
target genes are a group of zinc finger transcription factors; cubis interruptis in
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Drosophila (Methot and Easier, 1999), and the gli family in vertebrates (Jacob and 
Briscoe, 2003).
Ci was first identified in Drosophila and has both a transcriptional activator (CiA) and a 
repressor (CiR) iso form, the repressor isoform being generated by cleavage of CiA (za- 
Blanc et al., 1997). Ptcl activity regulates the activity of the seven-pass transmembrane 
protein Smoothened (Smo). In turn, Smo regulates proteolytic cleavage of the 
bi-functional Ci or Gli proteins. In the mouse, there are three Gli isoforms; Gli 1-3, 
which are characterised by five tandem C2-H2 zinc finger motifs (for a review see 
(Gunhaga et al., 2003;Jacob and Briscoe, 2003). Although they have cleavage sites and 
are therefore potentially bi-functional like Ci, only the repressor isoform of Gli3 (GH3R) 
has been identified in vivo. The regulation of Gli3R generation is mediated via control 
of Smo activity as for Ci modification in Drosophila. In the absence of Ptcl-mediated 
suppression, Smo inhibits the cleavage of the full-length activator iso forms of Ci or Gli3 
into their repressor isoforms. Since SHH signalling inhibits Ptcl-mediated suppression 
of Smo it therefore indirectly maintains the activator isoforms of Ci or GH3 by 
preventing their cleavage. However, in the absence of SHH signalling, Ptcl inhibits 
Smo activity and thus the repressor isoforms of Ci and GH3 are generated and move to 
the nucleus (Figure 1.10). Glil and 2 have only been identified in their activator forms 
and are expressed in ventral domains of the CNS (Bai et al., 2002;Hui et al., 1994). Glil 
does not have a pivotal role in SHH signal transduction, however, since g lil -/- mutants 
are phenotypically normal (Park et al., 2000). Gli2, on the other hand, is principally 
involved in transducing the ventralising activity of SHH and gH2-/- mutants have severe 
phenotypes (Park et al., 2000). Conversely, GH3 has a prominent role as a 
transcriptional repressor and is expressed in more intermediate and dorsal domains of 
the spinal cord. Gli3 repressor (GH3R) activity is important in the specification of 
intermediate cell types in intermediate domains and the inhibition of ventral cell types in 
dorsal domains (Litingtung and Chiang, 2000). The relative distribution of Gli proteins 
across the D/V axis of the CNS could feasibly contribute to the differential D/V effects 
of SHH. The targets of SHH signalling include homeodomain transcription factors, 
characterised by a specific 60 amino acid helix turn helix motif. As a consequence.
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SHH signalling has the capacity to trigger a cascade of transcriptional regulation which 
results in combinations of genes being expressed in specific regions as described above.
Figure 1.10 Sonic Hedgehog (SHH)-regulated processing of Drosophila Cubis Interruptus (Ci) 
and vertebrate Gli proteins. Smoothened (Smo) normally inhibits the processing of the 
full-length activator isoforms of Ci and Gli (CiA and GliA) into the repressor isoforms (CiR and 
GliR). In the absence of SHH activity. Patched 1 (Ptcl) represses Smo-mediated inhibition of 
CiR and GliR formation and thus the repressor isoforms are generated. However, upon 
SHH-binding to Ptcl, Smo keeps Ci and Gli as the activator isoform (Adapted from Motoyama, 
2006).
1,11 FGFs in CNS development
Members of the fibroblast growth factor (FGF) family are involved at many stages in 
CNS development (Goldfarb, 1996). They are first involved in the specification of 
neural tissue with FGF-8, FGF-2, FGF-4 and FGF-3 being present in the anterior neural 
streak (ANS), a prominent signalling centre before and during gastrulation (Riese et al., 
1995;Storey et al., 1998;Streit et al., 2000). In combination with other factors, different 
FGFs are involved in proliferation and differentiation of various cell types within the 
developing CNS. Of particular interest here are the roles and mechanisms of FGF-2 
signalling.
36
FGF
I'ci ’ i :
cyW)
FRS2 SOS,Shj
PLCy
Ras
± R a f
 MAPPK
T areets T areets
Figure 1.11 FGF signaling pathways. FGFRs dimerise upon ligand-binding and consequently 
cross-phosphorylate at intracellular tyrosine residues (red circles indicate phosphate groups). 
The phosphorylated receptors recruit and phosphorylate docking proteins such as fibroblast 
growth factor receptor substrate 2 (FRS2), which subsequently recruit other proteins to generate 
a large complex. Via SOS activation, the MAPK pathway can be activated through Ras and Raf 
activation, ultimately culminating in transcriptional activation of target genes in the nucleus. 
Phospholipase C (PLC) can be directly activated by phosphorylated FGFRs which activate target 
genes via protein kinase C (PKC) activation and activation of the MAPK pathway through Raf. 
MAPK activation, in turn, inhibits FRS2 and SOS activity and thus creates negative feedback 
loops. These are just some o f the pathways accessed by FGFR activation.
FGFRs are tyrosine kinase receptors (TKRs) which are activated upon ligand-induced 
dimérisation, which promotes auto-phosphorylation of intracellular tyrosine residues as 
a result. This instigates the recruitment of docking proteins such as FRS2 (fibroblast 
growth factor receptor substrate 2) which, in turn, are also phosphorylated and recruit 
intracellular signalling components. Few FGF-induced signalling cascades are activated 
directly by the phosphorylated FGF receptor and thus most FGF-induced signalling is 
transduced by docking complexes (Figure 1.11). A series of negative feedback loops, 
mainly via MAP-Kinase activation, are also in play, meaning FGFR-mediated signalling 
is a complex series of interactions (Schlessinger, 2004). In the CNS, four FGFR
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isoforms are known to be expressed (FGFR-1-4), each of which has multiple splice 
variants (Miki et al., 1992). Of these receptors FGF-2 binds to FGFRl with the greatest 
affinity and, like FGF-2, FGFRl is largely expressed in early neurogenesis in the 
developing brain (Ford-Perriss et al., 2001).
FGF-2 is found in both neuronal and non-neuronal cells and exists in several isoforms. 
The 18kD isoform is found in the cytosol, at the cell surface and also outside of some 
cells (including those in the cortical ventricular zone) and can therefore also act as a 
diffusible signal. FGF-2 is thought to act principally in the developing cortex since this 
is where most phenotypic effects are observed in fgf-2 -/- null mutants (Dono et al., 
1998;Vaccarino et al., 1999). Although its main functions are classically related to cell 
proliferation and survival (Murphy et al., 1990), a role in the specification of 
oligodendrocyte precursors has been implied more recently. FGF-2 is first found to be 
expressed ventrally in the developing cortex as early as E9.5 (Nurcombe et al., 
1993;Raballo et al., 2000) with an increase in expression identified from E l4-18; around 
the time of gliogenesis (Giordano et al., 1992;Powell et al., 1991;Weise et al., 1993). 
Moreover, early studies showed that low concentrations of FGF-2 induce ElO stem cells 
to produce mainly neurons but that increased levels of FGF-2 generate more and more 
glia (Reimers et al., 2001), raising the possibility that FGF-2 could be involved in 
oligodendrogenesis in vivo.
1.12 Time-lapse microscopy as a tool for lineage-tracing studies
Time-lapse microscopy has been employed over the last decade to observe the activities 
of single progenitor cells in vitro. Observing cell division and behaviour in real time 
enables lineage trees to be traced retrospectively since the cell types generated can be 
identified by immunocytochemical analysis and their lineal relationships can be 
determined by tracing the divisions that occurred. Cell behaviour is regulated by both 
cell-intrinsic and environmental factors. The contributions of such factors to the 
generation of cell lineages can be assessed using time-lapse microscopy. Individual cell 
behaviour can be recorded and compared when cultured in different conditions, via the 
addition of different signalling molecules. It is possible to observe directly, for example.
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whether the cell types derived from a single progenitor are altered in different culture 
environments. In this way, cell-intrinsic tendencies can be separated, to a certain extent, 
from the effects of extrinsic signalling events.
Using time-lapse microscopy Qian et al (Qian et al., 2000) addressed the timing of the 
emergence of neurons and glia from embryonic cortical NEPs in the presence of 
lOng/ml FGF-2 as a mitogen. Recording NEPs from E l0.5 mice, an age at which 
neurogenesis is still on-going, they showed that, as in vivo, neurons were generated first, 
followed by glia over 10 days in vitro. They observed repeated patterns of cell division 
whereby neurons were generated largely via asymmetric divisions while glia were 
generated by symmetric divisions. They also showed that lower concentrations of 
FGF-2 generated more neurons in multipotent clones while higher concentrations of 
FGF-2 reduced the number of neurons and increased the number of differentiated glia 
over time (Qian et al., 1997). Thus, they showed that while the NEPs maintained the 
pattern of generation of neurons being followed by glia in different concentrations of 
FGF-2, the relative proportions of neurons;glia in mixed clones could be altered. They 
also showed that the number of neurons generated in mixed clones decreased when 
NEPs from older embryonic cortices were used further indicating that there is a change 
in cortical NEPs over time with respect to the proportion of neurons and glia that were 
generated in mixed clones derived from them in vitro in the presence of FGF-2 (Qian et 
al., 2000). My thesis work revisits these time-lapse studies.
The first aim was to investigate further into the observation by Kessaris et al (Kessaris et 
al., 2004) that an increase in concentration of FGF-2 in cultures of El 3.5 NEPs causes 
an increase in the number of OLPs that are generated over 3 days. This increase in 
numbers of OLPs could occur via a number of mechanisms; increased proportion of 
NEPs in the starting culture that give rise to OLPs, increased proliferation of OLPs that 
are generated, preferential survival of OLPs within a mixed population, or a combination 
of any of these mechanisms. Using time-lapse to monitor cell divisions in real time and 
using immunolabelling to identify daughter cells that were generated in a lineage.
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lineage trees could be drawn retrospectively and cell division times and cell survival 
could be monitored to answer this question.
A second aim was to monitor the dynamics of oUg2 expression in lineages derived from 
embryonic cortical NEPs. In particular, the aim was to determine whether there were 
any differences in oUg2 expression patterns in response to different concentrations of 
FGF-2 in order to drill down further into how higher concentrations of FGF-2 might 
induce more OLPs to be generated. This was enabled through use of a transgenic mouse 
line” ' that was generated to express the reporter molecule enhanced green fluorescent 
protein (EGFP) under the same transcriptional regulatory control as endogenous oUg2. 
Use of this transgenic line for these time-lapse experiments meant that o//g2-expressing 
cells could be visualised directly in vitro by the visualisation of EGFP fluorescence. 
Thus, the patterns of oUg2 expression within emerging clones could be characterised. 
Since oHg2 is the earliest known marker of the oligodendrocyte lineage, the dynamics of 
oHg2 expression within a lineage, captured by time-lapse, could indicate the points at 
which OLPs might be specified. Since not all oUg2+ cells give rise to OLPs, however, 
immunolabelling at the end of experiments was also necessary in order to identify the 
cell types that were generated from both oUg2+ and oUg2- precursor cells.
A third aim was to investigate the responses to FGF-2 of NEPs derived from younger 
embryonic cortices than E13.5. Qian et al (Qian et al., 2000) observed that younger 
NEPs produce clones with more neurons and fewer OLPs even over 7 days and in 10 
ng/ml FGF-2. However, they did not investigate the response to higher concentrations 
of FGF-2 than 10 ng/ml. Thus, the question addressed by my thesis experiments was 
whether younger (E l0.5, El 1.5, E l2.5) cortical NEPs were intrinsically less responsive 
to the induction of OLPs by increasing concentrations of FGF-2 than El 3.5 NEPs. It is 
possible that some NEPs in the younger populations are more refractory to FGF-2 
signalling than others and therefore that an increase in FGF-2 concentration could 
ultimately induce OLP generation comparable to that in E l3.5 cultures. Alternatively, 
younger NEPs may be intrinsically unresponsive to FGF-2-induced OLP generation at 
any concentration of FGF-2. This was examined using time-lapse microscopy.
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It is important to note that my thesis experiments investigate the dynamics of cell 
division and differentiation in an in vitro setting and over a limited time frame and 
therefore cannot be strictly extrapolated to report on the behaviour of these cells in vivo. 
These time-lapse experiments give data on the potential of the cultured cortical NEPs to 
respond to different concentrations of FGF-2 in these specified culture conditions. 
Whether the cell fate potentials observed in vitro are recapitulated in the live animal 
would need to be answered with in vivo models.
Note. 1: The 01ig2;EGFP transgaiic mouse line was originally constructed in order to perform in vitro analysis o f 
PMN domain cells from E9.5 spinal cords to observe the gen^ation o f  OLPs and Motor Neurons (MNs) using time- 
lapse. This was with the aim o f  determining whether both cell types were always generated from a single oUg2+ 
precursor or whether there are also segregated populations o f  oUg2+ precursors that are dedicated to generating either 
MNs or OLPs, and at what stage in embryonic development might such specification o f OLP-dedicated and 
MN-dedicated precursors occur. However, the culture system proved to be unsustainable. Such early spinal cord 
cells were unable to be kept alive as clonal cultures or dense cultures and explants were unable to be observed in focus 
in the time-lapse set-up.
41
Chapter 2
M aterials and Methods
Unless otherwise stated, all chemicals and reagents where purchased from VWR 
Chemicals limited and were of AnalaR grade wherever possible.
Restriction enzymes and molecular biology reagents were purchased from New England 
Biolabs.
Radio-nucleotides were purchased from Amersham International.
Specialized bacterial media components were obtained from Difco laboratories Ltd, 
Detroit, Michigan, USA.
Most of the molecular techniques described here are taken from Sambrook et al (1989) 
Unless otherwise stated all culture media, foetal bovine serum (FBS), sheep serum and 
supplements were purchased from Invitrogen Life Technologies Ltd.
General chemicals and reagents were obtained from Sigma Aldrich Co Ltd apart from 
Laminin which was purchased from GIBCO BRL Life Technologies and Trypsin from 
Roche Molecular Biochemicals.
Falcon sterile plastic-ware was from Beckton Dickenson
13 mm diameter glass cover-slips were a Chance Propper Ltd product
Human recombinant FGF2 was purchased from ImmunoKontact
The small molecule agonist of Hedgehog signaling (Cur-0188168 or SHH-Agl.2)
(Frank-Kamenetsky et al., 2002) was provided by Curis Inc. Unless otherwise stated, the
working concentrations of reagents were as follows: FGF2, 10 ng/ml (-0.6 nM);
SHHAgl.2, lOOnM.
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2.1 Bacteriology
For general cloning and sub-cloning of recombinant plasmids Escherichia coli (E.coli) 
XL 1-Blue was used. For Phage artificial chromosome (PAC) cloning and sub-cloning 
E.Coli strain EL250 was used. This is a modified DHIOB strain (Gibco) containing 
defective lambda prophage (Yu et al., 2000) and arabinose flpe gene (Lee et al., 2001a),
2.1.1 Growth Media and agar plates
Bacteria were grown in Luria Bertani broth (LB broth; containing lOg Tryptone, 
5g NaCl, 5g bacto-yeast extract (SIGMA) per litre), or on LB agar plates (LB broth + 
30g/L bacto-agar). Solutions were sterilized by autoclaving at 151b/square inch for 20 
minutes and were stored at 4°C. When appropriate Ampicillin (AMP, final 
concentration lOOpg/ml for plasmid transformed bacteria and 20pg/ml for Phage 
artificial chromosome (PAC) transformed bacteria.), Kanamycin (15pg/ml for plasmid 
transformed and 12.5pg/ml for PAC) or Chloramphenicol (30pg/ml for plasmid and 
15pg/ml for PAC transformed) was added to LB broth or LB agar. Antibiotics were 
added to LB broth or LB agar after the temperature had cooled below 55°C. Agar was 
poured into 10cm Petri dishes (Falcon) and allowed to set at room temperature. Plates 
were stored at 4°C and were air dried for 1 hour before use. All XL 1-Blue cultures were 
grown at 37°C and E.Coli EL250 cultures were grown at 32°C. Liquid cultures were 
continuously agitated in a rotating environment shaker at 250rpm
2.1.2 Long term storage of transformed bacteria
Glycerol stocks of bacteria were made by adding glycerol to a final concentration of 
15% (v/v) to exponentially growing cultures and storing at -80°C. These were 
subsequently thawed and used to inoculate LB broth (plus antibiotic where appropriate) 
or streaked onto LB agar plates (plus antibiotic where appropriate) to derive single 
bacterial colonies.
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2.1.3 Preparation of Competent bacterial cells
Transformation of bacteria was done by electroporation of the specified DNA into 
electrocompetent bacteria; E.Coli strain XL-1 Blue or EL250. Electrocompetent cells 
were prepared using the following method (Dower et al., 1988);
To prepare electrocompetent XL-1 blue E.Coli for electroporation, 10ml of Super 
Optimal broth with Catabolite repression (SOC) medium (20% bacto-tryptone (w/v), 5% 
bacto-yeast extract (w/v), 0.5% NaCl (w/v) 2.5mM KCL 20mM glucose, adjusted to 
pH 7.0 with 5N NaOH) was inoculated with Sfil of relevant bacterial suspension from 
glycerol stocks and grown at 37°C in a shaking incubator overnight at 250rpm. 4ml of 
this overnight culture was used to inoculate 400ml of SOC medium and grown at 37°C. 
Samples were removed and the optical density at 600nm (O D ôoo) measured periodically 
until it reached at least 0.5 indicating that the bacteria were reaching the peak of their 
exponential growth cycle (3-4 hours in culture). 16 x 50ml centrifuge tubes were pre­
cooled on ice and the culture decanted into these and allowed to cool for 15 minutes. 
Bacteria were pelleted by centrifugation at 1500 x G for 15 minutes at 4°C in a 
pre-chilled rotator. All the following steps were done in a cold room at 4°C. The 
supernatant was discarded and the pellets gently re-suspended in 25ml of pre-chilled 
ultra-clean (autoclaved) Milli-Q® water. The contents of the 16 tubes were then pooled 
into 8 tubes which were centrifuged again at 1500 x G for 15 minutes at 4°C. The 
supernatant was discarded again and the pellets were washed a second time by adding 
25ml of cold ultra-clean water to each tube and again gently re-suspending the pellets. 
The contents o f these 8 tubes were then pooled into 4 tubes which were again 
centrifuged at 1500 x G for 15 minutes at 4°C. The supernatants were discarded and 
10ml of cold Milli-Q® water containing 10% glycerol (w/v) was added to each tube and 
all suspensions were pooled. 42fû aliquots of bacterial suspension were placed into 
1.5ml pre-cooled cryo-tubes which were then snap-frozen in liquid nitrogen before 
transferring to -80®C for storage. The same protocol was used to prepare EL250 bacteria 
except that the cultures were grown at 32°C and not 37°C.
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2.1.4 Electroporation of competent bacterial cells
Electrocompetent bacteria were transformed with either 2fi\ of a ligation reaction, or 
with a ligation reaction product that had been ethanol precipitated and re-suspended in 
5jLtl of water. The bacteria were thawed on ice and 40fil mixed with the DNA to be 
electroporated. This was added to a pre-cooled (on ice) 0.2cm electroporation cuvette 
(Bio-rad). Electroporation was carried out at 2.5kV (25pFD) capacitance and 2000 
resistance in a Bio-Rad Micropulsar.
Transformed bacteria had 500pl of warm SOC medium added (without antibiotics) and 
were incubated at 37°C before plating onto LB agar plates containing the appropriate 
antibiotic. Whenever it was possible blue-white selection was used to screen for 
recombinant plasmids. This was done when transforming XL 1-blue bacteria with a 
plasmid that provides ^-complementation (pBluescript© II) to the host bacteria’s 
expression of the component of the lacZ operon. Modified plasmids have the 
«-component interrupted since the multi-cloning site interrupts the sequence. For 
blue-white colony screens X-gal and IPTG were added to the LB plates (20pl of 
50mg/ml X-gal in DMF (w/v) and lOOpl of 0.1 M IPTG per plate) to act as substrates for 
any complete LacZ gene product. Transformed bacteria were thus white if ligation into 
the transforming plasmid had been successful but blue where ligation had been 
unsuccessful.
Slight modifications to this protocol were made for electroporation of EL250 Exoli with 
PAC DNA. The addition of PAC DNA to the electrocompetent bacteria and all 
subsequent steps was carried out using wide-bore pipette tips to avoid shearing of the 
DNA. Electroporation was at l.SkV and subsequent recovery time in warm SOC 
medium extended to 2 hours, all incubations with EL250 bacteria were at 32°C not 
37°C, as this lower temperature prevents activation of endogenous flpe activity.
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2.2 Nucleic Acids
2.2.1 Phenol and Chloroform extractions
Plasmid DNA samples to be extracted were made with TRIS-EDTA (TE) buffer (5mM 
Tris, pH 75, 0.5mM EOT A pH 8.0). An equal volume of TRIS pH 7.9-saturated 
phenol-chloroform was added and the mixture was briefly vortexed and then centrifuged 
at 10,000 X G for 10 minutes at 20°C. The upper aqueous phase was removed and re­
extracted with an equal volume of chloroform (containing 4% (v/v) Iso Amyl Alcohol, 
lAA), centrifuged as before and the upper aqueous phase collected. For
phenol-chloroform extraction of PAC DNA some amendments to the protocol were 
necessary. All mixing was done by inversion with no vortexing and the phenol- 
chloroform extraction step was repeated twice before re-extraction with 
chloroform:LAA. The DNA was then ethanol precipitated as described in 2.2.2.
2.2.2 Ethanol Precipitation of DNA
Sodium Acetate (pH 5.3) was added to all plasmid or genomic DNA extractions to a 
final concentration of 0.3M before precipitating the DNA by adding 2 x the volume of 
95% (v/v) Ethanol (ETOH, stored at -20°C). Samples were incubated on ice for at least 
15 minutes before centrifuging at 10,000 x G for 10 minutes. The supernatant was 
discarded and the DNA pellet washed in 70% ETOH and centrifuged again before 
removing the supernatant. The DNA pellets were air dried before re-suspending in an 
appropriate buffer. For ethanol precipitation of PAC DNA no sodium acetate was added.
2.2.3 Small scale plasmid preparation
To isolate 1-2/tg quantities of DNA, XL 1-blue E-coli bacteria were first transformed 
with the specified plasmid (see above for details of transformation). The transformed 
bacteria preparation was then streaked onto LB agar plates containing the appropriate 
selection antibiotic and incubated overnight at 37°C. 2ml of LB broth containing 
antibiotic was inoculated with a single colony of bacteria isolated from the agar plates. 
The inoculated LB broth was incubated with shaking at 250 rpm overnight (16 hours) at 
37°C. The overnight culture was transferred to an eppendorf tube and spun at
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10,000 X G for 1 minute. The supernatant was discarded and the pellet resuspended by 
vortexing in 100/d of Solution I (50mM glucose, 25mM Tris-HCl, pH 8,0 and lOmM 
EOT A pH 8.0). 200/d of Solution II (1% w/v SDS and 0.2N Sodium Hydroxide, made 
fresh each time) was added to each tube and the solutions were mixed by inversion. 
150/d of Solution III (3M sodium acetate, 11.5% w/v glacial acetic acid) was added and 
the lysate mixed by inversion before centrifuging at 1600 x G for 10 minutes. The 
supernatant was transferred to fresh eppendorff tubes and twice the volume of cold 
(-20°C) 99.7% (v/v) ethanol was added to each tube and mixed by inversion to 
precipitate the DNA. The DNA suspension was then centrifuged for 10 minutes at 
1600 X G at 4°C. The supernatant was discarded and the pellet was washed in 200/xl of 
70% ethanol (room temperature) and re-spun for I minute at 1600 x G. The supernatant 
was removed completely and the pellet was air dried and then dissolved in 40/d TE 
buffer.
2.2.4 Large scale plasmid preparation
To prepare > lm g  o f plasmid DNA, 50ml of terrific broth (TB, 12g/L bacto-tryptone, 
24g/L bacto-yeast extract, 4mI/L glycerol, 0.017M KH2 PO4 , 0.072M K2 HPO4 ) with 
appropriate antibiotic was inoculated with 200/d of an overnight culture or with a single 
colony taken from an agar plate. This was incubated overnight, shaking, at 37°C.
The overnight culture was spun at 2000 x G at 4°C for 10 minutes. The supernatant was 
discarded and the pellet re-suspended in 4ml of Solution 1 by vortexing and then 
incubated on ice for 5 minutes. 8ml of fresh Solution II was added and mixed by 
inversion and incubated for a further 5 minutes at room temperature. 6ml of Solution 111 
was then added and they were again mixed by inversion followed by a 5 minute 
incubation on ice. The solutions were next centrifuged at 2000 x G at 4“C for 
15 minutes and the supernatants were filtered through sterile muslin. 17ml of 
isopropanol were added per 50ml of filtrate and mixed by inversion before a further 
cycle of centrifugation at 2000 x G at 4°C for 15 minutes. The DNA was pelleted by 
discarding the supernatant and air drying the pellet before being resuspending in 2ml TE 
buffer and 2.5ml of 4.4M LiCl. This was incubated on ice for 1 hour and then
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centrifuged at 2000 x G at 4°C for 15 minutes. The supernatants were transferred to 
fresh falcon tubes and 9ml of 99.7% (v/v) ethanol was added to each and incubated at 
room temperature for 10-15 minutes to precipitate the DNA. They were then 
centrifuged at 2000 x G at 4°C for 15 minutes, the supernatants removed and the DNA 
pellets washed with 70% ethanol. The 70% ethanol was removed completely and the 
pellets were air dried before resuspending in 400/d of TE. This DNA suspension was 
transferred to fresh eppendorf tubes with 5/d of 4mg/ml DNase-free RNase A and 
incubated at 37®C for 15 minutes. 10/tl of 20% Sodium Dodecyl Sulphate (SDS) was 
then added and incubated at 70°C for up to 10 minutes before phenol-chloroform 
extraction and final DNA precipitation as previously described. The supernatants were 
discarded and the pellets air dried before being resuspended in 200/d of TE buffer.
2.2.5 Large scale PAC preparation
Extra care must be taken in preparing PAG DNA since its large size makes it susceptible 
to shearing. Thus, all mixing was done by inversion with no vortexing and wide bore 
pipettes were used for all pipetting or transfer of the DNA that was done.
400 ml of LB media with antibiotic was inoculated with 500/d from a starter culture 
(EL250 bacteria transformed with FAC DNA grown at 32°C overnight). This was 
incubated at 32°C shaking at 250rpm overnight. After incubation the culture was split 
equally into 8 falcon tubes and centrifuged at 2000 x G at 4°C for 10 minutes. The 
supernatant was discarded and each pellet resuspended in 8ml of FAC Solution I (FI) 
(50mM Tris-HCl, pH 8.0, lOmM EDTA, pH 8.0, 100/tg/ml RNase A) by pipetting with 
a 10 ml pipette. 8ml of fresh FAC Solution 2 (FIT) (0.2N sodium hydroxide, 1% SDS) 
were then added to each tube and this was mixed by inversion. The tubes were incubated 
at room temperature for 5 minutes before adding 8ml of solution FAC Solution 3 (Pill) 
(3.0M sodium acetate, 11.5% w/v glacial acetic acid) which was mixed by inversion 
until all the FII turned white. The suspensions were then incubated on ice for 1 hour 
before centrifuging at 2000 x G at 4°C for 15 minutes. The supernatant was transferred 
to fresh falcon tubes by passing through a double layer of sterile muslin and the filtrate 
was centrifuged at 2000 x G at 4°C for 15 minutes. The supernatant was again
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transferred to fresh falcon tubes and an equal volume of ice-cold isopropanol was added 
to each and mixed by inversion before incubating at room temperature for 5 minutes to 
precipitate the DNA before centrifuging again as before. The supernatants were 
removed completely and the pellets were air dried before resuspending in 0.25ml of TE 
buffer. The resuspended DNA was pooled and then split into 4 eppendorf tubes. The 
DNA suspensions were centrifuged at 16000 x G for 5 minutes to remove any debris and 
the clear supernatants were transferred to 4 fresh eppendorf tubes ready for 
phenol/chloroform DNA extraction followed by ethanol precipitation as previously 
described. The supernatants were discarded and the pellets air dried at room 
temperature until the edges began to look translucent at which point they were 
resuspended in 100/d of Ultrapure Milli-Q® water without trituration (the DNA should 
dissolve completely at room temperature within 10 minutes with occasional gentle 
agitation). Once resuspended, the DNA suspensions were pooled for further use.
2.2.6 Extraction of genomic DNA from mouse biopsy
Mouse genomic DNA was extracted either from small tail biopsies (~3mm lengths taken 
from postnatal mice) or from embryonic tissue. Samples were incubated in 500//1 of 
extraction buffer (lOOmM Tris-HCl, pH 8.5, 5 mM EDTA pH 8.0, 200mM NaCl, 0.2% 
SDS) with 0.48mg/ml of Proteinase K at 55°C overnight. lOOfil of 6M ammonium 
acetate was added to each sample and mixed by vortexing before incubating on ice for at 
least 10 minutes. After centrifuging at 16000 x G at 4°C for 10 minutes the supernatant 
was transferred to a fresh eppendorf, 500/^1 of room temperature isopropanol was added 
and mixed by briefly vortexing before centrifuging again at 16000 x G at room 
temperature for 3 minutes. The supernatants were removed and 500/d of room 
temperature 70% ethanol was added and vortexed briefly before centrifuging for a 
further 3 minutes at 16000 x G. The supernatants were then completely removed and 
the pellets left to air dry before resuspending in 100/zl of TE.
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2.3 Analysis of DNA
2.3.1 Restriction enzyme digests
All restriction enzymes were obtained from New England Biolabs (NEB) and reactions 
were carried out using the appropriate buffer supplied with each enzyme. When more 
than one restriction enzyme was used simultaneously, a buffer was selected that enabled 
optimal activity for both enzymes even if 100% efficiency was not possible for any one 
of them. The buffer selection was based on efficiency ratings found in the NEB 
catalogue. For analytical protocols, 50ng of plasmid DNA was digested in a 10-20/d 
total reaction volume at 37°C for 1 hour. For cloning purposes approximately Ipg of 
DNA was used to enable recovery of sufficient DNA to be used in subsequent steps of 
the cloning paradigm.
2.3.2 Agarose gel electrophoresis
Agarose gel electrophoresis was carried out as described in Sambrook et al (1989). 
Nucleic acid samples were electrophoresed through set gels made up fiom AnalaR grade 
agarose melted in Tris Actetate buffer (TAE) (0.04M Tris, 0.001 M EDTA, 0.35% 
glacial acetic acid) using a microwave. A Horizon 11.14 horizontal gel tank (Gibco 
BRL) was used and was powered by a BioRad Power Pac 300. The voltage applied for 
electrophoresis varied according to the size of the DNA samples (genomic DNA 
samples were run at lOOV, smaller plasmid DNA was run at 150V). Ethidium bromide 
was added to the gels to a final concentration of 0.5pg/ml to enable visualisation of the 
DNA fragments under a UV transilluminator. For gels running plasmid DNA samples, 
ethidium bromide was added before the gels were set. For gels running genomic DNA 
the ethidium bromide was added by soaking the gels in a dilute solution for 15 minutes 
after electrophoresis was complete. This prevents intercalation into the DNA distorting 
the running track of the samples. For the separation of DNA fragments of sizes 
0.1-10 Kb, 1% (w/v) agarose gels were used and 0.8% (w/v) gels were used for 
separation of larger genomic DNA samples. As a standard size marker, 5/d of a 
0.1-10 Kb marker ladder (HyperLadder I Bioline) was run alongside the samples to 
enable the identification of sample fragments of specified sizes. DNA samples to be run
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contained 10% (v/v) loading buffer (10 X stock, 50% (v/v) glycerol, ImM EDTA, pH 
8.0, 0.25% (v/v) bromophenol blue).
2.3.3 Pulse field gel electrophoresis
Pulse field gel electrophoresis (PFGE) was conducted in a BioRad contour-clamped 
homogeneous electric field elecrophoresis cell powered by a CHEF DR II control 
module and CHEF DR II drive module (BioRad). This was used for the separation of 
DNA fragments greater than 10Kb in size. 1% (w/v) agarose gels were made up in 
0.5 X Tris-Borate EDTA (TBE) buffer (45mM Tris Borate, ImM EDTA, pH 8.0) 
without ethidium bromide. As a standard size marker a 2mm plug of Pulse Marker^^ 
(Sigma, 0.1-200Kb) was placed in one of the wells. The samples of PAC DNA were 
loaded with 10% loading buffer (as described in 2.3.2) and were run overnight at 4°C in 
2 litres of 4°C, 0.5 x TBE being continuously circulated over the gel by a peristaltic 
pump. The programme of PFGE used was such that the gel was exposed to 6V/cm 
potential difference with an initial switch time of 2.1 seconds and a final switch time of 
10 seconds and this was run over 12 hours. After the gels were run, they were stained 
with ethidium bromide for visualisation with a UV transilluminator.
2.3.4 Quantitation of double stranded DNA
5fi\ of a 1/10 dilution (in water) of the sample DNA was run on a 1% agarose gel with 
ethidium bromide (as described above) alongside 5fi\ of a standard size marker. 
Hyperladder I (Bioline). When visualised, the levels of fluorescence of bands of 
different sizes indicated the concentration of the DNA fragment when compared to the 
fluorescence of the Hyperladder bands of the same size. This gives sample DNA 
concentrations to within lOng DNA//d which is sufficient for our purposes.
2.3.5 Ligation of fragments
Ligations were performed in 10^1 reaction volumes at 16°C overnight. The fragments to 
be ligated were appropriately digested with restriction enzymes to generate 
complimentary overhanging ends. The digested fragments were quantified as described 
and volumes for use were calculated on the basis that 50ng of vector should be used and
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the insert fragment should be present in a molar ration of 3:1 (insert : vector). The 
quantities of insert fragment to be used were thus calculated using the following 
equation: X = ((50/V) x I) x 3 where X is the quantity of insert fragment required in ng, 
V is the length of the vector in base pairs and I is the length of the insert fragment in 
base pairs. The reaction mix included volumes of vector and insert fragment DNA 
preparations, according to the above calculation, along with \fx\ 10 x T4 DNA ligase 
buffer, IjjX T4 DNA ligase (NEB), 0.5^1 lOnM ATP and made up to 10//1 with Ultrapure 
Mill-Q® water.
2.3.6 Blunt Ended ligation reactions
Blunting of overhanging ends on DNA fragments after restriction enzyme digest was 
done by mixing the DNA with 2^1 of 10 x buffer #1 (NEB), \fû mixed dNTPs (NEB) 
and 1 unit of the Klenow fragment of DNA Polymerase I from E. coli (NEB) per 
microgram of DNA in 20^1 of water. This reaction mixture was incubated at room 
temperature for 15 minutes before inactivating the Klenow by incubation at 70°C for 20 
minutes. These fragments may then be ligated as described above.
2.3.7 Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) was used to; identify orientations of inserts in 
plasmid and PAC vectors, amplify fragments of DNA from plasmids for cloning, 
amplify DNA fragments from constructed DNA cassettes to provide samples for DNA 
sequencing in order to check sequence fidelity and to genotype animals using extracts of 
genomic DNA as a template. Each PCR reaction contained; 2.5fi\ of lOx MgCh-free 
PCR buffer (promega), 2.0/d of 25mM Magnesium Chloride (Promega), 0.25//1 of 
mixed dNTPs (20mM each of dATP, dGTP, dCTP, dTTP, Amersham Biosciences), 
0.1/tl forward primer (100/^M from MWG), 0.1/d reverse primer (lOOptM from MWG), 
0.25/d Taq Polymerase (5/tg//d, Promega). *
The total reaction volume was made up to 23/il with ultra pure Baxter water and then 2/tl 
template DNA preparation was added such that the total reaction volume was 25/tl. The 
reaction tubes were immediately sealed and placed in an MWG-Biotech -Primus 96 PCR
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machine and the required PCR programme was run. The basic programme for the PCR 
was as follows;
Initial denaturing at 94°C for 4 minutes 
Denature again at 94°C for 30 seconds 
Anneal at 53°C for 45 seconds 
Extension of the DNA at 72°C for 1.5 minutes
This denature-anneal-extend cycle was repeated 37 times and then the reactions were 
held at 72°C for 10 minutes before dropping to 4°C for completion of reaction and 
storage.
For hi-fidelity amplification PCR reactions a different reaction mix and PCR programme 
was used. Each reaction contained 5fû of lOx buffer including 25mM MgCb, 0.5fi\ 
20mM dntps, 0.15^1 of each primer and O.lSfxl of HiFi Taq Polmerase (Roche) with Ifd 
template DNA and made up to a total volume of 50/il with Baxter water. The PCR 
programme was also modified to have a reannealing temperature of 65®C for 4 cycles 
followed by a step-down from 64-61°C over 4 more cycles with a final reannealing 
temperature of 60°C for 35 cycles before final extension at 72°C for 10 minutes as 
before.
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Amplification
fragment
Forward primer Reverse primer 
(5’-3’)
Product
size
01ig2
NLSrEGFP
GCC ACA ACG TCT ATA 
TCA TGG CC
TCC TGG GAG TCT CCT 
ACC CCG CC
600bp
3’ h om ology  
region
ATA AGC GGC CGC GCC 
GGC CAG CGG GGG 
TGC GTC CT
GCC CTT AAT TAA CCC 
TGG GCC AGG GAT GAA 
CCT GC
500bp
5’ hom ology  
region
TTG GCG CGC CGT CCT 
CAT TTA TTC CAG GCC 
GO
AGT CCA TGG TCC CAG 
GGA TGA TCT AAG CTC 
TCG
SOObp
NLS:EGFP
CCA TGG CAC CCA AGA 
AGA AGA GGA AGG 
TGG TGA GCA AGG 
GCG AGG AGC T
ACT AGT TTA CTT GTA 
CAG CTC GTC CAT GCC
800bp
Table 2.1 Primer sequences for amplification o f  vector and plasmid fragments.
2.3.8 Preparation of radiolabelled probes
cDNA probes were labelled with by random priming (Feinberg and Vogelstein, 
1984). 25ng of the purified probe DNA was diluted to a final volume of 45/tl of 
Ultrapure Milli-Q® water and denatured at 95°C for 5 minutes before rapidly cooling on 
ice for 2 minutes. It was briefly spun and then added to a reaction tube from the 
RediprimeTM II kit (Amersham Pharmacia Biotech) containing DNA Polymerase 
enzyme, random primers, dATP, dTTP and dGTP. 5jul of radioactive [^^P] dCTP was 
added and the reaction mix was incubated in a shielded container at 37°C for 1 hour to 
allow incorporation of radiolabelled dCTP. The radiolabelled probe was separated from 
unincorporated dNTPs by spin column chromatography (Micro Bio-Spin® P-30 Tris 
chromatography columns, BioRad laboratories). The purified radiolabelled probe was 
then denatured by heating again for 5 minutes at 95°C and then cooling on ice for 2 
minutes.
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2.3.9 Southern blotting
DNA fragment samples to be analysed were first separated in agarose gels in 1 x TAE as 
described above in the absence of ethidium bromide to prevent distortion of the running 
track of the DNA. The samples and a standard marker lane were run at a voltage 
appropriate to the size of the DNA in the samples. After electrophoresis, the gel was 
stained with ethidium bromide and visualised. The gel was photographed alongside a 
ruler such that the positions of different sized DNA fragments could be nominated a 
measurable position on the gel. The gel was then depurinated by soaking in 0.25M HCl 
for 30 minutes at room temperature with constant agitation and then washed in distilled 
water twice before treatment with denaturing solution (0.4M sodium hydroxide, 1.5M 
sodium Chloride) for 30 minutes at room temperature with agitation. After a further two 
rinses with distilled water, the gel was treated with neutralising solution (l.OM Tris, 
1.5M sodium Chloride, 0.5 M EDTA, pH 8.0, adjusted to pH 7.5 with hydrochloric acid) 
for 30 minutes, room temperature with agitation before being washed again as above. 
The gel was then rinsed in 10 x Sodium Chloride Citrate (SCC) (1.5M NaCl, 0.15M 
sodium citrate) in preparation for capillary transfer onto a Hybond XL nucleic acid 
transfer membrane (Amersham Biosciences). The gel was placed in direct contact with 
a nylon membrane optimised for nucleic acid transfer (Hybond^^-XL, Amersham 
Pharmacia Biotech UK Limited), The gel with the membrane layered on top of it was 
placed onto a layer of blotting paper soaked in 10 x SCC. A series of absorbent tissues 
was placed on top and gentle pressure applied overnight. Following transfer the DNA 
was cross-linked onto the membrane via UV irradiation (254nm, 0.15J/cm2) in a 
Stragene UV stratalinker. The cross-linked DNA could then be incubated with a 
specified radiolabelled probe for detection of required sequences. The membrane was 
pre-wetted with 2 x SCC (0.3M NaCl, 0.03M sodium citrate) in a hybridisation bottle 
with the side with the transferred DNA facing the inside of the bottle. It was then 
prehybridised with Salmon Sperm DNA (lOmg/ml stock Helena Biosciences). The 
salmon sperm DNA was denatured by heating for Sminutes at 95°C and then quickly 
chilled on ice for a minimum of 2 minutes. It was then added to 10ml MIB (0.225M 
NaCl, 15mM NaH2 ? 0 4 , 1.5mM EDTA, 10% PEG 8000, 7% SDS) to a final 
concentration of 100/ig/ml. The 2 x SCC was removed and the 10ml of MIB with
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salmon sperm DNA was added. The membrane was prehybridised at 65°C for one hour 
with constant rotation of the cylinder to ensure constant wetting in buffer. The 
denatured probe (prepared as described above) was then added and the bottle was 
re-sealed and rotated overnight at 65°C. After overnight hybridisation with the labelled 
probe the membrane was washed with Wash I solution (2 x SCC, 0.1% SDS) at 65®C for 
15 minutes with constant agitation. It was then washed in Wash II solution (0.1 x SCC, 
0.1 % SDS) at 65°C with agitation for 5 minutes or until radioactivity levels dropped to a 
reasonable and consistent level. The membrane was then transferred to 3mm filter paper 
and blot-dried briefly before wrapping in Saran Wrap and attaching to a fluorescent 
labelled pre-exposed HYperfilm MP (Amersham) which acts as a marker to orient the 
membrane in a sealed light cassette. The membrane was then sealed in a cassette with 
an intensifying screen and an unexposed HYperfilm. This was incubated at -80®C for a 
variable amount of time depending on the expected levels of radioactivity. Plasmid 
DNA contains high proportions of the DNA sequences to be identified and so retains a 
large amount of probe and thus requires only short exposure times of a few hours before 
the film is developed. However, when screening genomic DNA, the fragments of 
interest are in low abundance and thus hybridise very little probe making the signal is 
week and such blots may have to be left for up to two weeks before exposure is 
sufficient to develop the film.
2.3.10 DNA sequencing
DNA was sequenced “in house” using the WIBR Scientific Support Services. DNA was 
prepared and isolated from a small scale preparation as described above. It was washed 
once with 99.7% (v/v) ethanol, then twice with 70% ethanol and diluted in Ultrapure 
Milli-Q® water to a final concentration of at least lOOfmols and 6^1 was required per 
reaction. Before sequencing the DNA solution it was treated with RNase A (1 in 100 
dilution) for 15 minutes at 37°C. The prepared DNA was sequenced using Beckman 
Coulter DTCS quick start kits (Cat No 608120) along with the appropriate primer. All 
sequencing was carried out on a Beckman Coulter CEQ 8000 Genetic Analysis System. 
Primer sequences specific to promoter regions of the plasmids used were as follows 
(from 5’ to 3’);
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M13 Reverse, GGA AAC AGC TAT GAG CAT G 
M13-20, GTA AAA CGA CGG CCA GT
T3,AAT TAA CCC TCA CTA AAG GG; T7, GTA ATA CGA CTC ACT ATA GGG C 
Sp6, ATT TAG GTG ACA CTA TAG
2.4 Preparation of DNA constructs
2.4.1 Isolation of DNA for cloning
After separation of DNA by agarose gel electrophoresis the required band was excised 
from the gel with a clean scalpel. The DNA was extracted from the agarose by placing 
the excised gel band into a length of dialysis tubing filled with Ix TAE and sealing each 
end with clips. This was placed at the negative terminal end of a gel electrophoresis 
tank filled with Ix TAE and subjected to electrophoresis at 120V for 30 minutes. The 
DNA shifts from the gel into the surrounding Ix TAE within the dialysis tubing and the 
gel fragment was removed and the Ix TAE containing the DNA was harvested. The 
DNA was then extracted by one phenol/chloroform extraction followed by one 
chloroform extraction as previously described. The DNA was then ethanol precipitated 
as described. The supernatants were removed and the pellets were air dried before being 
resuspended in either TE or MilliQ® water. The DNA was then quantified in order to 
calculate the volumes that should be used in future protocols.
2.4.2 TOPO© cloning of PCR-amplified DNA fragments
PCR fragments could be reliably and efficiently inserted into a plasmid vector using the 
TOPO© cloning kit (Invitrogen Cat no. K4600-01). The kit includes vector DNA with 
specified modified insert ends (pCR©II-TOPO©) and a topoisomerase enzyme that 
specifically binds to these ends such that they unravel to accept and covalently bind to 
any PCR amplified product that is added. All PCR products have an overhanging 
deoxyadenosine (A) at the 3’end by nature of the activity of Taq Polymerase. The 
linearised TOPO© vector has single overhanging deoxythymidine (T) residues and is 
thus complementary to all PCR products. The Topoisomerase I that is included in the 
kit is covalently bound to the vector making these overhanging ends ‘active’ for
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annealing to and joining with any added PCR product. There are also specific promoter 
and restriction enzyme site sequences either side of the insert site such that the insert 
may be rapidly and reliably cloned by amplification and excision thereafter according to 
the TOPO© instruction manual.
2.5 PAC recombination
2.5.1 Induction of homologous recombination in EL250 Æ.co/f
Homologous recombination was carried out based on the protocol described by Lee et.al 
(Lee et al 2001) EL250 bacteria were first transformed with PAC vector DNA and the 
transformed bacteria were grown, shaking at 250 rpm, overnight in 5ml LB broth with 
12.5peg Kanamycin at 32°C. The overnight culture was then used to inoculate 50ml of 
fresh LB without kanamycin and grown shaking at 32°C until the ODeoo reached 0.4-0.8. 
Homologous recombination between the PAC vector and the linear insert was then 
induced in a sample of the culture by transferring 10ml of the culture to a 42°C water 
bath for 15 minutes to activate the arabinose flpe enzyme. The remainder of the culture 
was kept shaking at 32°C as a control. The 42°C-incubated culture was then rapidly 
cooled by gently agitating on ice for 5 minutes. 10ml of the 32°C uninduced culture was 
also rapidly cooled as a negative control. Both culture samples were then centrifuged at 
2000 X G for 8 minutes at 4°C. The supernatants were discarded and the pellets 
resuspended in 1ml of ice cold autoclaved, Milli-Q® water. Each suspension was 
transferred to a 1.5ml eppendorff tube and spun at 16000 x G for 20 seconds. The 
supernatants were again removed and the pellets washed a second time by resuspending 
in ice cold ultra pure water before centrifuging as above once more. This washing 
process was repeated three times and after the final centrifugation, the pellets were 
finally resuspended in lOOptl of sterile water. This yielded 2 cell populations, both 
containing the PAC vector DNA and one with the bacterial recombination enzymes 
having been activated. Both preparations were then electroporated with 100-300ng of 
the linearised targeting construct prepared as above and the transformed bacteria were 
immediately transferred to 500^1 warm LB broth and they were incubated then at 32°C 
for 90 minutes during which time the homologous recombination should take place in
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the bacteria that had been induced. Each preparation was then plated onto a selection of 
LB agar plates containing either; 15^g/ml chloramphenicol to select for recombined 
PAC DNA, or kanamycin (12.5/ig/ml) as a positive control. These were incubated at 
32°C overnight or over 2 nights if necessary (the DNA load can slow down bacterial 
growth in these preparations). Colonies growing on the chloramphenicol plates 
indicated successful recombination events in these cells and these are the colonies 
picked and selected for expansion by inoculating overnight cultures to make large scale 
PAC DNA preparations ready for Southern blot analysis to be performed to check 
analytically for the expected recombination event.
2.5.2 Removing the chloramphenicol cassette
It was necessary to remove the Chloramphenicol cassette from the successfully 
transformed bacteria before in ovo injection. This is done by employing the Jlpe enzyme 
activity in the EL250 bacteria since the Chloramphenicol cassette is flanked by fr t  sites. 
15ml of fresh LB broth was inoculated with 300/il overnight culture of the recombinant 
bacteria. The bacteria were grown, shaking at 37°C until the OD^oo reached 0.5-0.8 at 
which point sterile arabinose was added to a final concentration of 2% (v/v). The 
cultures were then incubated for 1 hour at 32°C and 1ml was then taken to inoculate 
10ml of fresh LB broth which was then incubated for a further 2 hours at 32°C. This 
preparation was then plated on LB agar plates containing both Ampicillin and 
Chloramphenicol. The ampicillin selects for recombinant bacteria and the 
Chloramphenicol excludes bacteria that have had the gene successfially excised and is an 
indicator of the efficiency of excision. The removal of Chloramphenicol can be 
confirmed by Southern blot analysis of large scale preparations of selected clones. 
Small scale DNA preparations were made from selected colonies as described. 
Recombination events were detected by pulse field gel electrophoresis of a restriction 
enzyme digest of the prepared DNA and analysis by southern blot. Comparisons of 
recombined DNA before and after Chloramphenicol removal should show a difference 
of about 1.3kb in size since this is the size of the Chloramphenicol cassette.
59
2.6 Making the transgenic mice
2.6.1 Linearization of recombined PAC
Transgenesis was achieved by in ovo injection of the linearised recombined PAC DNA 
that includes the transgene. The recombined PAC DNA had first to be amplified by 
making a large scale DNA preparation as described. The PAC DNA was harvested and 
85/il was digested overnight by Pvul restriction enzyme digest. The fragments were 
separated overnight by Pulse Field Gel Electrophoresis as described with the majority of 
the digest being run in the central lane with small sample lanes run either side as 
markers to estimate any drift in the separation across the gel. After the gel was run, the 
marker lanes were cut out and imaged with ethidium bromide such that the position of 
the PAC fragments could be identified without contaminating the main sample which is 
to be used for in ovo injection. The band containing the remnant Vector and that of the 
linearised transgene with up and downstream genomic sequences were identified. Both 
fragments were excised from the central lane of the gel using the marker lanes as 
guidance for their positions within the gel.
The two excised bands were then arranged in a mini gel tray as shown in Figure 2.1 A 
and covered with low melting point (LMP) agarose to be run at 50V for 9hrs at 4°C such 
that the linearised PAC DNA moves completely from the PFGE band into the LMP 
agarose (Figure 2.1 B). After the gel has run, the portion with the vector band was cut 
out and stained with EB to visualise how far the DNA had moved into the LMP gel 
(Figure 2.1 C). This was used to estimate how much of the LMP gel to excise in order 
to isolate the insert PAC DNA. This portion (approx 6mm) was cut out with a clean 
scalpel (Figure 2.1 C) and equilibrated with TENPA buffer (IM Tris-HCl pH7.5 , 0.5M 
EDTA pH 8.0, 5M NaCl) with 30/iM spermine and 70/tM spermidine by continuous 
inversion for 1.5 hrs after which the equilibrated block of gel was transferred to an 
eppendorf. It was melted by incubation at 68*C for 3 minutes in a water bath. It was 
then briefly spun in a microfuge followed by further 5 minutes incubation at 68°C in the 
water bath before being transferred to 42°C for a further 5 minutes. Keeping the bottom 
of the tube in the water bath to maintain the gel in a molten state, jS-agarase was added at
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2 units per 100/zl of molten agarose. This was mixed into the agarose by gentle pipetting 
up to 20 times with a wide bore pipette. The agarose was left to digest at 42°C for
3 hours before returning to room temperature upon which the digest should remain as 
liquid if digestion with the jS-agarase has been complete.
Figure 2.1 Vector and insert DNA bands excised from the pulse field gel and arranged in the 4% 
LMP mini gel (A). Shaded blocks indicate the location of the DNA. The vector and insert DNA 
move from the pulse field gel bands into the LMP 4% gel during electrophoresis (B). Note the 
DNA condenses into a smaller band in the 4% gel immediately adjacent to the excised PFGE 
blocks. Insert DNA is excised (pale block) and the block of vector DNA is visualised to 
determine where the insert block is located relative to the PFGE bands (C). From M. Grist
The PAC DNA in solution was then pipetted directly in equal volumes (~50/tl) using 
wide bore pipette tips onto three dialysis membranes (Millipore, pore size 0.5/zm) which 
were laid floating upon microinjection buffer (IM  Tris-HCL pH7.5, 0.5M EDTA pH 
8.0, 5M NaCL filter sterilised) in a 35mm petri dish containing 30fiM spermine and 
lOpM spermidine. The DNA solution was left to thus dialyse for Ihour at room 
temperature in a flow hood. After dialysis the DNA solution was retrieved with wide 
bore pipettes and stored at 4°C until required for in ovo injection.
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Preceding in ovo injection, the prepared, dialysed PAC DNA must be quantified in order 
to estimate the dilution at which it should be injected. This was determined hy running 
1/d and lOfii overnight by PFGE alongside a standardised PAC DNA preparation. It 
was then microfuged and diluted accordingly with microinjection buffer before in ovo 
microinjection.
2.6.2 In ovo injection and transplantation
Female (B6 x CBA) FI mice of 3-4 weeks of age were induced to superovluate by timed 
injection of follicle stimulating hormone (Folligon, Intervet) at 5pm on nominated day 1 
followed by injection with human gonadotrophin (hCG, Chorulon, Intervet) 45 hours 
later. At 5pm the evening of the injection of hCG when the induction of superovulation 
is complete, the females were mated with (B6 x CBA) FI males and the fertilised eggs 
were harvested the following morning for microinjection of the linear PAC DNA 
construct. On average, by mating 4-6 superovulated females 100-200 fertilised ova may 
be obtained.
These ova are incubated in MI6 medium before and after microinjection and may be 
stored as such over night at 37°C awaiting transfer into the receptive oviducts of 
pseudopregnant females which were prepared 24 hours in advance by mating females 
selected for their natural oestrus with vasectomised males. Microinjection was 
performed by U. Dennehey and P. lanarelli (Richardson Lab, WIBR), This involved the 
injection of the linear PAC DNA construct suspension in microinjection buffer (prepared 
as described above) into the pronuclei of the fertilised ova using a pulled micropipette 
and visualised under Leica microscope. Following injection of the PAC DNA the ova 
were left in MI6 medium at 37°C until they reached the 1 or 2-cell stage. Surviving 1 or 
2-cell stage embryos were then transferred into the oviducts of the pseudopregnant 
females (6-24 weeks old) under hypnorm/hypnovel anaesthetic. The litters horn from 
these recipient females were then analysed for the presence of the PAC transgene 
indicating its successful integration into the genome following the microinjection. 
Successful (B6 x CBA) FI transgenic males were mated with CDl females for timed 
mating.
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2.7 Analysis of mice and screening for transgenes
2.7.1 PCR genotyping
The PCR programme designed to amplify fragments of the transgene was applied to 
genomic DNA extractions obtained from tissue biopsies from putative transgenic litters. 
The primers designed to amplify genomic DNA fragments indicative of the inclusion of 
the NLS:EGFP transgene are in Table 2.1.
2.7.2 Southern blot genotyping
Genomic DNA extractions from tissue biopsies obtained as described were used for this 
purpose. 10^1 of the genomic DNA preparations were used in a restriction enzyme 
digest to yield fragment sizes of 3kb. The digestion mix was run on a 0.8% agarose gel 
and blotted as described above. The positive litter mates were identified using a probe 
that was a radiolabelled 5’ homology region fragment cut with Ncol/Asc and purified 
from the plasmid vector.
2.8 Immunohistochemistry
2.8.1 Tissue fixation and preparation
Embryonic tissue was fixed by immersion in 4% (w/v) Paraformaldehyde (PFA) 
overnight at 4°C. Postnatal animals were first perfused under terminal anaesthetic with 
cold 4% PFA and then spinal cord and brain were dissected out and post fixed by 
immersion in 4% PFA overnight at 4°C. For some antibodies fixation times had to be 
adjusted since some antigens are fixation sensitive (Table 2.2)
After fixation, all samples were then immersed in 20% sucrose overnight at 4°C for the 
purpose of cryopreservation before embedding in OCT and being quickly set by freezing 
on dry ice and stored at -80°C.
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2.8.2 Detection of antigens on tissue sections
Frozen tissue was prepared as described above and cut at ISfxm by cryostat sectioning 
(collected onto SuperFrost plus slides) and left to air dry for 1 hour. The sections were 
then covered in blocking solution (10% foetal calf or sheep serum in 0.1% Triton-X 100, 
Ix PBS) for 1 hour at room temperature. The block was removed before covering the 
slides in primary antibody, diluted in blocking solution (for antibody dilutions see table). 
The slides were incubated in the primary antibody overnight at 4°C. They were then 
washed ( 3 x 5  minutes) in 0.1% Triton-X 100 in xl PBS before adding the appropriate 
secondary antibody (diluted in blocking solution) and left to incubate on the slides for 2 
hours at room temperature. The slides were then washed again as above ( 3 x 5  minutes) 
before counterstaining with Hoechst (lOmg/ml stock at a 1:1000 dilution in 0.1% 
Triton-X 100 in IxPBS) for 5 minutes at room temperature followed by a further wash 
before mounting with Citiflour mounting medium and sealing the slide.
2.8.3 Detection of antigens on fixed cells on coverslips petri dishes
For cell preparations on coverslips or petri dishes, the growth medium was aspirated off 
and 4% PFA was added for 2-20minutes at room temperature before washing briefly by 
immersion into Ix PBS 8-10 times. The protocol for antibody incubation thereafter is 
the same as for the frozen tissue sections. All primary antibodies were diluted in 
0.1% (v/v) Triton-X 100, 10% (v/v) sheep serum in IX PBS at dilutions summarised in 
table 2. For the detection of the cell-surface antigens NG2 and 04  permeabilisation of 
cell membranes must be prevented and thus Triton-X 100 was excluded from both the 
washing solution and the antibody diluents. Fluorescent secondary antibodies were 
applied for 30 minutes at room temperature followed by washing by immersion. Nuclei 
were stained thereafter with Hoescht (sigma 1/1000) for 5 minutes at room temperature 
and following a further wash the coverslips were mounted in Citiflour (City University, 
UK) and stored at 4°C in the dark. For the detection of two antigens for which the 
primary antibodies were both raised in rabbit, a sequential protocol was employed 
whereby the first rabbit primary was ‘masked’ by the subsequent incubation of the 
sections/coverslips with goat anti- rabbit Fab fragments (1/200) for 1 hour at room 
temperature. The antigen may then be visualised by applying a mouse anti-goat
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Cy3-conjugated secondary before adding the second rabbit primary antibody. In these 
instances the antibodies were diluted in 0.1% Triton-X 100, 10% foetal calf serum in 
1X PBS since the mouse anti-goat Cy3 secondary would recognise too many components 
of the sheep serum to give a clear visualisation.
Andbody
Working
Dilution
Supplier
Rabbit anti-Oiig2 IgG 1:4000
DF308, a gift from David 
Rowitch
Rabbit anti-NG2 IgG 1:400 Chemicon
Monoclonal mouse anti-04 IgM- 
conditioned supernatant
1:4
Original cells from Raff lab 
(Sommer and Schachner 
1981)
Mouse anti- MNR2 IgG-conditioned 
supernatant
1:4
Developmental Studies 
Hybridoma Bank (DSHB)
Mouse anti-Panislet IgG 1:10 DSHB
Mouse anti-NeuN IgG 1:500 Chemicon
Mouse anti-Nestin supernatant 1:5 DSHB
Guinea Pig anti-GLAST polyclonal 1:5000 Chemicon
Mouse anti-GFAP IgG 1:400 Sigma
Rabbit anti-GFP 1:6000 AbCam
Rat anti-GFP IgG2a 1:4000 Fine Chemical
Mouse anti RC2 monoclonal IgM 
supernatant
1:4 DSHB
Table 2.2 Antibodies used for immunohistochemical analyses.
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2.9 Tissue Culture
2.9.1 Tissue culture media
Primary cell cultures were grown in modified rat Bottenstein and Sato’s medium 
(Bottenstein and Sato, 1979) as follows:
Dulbecco’s modified Eagle’s medium (DMEM) with Glutamax-1 and sodium 
bicarbonate supplemented with transferrin (0.1 mg/ml), progesterone (60ng/ml), sodium 
selenite (40ng/ml), thyroxine (40ng/ml) triiodo-L-thyronine (30ng/ml), putrescine 
(16^g/ml), insulin (5^g/ml), ImM N-acetyl-L-cysteine, 100/ig/ml 
penicillin/streptomycin and 0.5% foetal bovine serum. Media was further supplemented 
with growth factors where appropriate for different experiments.
2.9.2 Animals
Wild-type mice were of the CDl background (bred in-house at UCL). Transgenic mice 
were generated from a C57B1/6J x CBA/Ca FI (B6 X CBA) background. For breeding 
purposes, male mice were caged with females at 5pm and a vaginal plug was checked 
for the following morning. Fertilisation was considered to have occurred at midnight 
and thus embryonic day zero (EO) was deemed to be the morning that a plug was 
discovered. Noon on the day of discovery of the vaginal plug was designated embryonic 
day 0.5 (E0.5). Mid-gestation embryos were staged according to the morphological 
criteria of Theiler (Theiler, 1972). Pregnant females were culled by terminal anaesthesia 
in CO2 followed by cervical dislocation. The embryos were removed under sterile 
conditions, their stage confirmed by morphology (Theiller 1972) and were culled by 
decapitation.
2.9.3 Conditioned medium
Whole cortices were removed from E13.5 mice embryos and the meningeal membranes 
were mechanically dissected away in Earle’s balanced salt solution (EBSS). After 
coarse mechanical dissection with forceps, the tissue was enzymatically dissociated by
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incubation with trypsin at a final concentration of 0.00625% (w/v) at 37°C for 40 
minutes. DNAse was then added to a final concentration of 52.5/xg/ml and the digest 
was agitated without trituration to break up the tissue. The suspension was centrifuged 
at 1300 X G for 2 minutes, the supernatant discarded and the pelleted cells resuspended 
by gentle trituration in 250/^1 pre-warmed Sato’s. The single-cell suspension was seeded 
onto Poly-D-Lysine (PDL) coated tissue culture flasks in defined Sato’s medium with 
0.5% FBS (v/v) and penicillin/streptomycin (P/S, 200 units/ml Penicillin & Sodium, 
200/ig/ml Streptomycin in 0.85% saline). Primary cultures were grown at high density 
(70% confluency) over 2-3 days in vitro (DIV). The conditioned medium was then 
harvested and filtered through a 0.22 fim filter before being aliquoted and stored at 
-80°C.
2.9.4 Preparation of single cell suspension of cortical VZ cells
Mouse E l3.5 cortices were dissected according to the protocol outlined by Qian et al, 
1997. Briefly, E l3.5 mouse brains were dissected from the surrounding tissue in EBSS 
and the cortices were removed and transferred immediately to DNAse (52.5/^g/ml) with 
Dispase (0.5mg/ml Roche Diagnostics) in EBSS and incubated for 15 minutes at room 
temperature. The meningeal membranes were mechanically removed and the denuded 
cortices transferred to fresh room temperature EBSS for further dissection. The Medial 
and Lateral Ganglionic Eminences (MGE and LGE respectively) were mechanically 
removed and the remaining neocortex was enzymatically dissociated in 0.0625% (w/v) 
trypsin in EBSS for 40 minutes at 37°C. After incubation, the suspension was gently 
agitated to mechanically dissociate the cells in the presence of DNAsel (52.5jttg/ml) 
without trituration and immediately transferred 12ml pre-warmed, room temperature 
DMEM for centrifugation at 1300 x G for 2 minutes. The supernatant was removed and 
the pellet gently triturated with a P I000 pipette 4-6 times in 250^1 37°C, 0.5%-FBS 
Sato’s medium. Sediment and undissociated lumps were left to settle for 2 minutes and 
the cell density of the top fraction of single cell suspension was then calculated using a 
haemocytometer. Appropriate dilutions of the cell suspension were made according to 
the experimental paradigm and the cells were accordingly seeded onto PDL-coated 
(mol. Weight > 300,000) petri dishes or glass coverslips.
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2.10 Time-lapse microscopy
2.10.1 The Time-lapse Imaging system
The time-lapse imaging system is composed of an inverted research microscope (Leica 
HI07 DMIRB or an Olympus IMT-2) equipped with fluorescence and phase or 
brightfield optics. The microscope is contained within a Perspex heat jacket with a 
heater and thermostat keeping the microscope body, lenses and culture dishes at 37°C. 
A custom made adaptor, fitted onto a motorised stage (Prior), fits 3 x 35mm plastic 
culture dishes in airtight grooves directly above the lens. The stage, housed within a 
second Perspex box, is moved to locate fields of interest within the culture dishes. The 
second Perspex housing incorporates a CO2 sensor/controller (International Controlled 
Atmosphere Ltd) which regulates a flow of humidified air fan-mixed with CO2 to 
maintain the environment at 98% relative humidity and 10% CO2 / 90% air (v/v).
Perspex heat jacket
Air passed 
through water to 
be humidified
Motorised stage
Second Perspex 
housing for 3 x 
35mm petri dishes
Figure 2.2 Time-lapse set-up
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2.10.2 Image acquisition
Images were recorded with a chilled digital camera (Hamamatsu 1394 ORCA-285 S/N) 
mounted on the microscope and connected to a computer. Image acquisition was under 
the control of Simple PCI software (DigitalPixel). Both phase contrast illumination and 
epifluorescence were used. EGFP was excited using a mercury arc lamp with a custom 
EGF filter set (Q515LP dichroic and a HQ545/50m emission filter). Standard exciter 
filter sets with accompanying dichroics were used to enable visualisation of Rhodamine, 
Texas Red, FITC or CY5-conjugated secondary antibodies with narrow band-passes (all 
filter sets and dichroics from Chroma Technology). The Simple PCI software was used 
to control all motorised functions of the microscope; time-lapse interval and duration, 
image properties (exposure, resolution) and logging up to 100 fields of interest by 
assigning x,y,z coordinates and controlling image capture at each of these positions 
every 15 minutes until the end of the experiment. After recording, the cells were fixed 
and prepared for immunocytochemistry. Image capture of antigen expression was 
performed within the timelapse set up. It was not necessary to use 
immunocytochemistry for EGFP detection since its fluorescence barely quenches even 
after fixation.
2.10.3 Analysis of timelapse recordings
For each position in the culture dishes a cdx file was created which contained a series of 
images taken at 15 minute intervals compiled as a film of that position over the course of 
the experiment. Analysis of these cdx files was performed using the Simple PCI 
software which enables the progression through each film in a frame by frame manner. 
In this way, each clone could be traced through the course of the experiment and a 
lineage tree determined by observing all of the divisions that occurred and following 
each daughter cell that was derived. The timing of each cell division observed within a 
clone could be determined to an accuracy of within 15 minutes. The total number of 
daughter cells yielded could also be determined and the antigenic identity of surviving 
cells was accounted for by immunocytochemical analysis. Some clones were too 
complex for accurate lineage analysis and cells may also migrate out of the recorded 
field of view. Lineage trees are therefore not described for every cell filmed.
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EGFP expression was visualised directly in live cells in transgenic cultures. 
EGFP-expressing and EGFP-negative cells were traced throughout the recording as 
described above, and in addition the time at which EGFP appeared was also logged.
Each experiment yielded large numbers of cells that were filmed and traced to the end. 
High n-numbers within experiments allowed statistics to be applied to determine 
significant differences in division times of cells grown in different experimental 
conditions. Statistical significance between experiments was also tested to ensure 
consistency and repeatability.
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Chapter 3
OUg2 Transgenesis
3.1 Introduction
3.1.1 Chapter overview
in order to study the generation of oligodendrocyte precursor cells (OLPs) in vitro by 
time-lapse microscopy, a transgenic mouse was generated that expresses enhanced 
green fluorescent protein (EGFP), an engineered form of green fluorescent protein 
(Chalfie et aL, 1994;Chalfie, 1995) under the same transcriptional control as the 
basic-helix-loop-helix (bHLH) transcription factor oHg2 {oligodendrocyte lineage 
transcription factor  2).
3.1.2 Introduction to oUg2
bHLH transcription factors are characterised by a conserved basic-helix-loop-helix 
protein motif which is comprised of two ohelices and an intervening loop. bHLH 
proteins recognise and bind to a consensus hexanucleotide DNA sequence called an 
E-box (Ferre-D'Amare et al., 1993;Ma et al., 1994). They act as dimers, with amino 
acid residues within the bHLH region being responsible for both dimérisation and 
DNA-binding specificity. Residues in both helices are important for dimérisation, 
whereas helix 1 and the loop region are involved in DNA sequence recognition (Nair 
and Burley, 2000). bHLH factors are involved in the development o f diverse organ 
systems including muscle, the haematopoietic system and the central nervous system 
(CNS). While most bHLH factors in the CNS are involved in development of 
neurons, oligl and oUg2 are additionally involved in specification of 
oligodendrocytes. The olig genes form a distinct family of bHLH transcription 
factors, distinct from their proneural counterparts such as neurogenin-1 or mash-1. 
Oligl and 2 are 78% similar at the amino acid sequence level including particular 
amino acid clusters at their N- and C-termini (Zhou et al., 2000). The majority o f the 
conserved residues lie mainly in the helix portions of the bHLH motif. Since their
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loop regions have minimal amino acid sequence similarity, they likely bind to 
different DNA sequences (Takebayashi et al., 2000) although this has not been 
formally demonstrated.
Oligl contains 2 exons in a transcript 3.13 Kb in length (ensemble v.40) and is found 
on mouse chromosome 16 about 50 Kb upstream of oligl. In the spinal cord it is 
first expressed strongly in the ventral third of the spinal cord at embryonic day 9.5 
(E9.5) and becomes restricted to a tight band defining the motor neuron progenitor 
(pMN) domain by E l0.5. 0/*g2-expressing cells disperse dorsolaterally from E l2.5 
(Lu et al., 2000;Zhou et al., 2000) and by E l8.5, the entire spinal cord is populated 
with oligl+  cells. Oligl has a similar, but more dynamic expression profile than 
oligl in the spinal cord; it appears 12 hours later and at a much lower and 
progressively decreasing intensity, such that by E l0.5 it has declined to nearly 
undetectable levels although it reappears at E l2.0 in the same, restricted pMN 
domain as oligl (Zhou et al., 2000). In the brain, oligl is initially restricted at E l2.5 
to a ventral domain in the ventricular zone (VZ) of the forebrain, midbrain and 
hindbrain before oligl+  cells disperse fi-om E l4.5 onwards. By E l9, the entire 
forebrain is populated witb oligl+  cells although not all of these originate fi-om the 
early ventral sources (Kessaris et al., 2006).
These patterns of olig gene expression correspond to the oligodendrogenic zones of 
the early embryo (Lu et al., 2000) as defined by platelet-derived growth factor 
receptor-a (PDGFRo) expression which labels OLPs (Hall et al., 1996;Pringle and 
Richardson, 1993). Indeed many oHg2+ neuroepithelial cells (NEPs) give rise to 
oligl+  OLPs as confirmed by co-localisation with known OLP markers such as 
PDGFRa and soxlO (sex determining region Y homeobox 10) by in situ 
hybridisation (Zhou et al., 2000). Furthermore, since oligl-miW mice lack all 
oligodendrocyte lineage cells (and motor neurons) in the spinal cord, a required role 
in early stages of oligodendrocyte development is indicated (Lu et al., 2002;Park et 
al., 2004;Takebayashi et al., 2002;Zhou and Anderson, 2002). Furthermore, a recent 
paper by Sun et al (Sun et al., 2006) demonstrates that ectopic oligl expression (via 
the electroporation of an o//g2-containing vector to the dorsal spinal cord) leads to 
ectopic expression o f soxlO  followed by mature oligodendrocyte markers (MBP and
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PLP), providing evidence that oligl is upstream of sox 10 in the genetic hierarchy 
leading to myelin gene expression.
In oligl-nxiW mice, OLP production is unaffected, but expression of myelin-forming 
genes in maturing oligodendrocytes is prevented (Xin et al., 2005). Thus oligl may 
have a more significant role in the postnatal rather than the developing animal. This, 
along with the more dynamic nature of oligl expression with respect to that of oligl 
means oligl is likely to he a better marker for identifying multipotent NEPs that are 
involved in early OLP specification. In addition, unlike the expression profiles of 
most bHLH transcription factors, which are generally downregulated during cell 
differentiation, oligl persists in mature oligodendrocytes (Lu et al., 2000) and so it 
marks all cells o f the oligodendrocyte lineage from the precursors o f OLPs to the 
mature, differentiated cell. To identify neuroepithelial precursor cell (NEP)-derived 
lineages in which OLPs are specified, I generated a transgenic mouse line that 
expresses EGFP under oligl transcriptional control, thus allowing visualisation o f all 
oligl+  cells via EGFP fluorescence.
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3.2 RESULTS
3.2.1 Screening of the PAC library for 0//^2-containing clones
Although much is known about its expression profile, the regulatory elements 
involved in controlling oUg2 expression have not been described. Therefore, in order 
to create a transgenic mouse line that would faithfully transcribe an expression vector 
in the same pattern as oHg2, phage artificial chromosome (PAC) transgenesis was 
employed to enable insertion into the mouse genome of large regions of DNA that 
could include all potential regulatory elements required for authentic oUg2 
expression (Lee et ah, 2001).
The isolation of PAC clones that included an o%2-containing fragment was kindly 
performed by Mat Grist and Nicoletta Kessaris. A gridded PAC library (RPC121) 
from the UK HGMP Resource Centre was screened for o//g2-containing clones using 
a 300 bp probe isolated by EcoRI/Smal restriction digest. The probe consisted of a 
fragment spanning the 5 ’ untranslated region (UTR) and 200 bp of the oUg2 open 
reading frame (ORF). Three clones were isolated and characterised by restriction 
enzyme mapping and pulse field gel electrophoresis (PFGE) (Figure 3.1). Inverse 
polymerase chain reaction (PCR) cloning and DNA sequencing o f the ends of the 
insert mapped the extremities o f the oUg2 fragment precisely. PAC clone 
RPC121 512-G7 (named PAC-G7 herein) was chosen for further use -  a 178 Kb 
clone including the olig2 ORF with 140 Kb upstream and 38 Kb downstream 
sequence. This clone excluded oligl while including large regions upstream and 
downstream o f the oUg2 open reading frame (ORF) likely to include all the 
regulatory elements involved in endogenous oUg2 expression.
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Novel Histone H3 
1
Notl
1
Notl Noll 
4  2 2 k b . ^ |  1 1
Olig2
140kb 30kb
50kb
PAC RPC121-438-M11
'jLA
PAC RPC121-512-G7
PAC RPC 121-593-18
Figure 3.1 Schematic of the genomic region around the oUg2 locus including Notl sites and other known genes within this region 
{qligl 50Kb downstream, and a novel Histone-coding sequence 130 Kb upstream of the oHg2 locus -  ensemble v.40). The relative 
positions of the o%2-containing fragments contained within three PAC clones identified by library screening are shown with oligJ 
indicated in pink and the novel Histone H3 in blue. The lengths of these fragments were predicted by the genomic mouse sequence 
fhttp://www.ensemble.org/) after the extremities were precisely mapped by inverse PCR. PAC RPC121-512-G7 was selected for 
modification and transgenic mouse production.
3.2.2 Construction of the NLS-EGFP transgenc
A targeting vector was constructed to replace the oUg2 exon in the PAC-G7 vector 
with the sequence for nuclear-localising signal (NLS)- tagged EGFP (NLS;EGFP) 
(Tsien, 1998a;Tsien, 1998b). A diagram of the targeting construct is shown in 
Figure 3.2. Along with the sequence for EGFP, it included a chloramphenicol 
resistance cassette, 382 bp of sequence upstream of and including the oUg2 ATG 
initiation codon and 490 bp of oUg2 sequence downstream of the stop codon. The 
endogenous ATG sequence was included to maximise the likelihood that the 
targeting construct would be expressed under the same regulatory control as 
endogenous oUg2. This 5’ homology region was further designed to include an Ncol 
restriction site at the endogenous ATG codon and an AscI restriction site at its 5’ end 
in order to facilitate cloning. The 3’ homology region was designed to include a 
Notl restriction site at its 5’ end and a P ad restriction site at its 3’ end for the same 
reasons. Both the 5’ and 3’ homology regions were amplified by PCR from PAC-G7 
DNA using the programme detailed in Chapter 2, Section 2.3. The primers used 
were:
5’ homology forward primer:
5'-TTGGCGCGCCGTCCTCATTTATTCCAGGCCGG-3' highlighted Ascl site 
5’ homology reverse primer:
5’-AGTCCATGGTCCCAGGGATGATCTAAGCTCTCG-3’ highlighted Ncol site 
3’ homology forward primer:
5 ’-ATAAGCGGCCGCGCCGGCC AGCGGGGGTGCGTCCT-3 ’highlightedNotl 
site
3’ homology reverse primer:
5 -GCCCTTAATTAACCCTGGGCCAGGGATGAACCTGC-3 ’highlighted Pad 
site
The PCR products were isolated by agarose gel electrophoresis and purified 
(Chapter 2, Section 2.3) before being cloned directly into pCRII-TOPO® for DNA
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sequencing. Once the sequences were confirmed, the 3’ homology fragment was 
isolated from the TOPO plasmid by Notl/PacI digest and ligated into the 
pBluePacAsc plasmid to create pBluePacAscB’h (Figure 3.3).
EGFP coding sequences were amplified from the pBird plasmid (Figure 3.4) using 
Expand High Fidelity Taq Polymerase (EHFTP) (Roche) with primers that 
incorporated an NLS and an Ncol restriction site at the 5’ end and a Spel restriction 
site at the 3’end of the EGFP. The primers used were:
Forward primer:
5’-
CCATGGCACCCAAGAAGAAGAGGAAGGTGGTGAGCAAGGGCGAGGAGC 
T-3’ highlighted Ncol site
Reverse primer:
5 ’-ACTAGTTTACTTGTACAGCTCGTCCATGCC-3 ’ highlighted Spel site
In order to select positively for recombinant clones a chloramphenicol resistance 
cassette (Cm* )^ was included in the construct, inserted between the NLS:EGFP 
sequence and the 3’ homology sequence (Figure 3.2 C). This was obtained by Notl 
digest from the pI22 plasmid constructed and donated by P. lannarelli (Figure 3.5). 
The chloramphenicol resistance cassette includes flanking fr t  sites to allow its 
removal from the targeting vector prior to pronuclear injection. All the vector 
components were sequenced to ensure nucleotide sequence fidelity.
The components were individually isolated by appropriate digest and ligated together 
sequentially. The Cm*^  fragment was first ligated into the pBluePacAsc3’h 
(Figure 3.6) and the NLS:EGFP and the 5’ homology fragments were then added as 
shown in Figure 3.7.
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B) 0Hg2 ORF 
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Figure 3.2 A) PAC 512-G7 showing the regions upstream (5’) and downstream (3’) of the oHg2 locus. The oUg2 ORF is shown along with Notl 
restriction sites and the novel Histone coding sequence found upstream. B) Schematic of the oUg2 ORF with flanking genomic sequences to include 
some key restriction sites. C) Schematic of the linearised targeting vector pNLS:EGFP used in homologous recombination via the 5’ and 3’ regions of 
homology (homology sequences and sites of recombination with the oHg2 ORF sequence shown as grey boxes and grey dotted lines). The NLS:EGFP 
sequence and the chloramphenicol resistance cassette (Cm*^ ) are shown (blue/green and yellow boxes respectively) and the Cm*^  is flanked by frt sites 
used for its removal before pro-nuclear injection.
pBluePacAsc3'h 
3436 bp
Figure 3.3 pBluePacAsc3’h 
plasmid generated by ligation o f  
3 ’ homology fragment into 
pBluePacAsc via Pacl/Notl 
digest. The restriction sites 
involved in this ligation are 
highlighted by black boxes
pBird 
5483 bp
Figure 3.4 pBird plasmid 
containing an EGFP cassette, 
which was used as a template to 
amplify EGFP.
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PI22 frtCmRfrt 
4330 bp
plasmid
Cm"
Figure 3.5 pI22
containing the
chloramphenicol resistance 
cassette flanked by f r t  sites. This 
plasmid was kindly designed and 
made by Palma lannarelli and 
was used to isolate the 
ykf-flanked Cm" fragment via 
Notl/Spel digest. The restriction 
sites are highlighted by black 
boxes.
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Figure 3.6 Construction o f  the pBluePacAscCmR3’h vector. The first step was the 
isolation o f  the Cm'  ^ cassette flanked by f r t  sites from pI22 (se Figure 3.5) by Notl 
blunted digest (using DNA  Polymerasel Klenow fragment) along with Notl blunted 
digest o f  pBluePacAsc3’h (sites highlighted by black boxes). This linearised 
pBluePacAsc3’h and released the Cm*^  fragment. The two were then ligated to generate 
pBluePacAscCmR3 ’h.
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pBluePacAscCmR3'h 
4842 bp
Am'
SpeiyAscISpel/A sc
Li; ate
pBluePacA sc-5'hN L S:EG FPC m R 3'h  
SS91 bp
P l w l  ■ J559
by ligation o f  
This was done by
Figure 3.7 Construction o f  the NLS:EGFP targeting vector 
pBluePacAscCmR3’h with the 5 ’ homology and NLS.EGFP fragments, 
restriction enzyme digestion with Spel and A scl as highlighted by black and red boxes 
respectively. This generated the complete targeting vector named
pBluePacAsc5’hNLS:EGFPcmR3’h - named pNLSiEGFP.
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Component Digest Fragment size
5’ homology Ascl/Ncol 500 bp
NLSiEGFP Spel/Ncol 800 bp
Chloramphenicol resistance 
cassette (Cm^)
Notl 1.2 Kb
3’ homology Notl blunted/PacI 490 bp
Table 3.1 Table showing restriction enzyme digests used to isolate the different components 
of the NLS:EGFP construct. The expected sizes of the isolated fragments containing the 
sequence of interest are also shown.
3.2.3 Homologous recombination
Homologous recombination (Lee et al., 2001) was first employed to replace 
unwanted elements in the vector backbone with an ampicillin resistance cassette. 
This was kindly performed by N.Kessaris and colonies selected for ampicillin 
resistance were selected for further use.
Homologous recombination was employed again to replace the oUg2 ORF in 
PAC-G7 with the NLSiEGFP cassette via the designed 5’ and 3 ’ regions of 
homology (Figure 3.2 B,C). To do this, the targeting vector, pNLS:EGFP 
(pBluePacAsc5’hNLS:EGFPCmR3’h; Figure 3.7), was linearised with Pvul and 
isolated by gel electrophoresis. The purified fragment was electroporated into 
PAC-G7-containing EL250 bacteria and recombined clones were identified by 
chloramphenicol selection. Removal of the chloramphenicol resistance cassette from 
recombined clones was subsequently carried out by arabinose induction of 
endogenous flpe  activity. Removal of the resistance cassette was confirmed by 
Southern blot analysis which detected an 800 bp shift (Figure 3.8) using a probe that 
spans the 5* homology region o f the oUg2 ORF.
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Figure 3.8 Southern analysis following Bglll restriction digest of DNA from modified 
PAC 512-G7 clones before and after Cm*^  cassette removal. The digests were probed with a 
labelled fragment that is complementary to the oUg2 5’ homology from the targeting vector. 
The first lane is a sample of unmodified PAG 512-G7 vector DNA containing the olig2 ORF. 
Samples 1 -5 were prepared ifom modified clones after Cm*^  cassette removal by flpe activity. 
Samples 1 4’ are the corresponding PAC 512-G7 clones before Cm*^  removal.
83
3.2.4 Pronuclear injection of the modified vector construct
The isolated and purified construct was dialysed with microinjection buffer 
(Chapter 2, Section 2.6) and then quantified (Figure 3.9). The prepared DNA was 
injected at a concentration of ~1 ng/pl into the pronuclei of fertilised eggs which 
were transferred to recipient mothers by U. Dennehy and P. lannarelli.
Figure 3.9 Quantification o f  purified, 
linearised constmct DNA for 
microinjection. In order to quantify the 
relative concentration o f  the test sample, 1, 
5 and 10 gl o f  the purified linearised 
construct DNA were run alongside a 5 gl 
sample o f  a standard preparation (Std) o f  
PAC DNA which had previously been 
used successfully for microinjection. The 
DNA was diluted accordingly for 
microinjection.
5 lil I (jl\ 5 fû 10 /xl 
Std
3.2.5 Screening founder litters for the presence of NLS:EGFP
Pups bom from the recipient mothers were first screened for the presence of the 
transgene by PCR using genomic DNA as a template. The PCR primers were 
designed to amplify sequences only if the transgene was present, the forward primer 
being specific to a sequence in the EGFP fragment of the transgene, and the reverse 
primer specific to a sequence in the oHg2 3’ homology region.
Forward Primer:
5’- GCCACAACGTCTATATCATGGCC-3'
Reverse primer;
5 ’ -TCCTGGG AGTCTCCT ACCCCGCC-3 ’
PCR analysis identified 13 pups that contained the transgene (Figure 3.11) and this 
was checked by Southern blot. A probe specific to the 5’ homology region was 
applied to sample genomic DNA digested with Bglll. Six of the PCR positives were
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confidently confirmed to contain the transgene by Southern blot; 23/3, 24/3, 26/6, 
27/1, 27/2, 31/1 (Figure 3.12). However, founders 24/3 and 27/2 appeared to have 
weak expression and so were not used for initial characterisation of the transgenic 
lines.
+ /+  -/-  25/1 25/2 25/3 25/4  25/5 25/6 24/1 24/2 24/3 23/1 23/2  23/3 23/4 26/1 26/2 26/3  26/4 26/5  26/6
HjO +/+ 27/1 27/2 28/1 28/2 29/1 29/2 29/3 29/4 29/5  29/6  30/1 30/2  30/3  30/4 31/1 31/2  31/3  31/4 31/5
Figure 3.10 Genotyping by PCR of mouse litters bom from microinjected eggs. Mice 23/1, 
23/3, 24/3, 25/6, 26/1, 26/4, 26/6, 27/1, 27/2, 29/4, 30/4, 31/1 and 31/5 all showed a specific 
band at 600 bp that was strong enough to be confident that the PCR detected the presence of 
the transgene. Diluted modified PAC 512-G7 DNA was used as a positive control (+/+) and 
wild type mouse DNA (-/-) and water (H2O) were used as negative controls. The forward 
primer was specific to a sequence in the EGFP fragment of the transgene, and the reverse 
primer specific to a sequence in the oUg2 3’ homology region
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Figure 3.11 Southern analysis of genomic DNA for genotyping of putative transgenic founder mice. Genomic DNA obtained by tail 
biopsy was digested with Bglll. The blot was hybridized with a labeled 500 bp probe that was complementary and hybridised to the 
5’ homology region found in both the targeting vector and in genomic oUg2. The expected wild type band can be seen in all samples 
at 900 bp. As a positive control, a sample of genomic DNA spiked with modified PAC 512-07 DNA was used and a 3.1 Kb band 
was, representing a fragment including the transgene with the Cm"^  still present. Samples from the putative founders all had the 
endogenous band at 900 bp and samples 23/3. 24/3, 26/6, 27/1, 27/2 and 31/1 also had the transgenic band at 2.3 Kb (no Cm"^ ).
3.2.6 Characterising the expression of the NLS:EGFP transgene in the spinal 
cord
OUg2 and EGFP expression in the embryonic spinal cord
Expression of the EGFP transgene in founder mouse lines was characterised to 
assess whether it faithfully recapitulated that of endogenous oHg2. As a control, wild 
type mice were harvested at E10.5, E12.5 and E16.5 and analysed for the presence of 
endogenous 01ig2 protein by immunohistochemistry. As expected, 01ig2+ cells 
were seen in a restricted domain (pMN) at E l0.5, dispersed dorsolaterally from 
E12.5 onwards and distributed throughout the spinal cord at E16.5 (Figure 3.13).
EGFP expression was assessed in E l0.5, E l3.5 and E l6.5 oHg2-EGFP mice and 
compared with expression o f 01ig2 protein. At E l0.5, like 01ig2+ cells, EGFP+ 
cells were seen in a tight band in the ventral part o f the spinal cord corresponding to 
the pMN domain (Figure 3.14 A). At this age EGFP was present both in the cytosol 
as well as in the nucleus o f expressing cells (Figure 3.14 A inset). Like endogenous 
01ig2+ cells, EGFP+ cells dispersed through the spinal cord from E l3.5 onwards 
with a high density of EGFP+ cells maintained at the pMN domain (Figure 3.14 B 
inset 1). They became uniformly distributed throughout the spinal cord by E l6.5 
(Figure 3.14 C). At these later embryonic ages EGFP was exclusively nuclear 
(Figure 3.14 B inset 2) demonstrating the effectiveness o f the NLS associated with 
the transgene.
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Figure 3.12 0Ug2 expression in the developing embryonic murine spinal cord as detected by immunohistochemistry. At E9.5 the spinal 
cord is already segregated into tight domains o f  transcription factor expression (A). O lig l is expressed within the pMN domain at this 
stage and remains restricted until E l0.5 (B). From E l2.5 (C) onwards some 01ig2+ cells disperse dorsolaterally (arrows) from the pMN 
domain, but a concentrated region o f o/ig2-expressing cells within the pMN domain remains (inset). The dispersal continues from E12.5 
and the spinal cord contains 01ig2+ cells throughout from around E l6.5 (D).
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Figure 3.13 EGFP expression in transgenic embryonic spinal cords in different founders as 
assessed by immunohistochemical identification o f  EGFP protein. At El 0.5 (A), EGFP was 
seen in a restricted band corresponding to where the pMN domain is located. This was true 
for all founder lines analysed, three o f  which are shown here. The EGFP expression at this 
age was diffuse, being located in the cytosol o f  expressing cells (inset). At El 3.5 (B), like 
endogenous 01ig2 protein, EGFP was found in cells dispersing away from the pMN domain 
(arrows) with a h i^  density o f  EGFP+ cells still persisting at the pMN domain (inset 1 for 
26/6). Unlike at E10.5, however, by E13.5 the EGFP has been translocated to the nucleus 
o f  expressing cells (inset 2 for 31/1). By E16.5 (C) the spinal cord is populated with EGFP+ 
cells.
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In order to confirm that the EGFP co-localised with 01ig2 protein, double-labelling 
with anti-01ig2 and anti-GFP antibodies was carried out. Immunohistochemical 
analysis was used, since the in situ hybridisation probes for EGFP gave a low, 
unreliable signal. At E10.5, 01ig2 and EGFP were found in the same cells although 
nuclear accumulation of EGFP lagged behind that of 01ig2 (Figure 3.14 A). This 
was true for the three founder lines analysed. At E l3.5 however, not all Qlig2+ cells 
expressed EGFP. 01ig2+/EGFP- cells were seen predominantly in or near the 
ventricular zone (VZ) (Figure 3,14 B inset and C) and are likely to be due to a delay 
in EGFP transcription and translation relative to that of oUg2, This notion is 
supported by the finding that 96 +/- 2% of older, migrating 01ig2+ cells expressed 
EGFP. At E16.5, there were 01ig2+/EGFP+ cells distributed throughout the spinal 
cord (Figure 3.15). However, there was a difference in the extent of 01ig2/EGFP 
co-localisation in the dorsal and ventral portions of the spinal cords. 93 +/- 6% of 
01ig2+ cells in the ventral cord co-expressed EGFP, while, in the dorsal cord, only 
68+ /-7%  of 01ig2+ cells were EGFP+ (Figures 3.15 and 3.16), This might be 
attributed to the absence of a regulatory element in the transgene that is specifically 
responsible for oUg2 expression in dorsally-derived OLPs. Alternatively, the 
01ig2+EGFP- cells might be younger 01ig2+ cells that have not upregulated the 
transgene-derived EGFP at this time.
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Figure 3.14 01ig2/EGFP co-localisation in transgenic spinal cords at different embryonic 
ages, as detected by immunohistochemistry. A) At E l0.5 01ig2 and EGFP were expressed 
strictly within the pMN domain with 100% overlap, although EGFP fluorescence was more 
diffuse than for 01ig2 since the protein was present in the cell cytosol as well as in the 
nucleus. At E l 3.5 (B,C) 96 +/- 2% o f migrating 01ig2+ cells were EGFP+. 01ig2+/EGFP- 
cells were mostly found near the pMN domain as shown in panel B (arrows). There were 
also some EGFP+/01ig2- and EGFP+/weakly 01ig2+ cells at E l3.5 (C arrows). These were 
mostly found migrating ventrolaterally (solid arrows) or around the ventral white matter 
(dotted arrows).
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Figure 3.15 01ig2/EGFP co-localisation in transgenic E16.5 spinal cord, detected by immunohistochemistry. 68% o f 01ig2+ cells 
were EGFP+ in the dorsal half o f the spinal cord (inset 1 and 2) while there was 93% co-localisation in the ventral cord (inset 3).
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F ig u re  3 .1 6  Distribution o f  Oiig2+/EGFP+ cells in the dorsal and ventral halves o f  El 6.5 
transgenic spinal cords in which there was an apparent discrepancy in co-localisation in 
these two regions. 93 +/- 7% o f  01gi2+ cells were EGFP+ in the ventral spinal cord, 
68 +/- 2% p f 01ig2+ cells were EGFP+ in the dorsal spinal cord. This suggests that the 
dorsal expression o f  oUg2 is not mimicked by the transgene. Percentage o f  
01ig2+/EGFP+ cells is relative to the total number o f  OIig2+ cells identified. Data is 
presented as mean +/- standard error mean from 3 animals, 3 sections analysed from each, 
all from founder line 26/6.
EGFP protein persists in early motor neurons after oUg2 down-regulation
Som e E G F P +/01ig2- ce lls  w ere identified in, or c lo se  to, the ventral horns o f  the 
spinal cord (Figure 3 .1 4  D ). S ince this is where m otor neurons reside, it seem ed that 
these ce lls  m ight b e m otor neuron precursors in w hich oUg2 and EGFP transcription  
had dow n-regulated, but EGFP protein had not yet been degraded. This is a likely  
possib ility  sin ce EGFP has a h a lf  life  o f  m ore than 20  hours in liv e  ce lls  (Corish and 
Tyler-Sm ith, 1999), but the h a lf life  o f  01 ig2  is lik e ly  to be m uch shorter. To 
confirm  this idea, E l 3.5 spinal cords w ere subjected to double-labelling for EGFP 
and M N R 2, an early marker for m otor neurons (Tanabe et al., 1998). This revealed  
co-expression  o f  these tw o markers in the ventral horns at E 13.5 (Figure 3.18 A -D )  
although there w as no co-localisation  at E l4.5 (Figure 3.18 E-G). OUg2 is expressed  
in m otor neuron precursors, but rapidly downregulated in post-m itotic m otor neurons 
(N ovitch  et al., 2 0 0 1 ) and since EGFP fluorescence is also absent by E l 4 .5  it appears 
that EGFP is transcribed and translated in parallel w ith  oUg2, but that EGFP protein  
persists longer than 01 ig2  after m R N A  synthesis has stopped.
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Figure 3.17 (above) M NR2 co-localisation with EGFP in the E l 3.5 and E l4.5 murine 
transgenic spinal cord. B y E l 3.5 motor neurons have been generated and have migrated to 
the ventral horns (A). Co-localisation between MNR2 and EGFP is seen in clusters o f  motor 
neurons in the ventral horns (arrows, B), There were also EGFP+/MNR2- cells (arrow 
head, B) which were presumably migratory OLPs. B y E l4.5 (C) there was no 
co-localisation between M NR2 and EGFP indicating degradation o f  the EGFP protein in 
motor neurons by this time. There were obvious M NR2+ cells (dotted arrows) which were 
EGFP- and also some EGFP+ cells that are not M NR2+ (arrow) which were, again, 
presumably migratory OLPs. Founder lin e  26 /6 .
3.2.7 Characterising the expression of the NLS:EGFP transgene in the 
telencephalon
OUg2 and EGFP expression in the developing brain
Having confirmed that EGFP expression follows that o f oUg2 in the spinal cord, I 
analysed its expression in the developing brain. As a control, wild type brains were 
sectioned and analysed for endogenous Glig2 protein at E l0.5, E l3.5 and E l6.5. 
Glig2+ cells were seen at E l0.5 in the LGE, MGE, ventral tectum and hypothalamus 
(Figure 3.19 A). After E l3.5 (Figure 3.19 B) they were dispersed dorsolaterally and 
the telencephalon contained many Glig2+ cells by E l6.5 (Figure 3.19 C). The 
profile of EGFP+/Glig2+ cells was more complex in the telencephalon than in the 
spinal cord however, with the appearance of EGFP fluorescence being delayed with 
respect to Glig2 protein. The first EGFP expression in the anterior forebrain was 
seen at around El 3.5, but only in migrating cells, all o f which co-labelled with Glig2 
(Figure 3.20). In more posterior sections, many more EGFP+ cells were identified 
although there were only a few Glig2+ cells that co-expressed EGFP within the VZ 
(Figure 3.21). However, all migrating cells co-expressed Glig2 and EGFP 
(Figure 3.21). At E l6.5 a similar profile was seen since few VZ cells were EGFP+, 
but 93 +/- 8% of migrating Glig2+ cells outside the VZ were EGFP+ (Figure 3.22) 
and 88 +/- 5% o f Glig2+ cells were EGFP+ in the early cortex. Some of these 
cortical Glig2+/EGFP- cells could be a population of dorsally-derived GLPs 
(Kessaris et al., 2006) which are generated later in development and therefore may 
not yet have activated EGFP or else the transgene may not have the necessary 
regulatory elements for EGFP activation in such GLPs. There were also a few 
EGFP+/Glig2- cells (Figure 3.22) which could be attributed to EGFP protein
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persisting after oUg2 down-regulation during differentiation o f cortical neurons, as 
has been described recently by Furusho et al (Furusho et al., 2006). These data 
indicate a delay in EGFP expression with respect to oUg2 in the brain. This was not 
unexpected since endogenous oHg2 expression is more complex and dynamic in the 
telencephalon than in the spinal cord. In addition two of the four lines showed 
ectopic EGFP in the cortex at E l3.5 (Figure 3.23) and were thus excluded from 
further analysis.
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Figure 3.18 01ig2+ cells in the developing embryonic murine brain at the level o f the midbrain at E10.5, E13.5, and E16.5 as detected by 
immunohistochemistry. By E l0.5 (A) 01ig2+ cells are seen in the ventral tectum (TE) and the ventricular zone o f the presumptive lateral 
and medial Ganglionic eminences (GE). At E l3.5 01ig2+ cells are found in the Lateral and Medial Ganglionic eminences (LGE and 
MGE) and by E l6.5 they are found throughout the telencephalon.
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Figure 3.19 01ig2/EGFP co-localisation in the anterior telencephalon at El 3.5, as identified by immunphistochemistry. 01ig2+ 
cells at the VZ are EGFP-negative, but all migrating 01ig2+ cells co-express EGFP (inset). Founder line 26/6
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Figure 3.20 01ig2/EGFP co-localisation in the transgenic E l3.5 diencephalon. 01ig2+ cells around the VZ were EGFP-negative (panel I 
solid arrows), but there were many migrating 01ig2+ cells and these all co-expressed EGFP (panel 2 dotted arrows). Migrating cells 
proximal to the VZ were also EGFP+ (panel 1 dotted arrows). Founder line 26/6.
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Figure 3.21 01ig2/EGFP co-localisation in E l6.5 transgenic brain. Oüg2+ cells in the VZ were EGFP-negative (large 
arrow) indicating delayed EGFP activation relative to oUg2. In the developing corpus callosum (inset 1) where oHg2 has 
been expressed for longer, most 01ig2+ cells co-expressed EGFP (dotted arrows), although there were occasional 
01ig2+/EGFP- cells (solid arrows). 93 +/- 8% o f migrating 01ig2+ cells co-expressed EGFP (inset 2). In the cortex (inset 
3), 88 +/- 5% o f 01ig2+ cells co-expressed EGFP with occasional clusters o f 01ig2+/EGFP- cells being identified (arrows, 
inset 3). There were also occasional EGFP+/01ig2- cells (dotted arrows, inset 3). Founder line 26/6.
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Figure 3.22 Ectopic EGFP expression in E l3.5 transgenic brain from founder line 27/1. 
There was extensive EGFP expression in the developing cortex (inset) where olig2+  cells do 
not exist at this age. The red immunostaining in cortical region is from meninges that were 
not removed. The region o f  EGFP expression around the LGE and MGE also far exceeded  
that o f  01ig2 (arrows).
3.2.8 EGFP expression in the adult
At PIO in the spinal cord, 70 + /-  3% o f  0 1 ig2+  ce lls  w ere EGFP+. H ow ever, at 
P30-45 on ly  45 + /- 6% o f  01 ig2-expressing  ce lls  were also EGFP+ (Figure 3.24). 
Similarly, in the brain, the percentage o f  01 ig2+  ce lls that co-expressed  EGFP 
decreased sign ificantly  betw een PIG and P30 - at PIG there w as 84 + /- 6% c o ­
localisation in the corpus callosum  and 77+ /- 11 % in the cortex, but this w as reduced  
in P3G-45 anim als to 47  + /- 1 % in the corpus callosum  and 68 + /- 6% in the cortex 
(Figure 3 .25). T he explanation for this is unclear although it is possib le that 
transcriptional regulation o f  oUg2 is  different in the adult and the em bryo and that the 
N LS.EG FP  transgene insert lacks adult-specific control elem ents. A lternatively, the 
transgene m ight b e selectively  inactivated through D N A  m odification  in older 
animals.
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Figure 3.23 01ig2/EGFP co-localisation in the PIO and P30 transgenic spinal cord as determined by immunohistochemistry. At PIG, 70 +/- 3% of  
01ig2+ cells co-expressed EGFP, but this is dramatically reduced by P30 to 20 +/ 7% co-localisation. The total number o f  01ig2+ cells also 
decreased at P45. Founder line 26/6.
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Figure 3.24 01ig2 and EGFP co-localisation in the postnatal transgenic brain as determined 
by immunohistochemistry. The proportion o f  01ig2+ cells co-expressing EGFP dramatically 
decreased between PIO and P30 in the corpus callosum while the proportion o f  
01ig2+/EGFP+ cells (with respect to the total number o f  Olig2+ceIls) remained fairly similar 
in the cortex between PIG and P30. At PIO, there was 84% co-localisation in the corpus 
callosum and 77% in the cortex. At P30-45, there was 47% co-localisation in the corpus 
callosum and 68% in the cortex. Founder line 26/6.
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3.2.9 Confirming the identity of EGFP+ cells in the brain and spinal cord
To further examine the identity of the EGFP+/01ig2+ cells, brain and spinal cord 
sections were stained with anti-GFP along with either anti-PDGFRa (OLP marker), 
anti-GFAP (generic astrocyte marker) or anti-NeuN (neuronal marker) antibodies.
In both spinal cord and brain sections, 100% of PDGFRc^ cells co-expressed EGFP 
at El 3.5 (Figure 3.25 and 3.26). However, in the VZ of the brain and spinal cord at 
E l3.5 there were a number of cells that were EGFP+/ PDGFRa These could have 
been early OLPs that had not yet up-regulated PDGFRa or OUg2+ progenitors that 
were not o f the oligodendrocyte lineage. GFAP was only looked for in the postnatal 
animal since expression is weak embryonically. At PIO there was no clear 
co-localisation o f EGFP and GFAP in the brain or spinal cord (Figure 3.27). Some 
overlap between EGFP+ nuclei and GFAP+ processes was observed in the corpus 
callosum o f the brain and periphery of the spinal cord, but it was difficult to 
determine whether they belonged to the same cell since cell density was high and 
assignment of a nucleus to GFAP+ processes was problematic. Since some 
astrocytes are reported to be derived from oUg2+ precursors, it is likely that if  any of 
these cells were genuinely EGFP+/GFAP+ they were likely to be such lineal 
descendants, in which EGFP protein had not yet been degraded. None o f the EGFP+ 
cells co-localised wtih NeuN at E l6.5 in the brain or spinal cord (Figures 3.28, 3.29) 
nor in the PIO brain or spinal cord (Figures 3.30 and 3.31). It is possible that some 
neurons and astrocytes were once oUg2+, but the EGFP may have been degraded by 
the time NeuN or GFAP were expressed.
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Figure 3.25 PDGFRos^EGFP co-localisation in the transgenic E l3.5 spinal cord as 
determined by immunohistochemistry. 100% o f  PDGFRod- cells were EGFP+. These were 
seen dispersing dorsolaterally from the pMN domain (arrows, panel A). There were, 
however, many EGFP+/PDGFRa- cells within the pMN domain (arrows, panel B). All 
EGFP+ cells found more lateral to the pMN co-expressed PDGFRo: as shown in panel C. 
Founder line 26/6.
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Figure 3.26 PDGFRo/EGFP co-localisation in the transgenic E l3.5 brain as determined by 
immunohistochemistry. All PDGFRcri- cells co-labelled for EGFP (solid arrows A,B)- 
Although some cells appeared PDGFRcrf/EGFP- (arrow heads C), upon closer inspection, it 
was clear that these were cells in which the nucleus has not been included in the section and 
tk PDGFRorf staining was o f  cell processes where the presence o f  EGFP could not be 
identified. Within the VZ there were many cells that were EGFP+/ PDGFRof- (dotted arrow 
panel A) and there was the occasional cell that appeared EGFP+/ PDGFRcü- in more lateral 
positions as well (arrow heads, panel B). Founder line 26/6.
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Figure 3.27 EGFP and GFAP expression in the PIO transgenic brain and spinal cord as 
determined by immunohistochemistry. There was no obvious co-localisation o f  EGFP and 
GFAP in the brain or spinal cord at this age. There were instances where GFAP+ processes 
were proximal and overlapping with EGFP+ nuclei, but these could not be clearly assigned 
to the same cell (arrows in the magnified image o f  the inset from the corpus callosum panel). 
Pictures were taken at low exposure for GFAP fluorescence since it otherwise saturated the 
image. Therefore, there appeared to be little/no staining in the grey matter o f  the spinal cord, 
but at higher levels o f  exposure, it could clearly be seen and there was no co-localisation 
with EGFP Founder line 26/6
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Figure 3.28 NeuN and EGFP expression in transgenic El 6.5 spinal cord as detected by 
immunohistochemistry. There was no co-localisation between NeuN and EGFP in the spinal 
cord at this age.
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Figure 3.29 NeuN and EGFP expression in the transgenic E l6.5 brain as detected by 
immunohistochemistry. There was no co-localisation between NeuN and EGFP in the brain 
at this age.
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Figure 3.30 NeuN and EGFP expression in the PIO transgenic spinal cord as detected by 
immunohistochemistry. There was no co-localisation o f  NeuN and EGFP at this age. 
Although at first glance there appeared to be some co-localisation, upon closer inspection, it 
could be seen that this was simply two nuclei close together (inset 2 and 3). The sections 
were thick (30 /rm), meaning that nuclei at different levels throughout the slice could be 
seen. There were also some blood vessels (arrow in main panel and inset 1) which, when 
nearby an EGFP+ cell, gave the impression o f  co-localisation. Founder line 26/6.
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Figure 3.31 NeuN and EGFP expression in the transgenic PIO brain as determined by
immunohistochemistiy. There was no co-localisation in either the striatum (A) or in the 
cortex (B).
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3.2.10 In vitro analysis of EGFP expression
To confirm that EGFP+ cells were bright enough to be useful for live cell imaging, 
expression was visualised in vitro. Smears of spinal cord tissue from freshly killed 
transgenic mice were examined directly for EGFP fluorescence in live cells. 
Individual fluorescent cells were visible in the light microscope when spinal cord 
cells were dissociated. When plated onto Poly-D-Lysine-coated petri dishes the 
EGFP could also be directly visualised by time-lapse microscopy, confirming that 
the EGFP could be used to identify transgene expression in live cells.
To determine whether EGFP could be induced in culture in parallel with oHg2, 1 
prepared cultures from transgenic embryos as follows; E l3.5 cerebral cortex from 
oHg2-EGFP transgenic mice were dissociated and the NEPs cultured in the presence 
of 10 ng/ml FGF2 to induce the expression of oUg2 (Kessaris et al., 2004;Qian et al., 
1997). EGFP was visualised within 24 hours o f plating the cells at which point the 
cells were fixed and counterstained for 01ig2; 100% co-localisation was observed 
(Figure 3,33). These data confirm that oUg2 induction was mirrored by EGFP 
expression in this culture paradigm and that NLSiEGFP transgene expression could 
therefore be used as a reliable surrogate for olig2 in culture.
I l l
Figure 3.32 Live imaging o f  EGFP. (A) EGFP+ cells from a smear o f  spinal cord cells 
obtained after acute dissection from a transgenic P 10 mouse. The EGFP in these cells was 
imaged directly using a fluorescence microscope. (B) Cells induced to express olig l, and 
therefore the transgene in culture, imaged directly using time-lapse microscopy. To ensure 
that the first appearance o f  EGFP corresponded to expression o f  01ig2 protetin, cortical 
NEPs cultured in 10 ng/ml FGF-2 were filmed using time-lapse microscopy. Upon the first 
appearance o f  EGFP fluorescence (C) the cells were fixed and counter-stained for 01ig2 (D). 
Every EGFP+ cell was 01ig2+ and there were no 01ig2+/EGFP- negative cells.
112
3.3 DISCUSSION
3,3.1 EGFP co-localisation with OUg2 in transgenic mice
The aim of the work described in this chapter was to generate a transgenic mouse 
line that labelled all cells expressing the bHLH transcription factor OHg2. 
Immunohistochemical analysis showed that EGFP expression in the spinal cord 
mirrored that o f endogenous OUg2, At E l0.5 all 01ig2+ cells co-expressed EGFP 
and vice versa. However, at E l3.5 there were also EGFP-/01ig2+ and 
EGFP+/01ig2- cells in spinal cord sections. The presence of EGFP-/01ig2+ cells 
could be due to lack of expression of the transgene in some 0Iig2+ cells, although it 
is more likely due to a delay in transcription of the transgene with respect to oUg2 
since most EGFP-/OIig2+ cells were found close to or within the VZ which is where 
NEPs first activate oHg2. EGFP+/01ig2- cells in the spinal cord were early motor 
neurons as revealed by the fact that they co-expressed MNR2.
Expression in the brain was more complex than in the spinal cord, with appearance 
of EGFP being delayed with respect to 01ig2 protein, although there was more 
EGFP/01ig2 overlap in more posterior sections and in migrating 01ig2+ cells outside 
the VZ, This is consistent with the idea that activation of transgene expression is 
simply delayed relative to oUg2, As in the spinal cord, some EGFP+/01ig2- cells 
were also found in the brain. It is known that oHg2+ precursors give rise to both 
motor neurons and OLPs in the spinal cord (Lu et al., 2002;Takebayashi et al., 2002) 
and there is also evidence that oHg2+ precursors in the brain produce neurons as well 
as OLPs (Furusho et al., 2006). It is likely, therefore, that the EGFP+/01ig2- cells 
identified here were derivatives of oHg2+ precursors that had recently 
down-regulated oUg2 and were not destined to generate OLPs. The question of their 
identity still remains as there was no co-localisation between EGFP and GFAP or 
NeuN in the embryo or the adult. However, EGFP might have degraded by the time 
these markers were expressed. Thus, although most EGFP+ cells are of the 
oligodendrocyte lineage (as confirmed by PDGFRof labelling), there are populations 
derived from OUg2+ precursors that must belong to other lineages. This should be 
investigated further. Markers that could be used include Doublecortin to identify 
neuroblasts, Nestin or Glast to identify early NEPs and SI 00/5 for astrocytes.
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3.3.2 EGFP expression in the adult
100% of EGFP+ cells co-expressed 01ig2 in adult (P30-45) transgenic mice 
suggesting that, in the adult, all EGFP+ cells are of the oligodendrocyte lineage. 
This, however, constitutes only 50-70% o f the total 01ig2+ cells in the adult. Down- 
regulation o f transgene expression in adult cells is not uncommon (Johansen et al., 
2002;Pettersson et al., 1989). The insertion site of the transgene can influence the 
dynamics o f expression (Clark et al., 1994). It is also possible that regulatory control 
o f oHg2 differs in the adult and embryo and the transgene might not contain the 
elements required for accurate expression in the adult.
3.3.3 EGFP expression in vitro
Given the discrepancies between transgene vs. endogenous oHg2 expression in vivo, 
it was important to ascertain whether the transgenic mouse was suitable for use as a 
reporter in an in vitro assay. I found that 100% of 01ig2+ cells that were 
specified in vitro in response to FGF-2 also expressed EGFP, confirming that the 
transgene contained the necessary regulatory elements for induction in vitro, and was 
therefore suitable to use in the time-lapse microscopy experiments described in the 
next chapter.
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Chapter 4 
Time-lapse microscopy of neuroepithelial 
precursor cells in vitro
4.1 Introduction
4.1.1 Chapter overview
The ability o f multipotent neuroepithelial precursor cells (NEPs) to give rise to 
specific neurons and glia at particular times and spatial locations is likely the result 
of a combination of both cell-intrinsic properties and environmental cues. Many 
experiments designed to investigate this look at single time-points; analysis of single 
time points in cultures and fate mapping of labelled populations in vivo. The aim of 
the work described in this chapter was to use time-lapse microscopy to investigate 
the real-time behaviour of single embryonic cortical NEPs as they divide and 
differentiate in vitro in response to the mitogen FGF-2 (for experimental details see 
chapter 2 methods and materials, section 2.9).
4.1.2 Introduction to FGF-2 in development
As discussed in chapter 1, members of the FGF family have a catalogue of roles 
throughout development of the mammalian central nervous system (CNS). FGF-2 is 
well documented as being involved at multiple stages within the oligodendrocyte 
lineage (Bansal et al., 1996;Bansal, 2002;Fortin et al., 2005), but of interest here is 
the potential involvement of FGF-2 in regulating the initial specification of OLPs 
from NEPs. Developmentally, most OLPs are derived from ventral zones of the 
CNS (Qi et al., 2002;Riehardson et al., 1997;Rowitch et al,, 2002;Tekki-Kessaris et 
al., 2001;Woodruff et al., 2001), their specification critically depending on Sonic 
Hedgehog (SHH) signalling (Agius et al., 2004;Alberta et al., 2001;0rentas et al., 
1999;Tekki-Kessaris et al., 2001 ;Wijgerde et al., 2002). However, there are also 
dorsal sources o f OLPs which are thought to contribute 10-15% of all
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oligodendrocytes in the spinal cord and up to 50% in the forebrain by birth (Fogarty 
et al., 2005;Kessaris et al., 2006;Richardson et al., 2006) and these are likely to be 
derived via a SHH-independent mechanism. FGF-2 is a possible candidate for such 
SHH-independent oligodendrogenesis since it has been shown to induce OLPs in 
vitro from dorsally derived NEPs from the embryonic brain and spinal cord even in 
the absence of SHH signalling (Chandran et al., 2003;Gabay et al., 2003;Kessaris et 
al., 2004). Furthermore, Naruse et al (Naruse et al., 2006) recently demonstrated that 
injection of FGF-2 into cerebral ventricles of El 3.5 mouse embryos (time o f onset of 
gliogenesis) induced the precocious emergence of OLPs in the dorsal forebrain of 
recipient mice, providing in vivo evidence for an otherwise culture-based 
phenomenon.
4.1.3 FGF-2 - mltogenesis vs. cell fate induction
FGF-2 is classically described as a mitogen and is thought to promote cortical 
precursor proliferation by increasing the rate of transition from G1 to S phase (Li and 
Cicco-Bloom, 2004). In vivo, ectopic exposure of mouse embryonic cortical 
ventricular zones to FGF-2 at E l3 causes a 70-80% increase in the number of glia 
found in the postnatal brain (Vaccarino et al., 1999), while characterisation of 
FGF-2-/- knockout mice reveals a much reduced brain size with far fewer neurons 
and glia than in controls (Murtie et al., 2005;Raballo et al., 2000). Such 
experimental data leads to the idea that FGF-2 regulates cell number and evidence 
suggests that this is largely due to effects on cell division since no differences are 
seen in levels of apoptotic markers, but many more cells are seen to be entering 
S phase in the presence of FGF-2 (Vaccarino et al., 1999). As well as its role as a 
mitogen however, FGF-2 signalling is also known to affect cell migration, survival 
and cell fate determination (Bansal et al., 2003;Besser et al., 1995;Boilly et al., 
2000;Ford-Perriss et al., 2001;Fortin et al., 2005;Gabay et al., 2003;0mitz and Itoh, 
2001;Yamaguchi and Rossant, 1995). Of relevance here, it has been shown in vitro 
that FGF-2 induces the expression of olig2 and the generation o f OLPs in cortically 
derived NEPs within 24 hours of culture (Kessaris et al., 2004;Qian et al., 1997). 
These oUg2+ cells are presumed to go on to differentiate into mature 
oligodendrocytes as identified by markers such as 0 4  and NG2. Furthermore, 
increasing numbers of oHg2+ cells are generated in the presence o f higher 
concentrations o f FGF-2 indicating a dose-dependent response. This could be
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attributed to increased oUg2 induction, cell division, cell survival or all o f the above. 
One ligand can certainly initiate a range o f responses depending on the nature of the 
receptive cell and its environment. One way of altering a cell’s response to a ligand 
is to alter the potency or duration o f ligand binding. An example of this is in neurons 
and neural networks, in which sustained signalling events result in long term changes 
in a neuron’s transcriptional profile and activity (long term potentiation), whereas 
transient signals result in short-term intracellular responses (Bliss and Collingridge, 
1993). This is also well-described for cell responses to neurotrophin signalling 
through tropomysin-related kinase (Trk) receptors which promote cell differentiation 
through sustained signalling events and proliferation through more transient receptor 
activation (Arevalo et al., 2004;Marshall, 1995). The separation o f cell responses to 
FGF-2 signalling has been documented (Bailly et al., 2000;Boilly et al., 2000;Boilly 
et al., 2000;Isacchi et al., 1991;Piotrowicz et al., 1999) and there is evidence that 
different intracellular events are initiated via reception of different bandwidths of 
FGF-2 concentration (Garcia-Maya et al., 2006).
Another way of achieving differential responses to a given ligand is to alter the 
receptor compliment of the cell (Lillien and Cepko, 1992;Lillien and Wancio, 
1998;Sun et al., 2005). The differential responses of oligodendrocytes to FGF-2 at 
different stages of differentiation, for example, are meditated via signal transduction 
through different receptors isoforms as discussed in chapter 1. Recruitment of 
different signalling pathways downstream of the receptor can also modulate the 
intracellular responses that are elicited. An example of this is again provided by 
FGF-2 signalling, since proliferation and migration can be initiated through separable 
intracellular pathways in a variety o f cell types (Besser et al., 1995;Daviet et al.,
1990;Piotrowicz et al., 1999;Presta et al., 1989;Sa and Fox, 1994). Pharmacological 
analysis has indicated that proliferation is commonly induced via activation of 
protein kinase C (PKC), but a unique pathway for differentiation (of fibroblasts) or 
migration has not been identified, nor has the mechanism by which different 
pathways may be recruited independently through activation of a common receptor 
isoform. The presence/absence of cofactors can also affect the result o f the 
application of a ligand to a cell and heparin sulphate proteoglycans (HSPG) are 
frequently a critical component of FGF signalling (Barolo and Posakony, 
2002;Brickman et al., 1995;Granerus et al., 1993;McKeehan et al., 1999;Nurcombe
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et al., 2000). Finally, the extracellular matrix can also affect cellular responses to a 
ligand. Components of the extracellular matrix can be involved in localising and 
concentrating ligands in the vicinity of receptive cells and might also take part in 
signalling events themselves (Barolo and Posakony, 2002;Ingber and Folkman, 
1989;Kanda et al., 1999). Thus, a given signalling pathway may be redeployed 
several times over and yet elicit different cellular effects (Barolo and Posakony, 
2002).
4.1.4 Age-dependent changes in response to signalling in development
Edlund and Jessell proposed that, during development, cells undergo a transition 
from being dependent on exogenous signalling for fate decisions to a cell-intrinsic 
programme (Edlund and Jessell, 1999). Various developmental systems illustrate 
this idea with multipotent progenitors at early stages becoming fate-restricted and 
less responsive to exogenous signals over time (Lo and Anderson, 1995). In CNS 
development, during which neurons are bom before glia, it is possible that there is a 
time-dependent change in the properties of neural progenitors such that they become 
inherently more likely to generate glia; alternatively, the environment might change 
and become more favourable to gliogenesis with time. The environment of cells in 
the developing embryo is constantly changing with differential availability of 
extracellular ligands and matrix components which, as discussed above, can elicit 
various intracellular responses. As a consequence, receptive cells will alter their 
complement of activated proteins and gene expression and will therefore likely 
respond differently to a given ligand at different stages of development. Differential 
responsiveness combined with differential availability of signalling molecules is a 
fundamental component of CNS patterning and development.
4.1.5 Sonic Hedgehog in CNS development
As a morphogen, Sonic Hedgehog (SHH) is required at a particular concentration for 
the induction of oUg2 in the pMN domain of the spinal cord (Orentas et al., 
1999;Orentas et al., 1999;Poncet et al., 1996;Pringle et al., 1996). Moreover, there is 
no generation of oUg2+ cells, OLPs or motor neurons in the spinal cord in the 
absence of SHH signalling (Alberta et al., 2001;Ericson et al., 1996). In the brain, 
early elimination o f SHH signalling using a conditional mutant, results in both the 
absence of OLPs and o f dopaminergic and serotinergic neurons. Elimination of SHH
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at later embryonic ages however, results in these neurons being present, though in 
reduced numbers compared to wild type mice (Blaess et al., 2006;Dahmane et al., 
2001). Thus, between E9 and E ll SHH is evidently important for some neuronal 
specification in the brain and its continuing presence is required for expansion of 
neuronal pools along with oligodendrogenesis. This is reminiscent of SHH 
signalling with respect to MN and OLP specification in the spinal cord pMN domain 
(Orentas et al., 1999). However, there are also differences between the requirements 
for SHH in the brain and in the spinal cord. For example, SHH is required for 
normal development of dorsal structures in the brain (Theil et al., 1999;Tole et al., 
2000), whereas its absence in the dorsal spinal cord is a prerequisite for dorsal 
domain specification and ectopic dorsal SHH signalling leads to ventralisation of 
these domains. This could relate to the distribution of Gli protein isoforms (Glil-3) 
in the brain since these are the main transducers of sonic hedgehog signalling and are 
thought to transduce SHH signalling differentially (Altaba et al., 2003;Jacob and 
Briscoe, 2003;Litingtung and Chiang, 2000;Litingtung and Chiang, 2000). The role 
of SHH signalling in dorsal brain specification is though to be mediated partly via 
Gli3A activity (Theil et al., 1999;Tole et al., 2000) as well as via repression o f 
ventral cell types by GH3R activity. The data I describe in this chapter includes 
analysis of the responses of dorsal cortical NEPs to SHH and FGF-2 with respect to 
oUg2 induction. SHH is also known to have both proliferative and cell survival 
effects (Cayuso et al., 2006;Charrier et al., 2001;Placzek et al., 1993;Rowitch et al., 
1999) and these properties were therefore also assessed for both FGF-2 and 
SHH-treated cultures, using time-lapse microscopy.
This chapter also addresses potential o f NEPs from cortices of different embryonic 
ages to respond to different concentrations of FGF-2 over 1-3DIV in order to analyse 
the responsiveness to FGF-2 with respect to OLP generation. While these 
experiments only indicate fate potential in vivo, they give an indication of the 
intrinsic ability of these cells to respond to FGF-2 signalling over a short time span.
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4.2 RESULTS
4.2.1 Experimental paradigm for investigating the induction of OUg2 in dorsal 
NEPs
Preparations of NEPs from the dorsal telencephalic cortex of E13.5 mice were 
prepared as described in chapter 2, section 2.9. This produced a single cell 
suspension of NEPs which did not give rise to 01ig2+ cells (determined by 
immunolabelling with anti-01ig2 antibody) when cultured in medium without FGF-2 
over 3 days in vitro (DIV), but generated many neurons in this time. If left over 
7D1V, OLPs were eventually seen to be generated in the absence of FGF-2 
However, when FGF-2 was added to the culture medium to a final concentration of 
10 ng/ml, Qlig2+ cells appeared within 24 hours (as determined by immunolabelling) 
followed by sequential emergence of late-OLP and oligodendrocyte markers over 
time (Figure 4.1). All cell preparations were cultured in a 1:1 mixture of Bottenstein 
and Sato’s defined medium (Bottenstein, 1986;Bottenstein and Sato, 1979) with the 
same medium that had been conditioned over a dense cortical-cell culture prepared 
from El 3.5 embryos. For full experimental details of the preparation of conditioned 
medium see chapter 2, section 2.9. This mixture of Bottenstein and Sato’s defined 
medium combined with conditioned medium is named ‘basic medium’ and any 
supplements that were added are specified.
B tub tliro iig2
B tubH I/0lig2
Figure 4.1 Schematic o f  the experimental culture set-up. The neocortex was excised to 
exclude the lateral and medial ganglionic eminences (LGE and MGE respectively) such that 
endogenous zones o f  oligodendrogenesis (shown in green) at this time were not included in 
the culture. When cultured in control conditions without FGF-2, no 01ig2+ cells emerged 
over 3 days in vitro (DIV) and 100% o f counted cells were /3-tubulin III positive (red). 
Conversely, in the presence o f  10 ng/ml FGF-2, the number o f  /3-tubulin III+ neurons 
observed was reduced and many 01ig2+ cells (green) were generated.
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4.2.2 FGF-2 diverts NEPs from being neurogenic to gliogenlc
In a preliminary characterisation o f the cells in this culture set-up, immunolabelling 
was first performed on low density cultures seeded onto PDL-coated glass coverslips 
at a density of IxlO'^ cells per coverslip, grown in either basic medium alone or basic 
medium treated with 10 ng/ml FGF-2. Both control and FGF-2-treated cultures were 
fixed at 1 or 3 DIV and assessed for the presence of Glast, 01ig2, Dcx (Doublecortin) 
and /3-tubulin III to identify radial glial cells (RGC), OLPs, neuroblasts and neurons 
respectively. At 1 DIV in controls there were no Glig2+ cells, but in the presence of 
10 ng/ml FGF-2, 47 +/- 10% o f the cells were 01ig2+ (Figure 4,2 A, B). However, 
there were high numbers of Glast+ cells in both controls and FGF-2-treated cultures 
(Table 4.1; Figure 4.2 A, B).
% of OUg2+ 
ceils
% of Glast+ 
cells
% of Dcx+ 
cells
% of 
j3-tubulin III+ 
cells
Control 0 69 +/-12 95 +/- 3 88 +/-10
10 ng/ml FGF-2 47 +/-10 55 +/-10 34 +/- 2 34 +/- 2
Table 4.1 Profile o f  markers expressed in E l3.5 cortical NEP cultures at 1 DIV in control 
and FGF-2-treated preparations as detected by immunolabelling. Data is presented as 
mean + /- standard deviation for triplicate experiments with 10 fields o f  view  analysed in 
each.
81 4-/- 12% of the Glig2+ cells in 10 ng/ml FGF-2 co-expressed Glast (Figure 4.2 A) 
and these were presumed to be RGCs undergoing specification without having yet 
down-regulated Glast. Most of these Glig2+/Glast+ cells were presumed to go on to 
follow the oligodendrocyte lineage since 71 +/-5% of Glig2+ cells in FGF-2-treated 
cultures co-expressed the early GLP marker NG2 at 1 DIV. Corresponding with the 
absence of Glig2+ cells in controls, there were no NG2-I- cells in control conditions at 
1 DIV either. In control cultures without FGF-2, a neuronal profile was determined; 
95 +/- 3% of cells in control cultures expressed the neuroblast marker Dcx and 
88 +/- 10% of cells in controls expressed /3-tubulin III (Figure 4.2 C, D) with all 
/3-tubulin III+ cells co-expressing Dcx. Control cultures at 1 DIV were therefore 
predominantly neuronal. In contrast, in FGF-2-treated cultures only 34 +/- 2% of
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cells expressed Dcx (with complete co-localisation with /5-tubuIin III), which was 
about 1/3"* of the percentage of Dcx+ cells in controls and none of which 
co-localised with 01ig2. These data suggest that the starting population is inherently 
neurogenic in the absence o f exogenous signalling, but that 10 ng/ml FGF-2 diverts 
NEPs from generating mostly neurons to generating both neurons and glia even by 
1 DIV.
At 3 DIV in 10 ng/ml FGF-2, the number of 01ig2+ cells had increased --5-told from 
6 8 +/-8 cells per field of view at 1 DIV to 381 +/- 62 cells by 3 DIV which 
corresponded with a ~5-fold increase in total cell number (Figure 4.3 A, B). The 
number of /3-tubulin III+ neurons doubled over the first two days in vitro and 
remained constant thereafter; 48 +/- 10 neurons at 1 DIV, 108 +/- 10 at 2 DIV, 
97 +/- 20 at 3 DIV (Figure 4.3 A; P = 0.7 for number of neurons at 2 vs. 3 DIV). This 
indicates that neuronal progenitors divided once on average and gave rise to 
post-mitotic neurons in FGF-2-treated cultures. Conversely, in control conditions 
without FGF-2, there were no 01ig2+ cells generated even by 3 DIV 
(Figure 4.3 C, D) and the increase in total cell number over 3 DIV was attributable to 
an increase in the number o f /3-tubulin III+ neurons; 158 +/- 9 neurons at 1 DIV, 
356 +/- 77 at 3 DIV. By 3 DIV in these controls, 100% of the cell population was 
/3-tubulin 111+ neurons (Figure 4.3 D). These data indicate an initial induction of 
oUg2 in NEPs by FGF-2 signalling and a subsequent expansion of this oHg2+ 
population.
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Figure 4.2 Immunolabelling o f  E l3.5 cortical NEPs at 1 day in vitro (DIV) in control and 
FGF-2-trcatcd conditions. Anti-01ig2, Glast, /8-tubulin III and Dcx antibodies were used to 
identify presumptive glia, radial glial cells, neurons and neuroblasts respectively. 47 +/- 
10% o f  cells expressed 01ig2 at 1 DIV in 10 ng/ml FGF-2 (lOF) while there were no 01ig2+  
cells in control conditions (A and B). More than 50% o f cells in both conditions express 
Glast (B) with 81% o f  01ig2+ cells co-expressing Glast in 10 ng/ml FGF-2 (A middle and 
right panels). The proportion o f  /3-tubulin III+ neurons was -three times higher in controls 
than in FGF-2-treated conditions (C,D) and there was a corresponding distribution o f  Dcx+ 
cells (D). All /8-tubulin III+ neurons co-expressed Dcx and there was no overlap o f 01ig2 
with /3-tubulin III or Dcx in FGF-2-treated cultures (C).
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Figure 4.3 Characterisation o f  cell populations in 10 ng/ml FGF-2 (10F) and control conditions over 3 days in vitro (3DIV). Total cell 
population increased ~5-fold over 3 days in 10 ng/ml FGF-2, corresponding to a ~5-fold increase in 01ig2+ eells (A,B). The number 
o f  ^ -tubulin 111+ doubled from 1-2 DIV and thereafter remained constant over time in 10 ng/ml FGF-2 (A). Cell number increased in 
control conditions by -2-fold, attributable to a doubling in the number o f /3-tubulin III+ neurons (C). By 3 DIV 100% o f cells counted 
were /3-tubulin III+ neurons in control conditions (D) indicating that the neuroblasts identified as Dcx+ cells at 1 DIV have given rise 
to post-mitotic neurons by this stage. Data is shown as mean +/- standard errors.
4.2.3 Time-lapse microscopy
NEPs were plated at clonal density (1x10^ cells per ml of culture medium) onto 
35 mm tissue culture dishes and were allowed to settle overnight before being 
transferred to the time-lapse set-up. This meant that the start o f filming was at 
18 hours after plating (18h). Previous experiments showed that there are no 
divisions over this time and cell survival is improved when cultures are left to settle 
in a standard incubator rather than in the time-lapse set-up. Up to 120 single cells 
within the culture dishes were selected to be filmed and an image was captured every 
15 minutes to compile time-lapse movies so all divisions were recorded over the 
culture period. Lineage trees were drawn retrospectively and the cell types derived 
from each starting NEP were identified by immunolabelling performed within the 
time-lapse set-up as described in chapter 2, section 2.9. The number o f starting cells 
that were seen to divide at least once was noted and, if  the majority of cells within a 
clone survived the culture period (less than 1/8^ of the cells dying) then they were 
counted as ‘surviving clones’. Cells that did not divide were also noted although few 
of these survived the culture period so immunocytochemical analysis was not 
possible for many o f them.
4.2.4 Three types of clones are derived from FGF-2 treated cultures, but only 
neurons are derived in control conditions within 48 hours of culture
In the presence of 10 ng/ml FGF-2, the proportion o f starting cells that was seen to 
divide was ~1.5-times that seen in control conditions; 54 +/- 13 % of the single cells 
filmed divided in FGF-2 as compared to 35 +/- 7 % in controls (Table 4.2). This 
confirmed that FGF-2 had a mitogenic effect on at least a subset of NEPs in these 
cultures. When filmed for 90 hours in 10 ng/ml FGF-2, 63 +/- 15% of dividing cells 
gave rise to clones in which most cells survived until the end of the experiment. 
However, no clones survived as long as 90 hours in control cultures (Table 4.2), 
indicating that FGF-2 also had a survival effect and meant that clonal analysis of 
FGF-2 treated vs. control cultures could not be compared at 90 hours. However, 
when the culture period was reduced to 48 hours, 65% of dividing cells in controls 
and 75 % in FGF-2 gave rise to surviving clones (Table 4.2). In 48 hour controls, 
100% of dividing cells produce only /3-tubulin III+ neurons (N-clones; Table 4.3; 
Figure 4.4 E, F, G).
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% of single cells that 
divided
% of clones that 
survived
Control -  48 hours 31 +/-12 65 +/-21
Control -  90 hours 40 +/-18 0
10 ng/ml FGF-2 -  48 hours 47 +/- 8 75+/-4
10 ng/ml FGF-2 -  90 hours 62 +/- 24 63 +/-15
Table 4.2 Comparison of the percentage of single cells in starting cultures that divided 
during the filming period and percentage of clones that survived for immunocytochemical 
analysis of control and FGF-2-treated preparations analysed at 48 and 90 hours. Data is 
presented as mean +/- standard deviation for triplicate experiments (5 experiments for 90 
hour data).
% o + % 0+/0- %o- %N
Control -  48 hours - - 100 100
10 ng/ml FGF-2 -  48 hours 62 +/- 20 29 +/-15 9+/-5 9+/-5
10 ng/ml FGF-2 — 90 hours 46 +/-15 34 +/-13 21 +/-13 0
Table 4.3 Summary of clone types produced in control and 10 ng/ml FGF-2-treated cultures 
over 48 and 90 hours. Of the surviving clones, the relative proportions of neuron-only (N), 
Qlig2-only (0+), mixed (0+/0-) and Qlig2-negative (0-) clones were calculated. Data is 
presented as mean +/- standard deviation for triplicate experiments (5 experiments for 90 
hour data).
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Figure 4.4 Analysis o f  48 hour time-lapse cultures in control conditions. A) Brightfield 
image o f  a typical neuronal morphology observed for many non-dividing cells and dividing 
cells that did not survive the culture period. B,C,D are stills from a time-lapse movie o f  cells 
in control conditions showing a starting cell (B; arrow) that did not divide, but extended a 
long neurite by 48 hours (C) and stained for /8-tubulin III (D; green). E,F,G are stills from a 
time-lapse recording o f  a dividing dedicated neuroblast in control conditions where a starting 
cell (E) divided twice to give 4 cells at 48 hours (F) which all stained for /3-tubulin III (G; 
green).
In contrast, three main classes of clone types were derived from single cells in 
10 ng/ml FGF-2; 62 +/- 10 % produced daughter cells which all expressed 01ig2 
protein (0+  clones; Figure 4.5 A, B, C), 29 +/-7 % produced a mixed population of 
daughter cells including 01ig2+ and 01ig2- cells (0+ /0 ; Figure 4.5 D, E, F) and 9 +/- 
3 % contained no 01ig2+ cells at all (O- clones; Figure 4.5 G). At 48 hours, all cells 
in the O- clones in FGF-2-treated cultures were /3-tubulin 111+ neurons (N-clones) 
and were derived from 2-3 divisions, therefore yielding 8 neurons as a maximum. 
However, not all of the 01ig2-negative cells in the 0+ /0 - clones were /8-tubulin 111; 
some were Glast+ (Figure 4.5 E,F) and some were immunocytochemically 
unidentified (negative for GFAP, Glast and RC2). Thus, while control conditions 
yielded only neurons, only 9% of clones were N-clones in FGF-2, indicating that 
some NEPs were diverted from producing only neurons to being gliogenic in the 
presence of FGF-2, which is consistent with data from the coverslip cultures 
(section 4.2.2).
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F ig u re  4 .5  Clone types derived over 48 hours in 10 ng/ml FGF-2. An 0 +  clone derived 
from a single cell in the starting culture is shown as stills from a time-lapse movie in panels 
A-C. All the derived daughter cells were 01ig24- at 48 hours (C). Panels D-F, show an 
0 + /0 -  clone (derived from a single cell) in which some o f  the 01ig2+ cells co-localised with 
Glast (D,E; white arrows), and the 01ig2-negative cells were /3-tubulin III+ neurons (F; white 
arrows). An example o f  an O- clone in which all cells were j8-tubulin III+ neurons is given in 
panel G. Floescht-stained nuclei that were apparently /3-tubulin Ill-negative (G; white 
arrows) were dead cells since they were pyknotic. A  graphical representation o f  the 
distribution o f  clone types derived in 10 ng/ml FGF-2 is given in panel H.
Most non-dividing cells did not survive the culture period in either treated or control 
cultures and could therefore not be identified by immunocytochemistry. However, 
most of these cells had a morphology indicating that they were neurons since they 
had extended processes and large cell bodies (Figure 4.4 A). Of the non-dividing 
cells that did survive, 100% were /8-tubulin III+ neurons in both conditions.
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4.2.5 Clones change from being 0 +  to 0 + /0 -  in 10 ng/ml FGF-2 over time
When FGF-2-treated cultures were filmed for 90 hours, a different distribution of 
clone types was seen; 46 +/- 8 % were 0+  clones, 33 +/- 6 % were 0+ /0 - mixed 
clones and 21 +/- 6 % were O- clones (Figure 4.6). Compared to the data collected at 
48 hours, the proportion of 0+  clones was reduced, 0+ /0- clones were in about the 
same proportion, and the proportion of O- clones increased (Figure 4.6). 
Furthermore, at 90 hours O- clones contained Glast+ cells and/or 
immunocytochemically unidentified cells as well as tubulin 111+ neurons. 
However, in 48 hour cultures, O- clones contained only neurons (N-clones). These 
data suggest that some j8-tubulin III+ cells might de-differentiate over time as there 
were no neuron-only (N) clones at 90 hours. Since there was also a decline in 0+ 
clones between 48 and 90 hours in culture, the data further indicates that the induced 
expression of oHg2 is not necessarily maintained in cells. Alternatively, since not all 
cells within a clone survived even over 48 hours, it is possible that some of the cells 
that died were multi potent progenitors that could give rise to /3-tubulin 
III-negative/01ig2-negative cells over 90 hours. Cultures were not filmed for more 
than 90 hours since clone sizes grew too large to be able to trace lineages with any 
accuracy and cell death could not be monitored accurately either.
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Figure 4.6 Differences in the distribution of clone types derived in FGF-2-treated cultures at 
48 hours vs. 90 hours. The percentage of 0+ clones was reduced at 90 hours while the 
percentage of 0+/0- clones was roughly the same and the percentage of O- clones had 
increased. However, at the 90 hour time-point, while the number of O- clones had increased, 
they all contained both /3-tubulin III+ neurons and unidentified cells, none of them 
contained only neurons (N clones). This is in contrast to the 48 hours time-point when all O- 
clones contained only neurons (N). Data is shown as mean +/- standard deviations.
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4.2.6 OUg2 can be induced at many points within a lineage
To investigate more closely how the different clone types were generated, where 
possible, lineage trees were drawn from time-lapse recordings.
Many clones demonstrated two distinct branches within a lineage, one 0 +  and the 
other 0 -. Such a lineage is shown in Figure 4.7 in which the two branches contain 
either only 01ig2+ cells or only neurons, respectively. Other lineages gave rise to a 
mixture of Qlig2+ and Glig2-negative cells in a much more irregular distribution as 
exemplified in Figure 4.8. Such a distribution o f Glig2+ cells within a lineage could 
arise by both up-regulation and/or down-regulation of oUg2 expression at specific 
branch points and possibly also by induction at the level of the individual daughter 
cells.
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Figure 4.7 (above) Stills from a time-lapse recording o f  an El 3.5 cortical NEP preparation 
in the presence o f  10 ng/ml FGF-2 in which a single cell (black arrow 18h panel) gave rise to 
an 0 + /0 -  clone in which half the daughter cells were 01ig2+ (green) and half were 
/3-tubulin III+ neurons (red) by 69 hours (A). The retrospective lineage tree (B) drawn from 
this movie showed that this segregation likely occurred via an initial asymmetric division 
whereby one branch pursued a glial fate while the other was neuronal. X = dead cell
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Figure 4.8 Stills and a lineage tree from a time-lapse recording o f  an E l3.5 cortical NEP 
preparation in the presence o f  10 ng/ml FGF-2 in which the distribution o f  01ig2+ cells in 
the final clone did not follow a regular pattern. The mixture o f  01ig2+ and 01ig2-negative 
cells, including /3-tubulin III+ neurons, indicated that oUg2 was probably up-regulated late in 
the lineage, possibly at the two branch points indicated by black arrows on the lineage tree. 
Note that the 01ig2+ cell indicated by a white arrow at 78 hours migrated in from a 
neighbouring clone and did not belong to this lineage. The green fluorescence in the 
/3-tubulin Ill-stained panel (black arrows on the stills) was not a cell, but an artefact.
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To follow the dynamics of oUg2 expression in real time, OUg2-EGFP transgenic 
mice were used as a source of cells. It was first important however, to confirm that 
transgenic cultures behaved in a similar manner to wild type. Visualisation of EGFP 
fluorescence in real time determined that 76 +/- 3 % of dividing NEPs from 
transgenic animals gave rise to at least some EGFf-expressing daughter cells 
(Figure 4.9). The proportion of EGFP+ clones was comparable to the 79% of 
surviving clones that contained 01ig2+ cells in wild type cultures as determined by 
immunolabelling for 01ig2 protein (number of 0+  clones plus the number 0+ /0- 
clones). This established that transgenic cultures mirror wild type cultures with 
respect to frequency of clones that express oUg2.
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Figure 4.9 Frequency o f  EGFP-expressing clones expressed as a percentage o f  the total 
clones observed. These data were collected from three -90-hour time-lapse experiments, 
over which a total o f  80 single NEPs in the starting cultures divided. O f all clones analysed 
76 +/-3% o f  these gave rise to at least some EGFP+ daughters. 24 +/- 3 % were 
EGFP-negative. This data is shown as mean +/- standard deviations.
Transgenic lineages were analysed in more detail to determine the dynamics with 
which oHg2 appears in FGF-2-treated cultures over 3 DIV. EGFP fluorescence was 
recorded in real time and the cells were fixed at the end of the recording period to be 
immunolabelled for 01ig2, /S-tubulin III and Glast for clone classification (chapter 2, 
section 2.9).
Figure 4.10 is an example of an 0+  clone in which the starting cell upregulated 
EGFP+ before the first division and maintained in all the daughter cells which were 
also 01ig2+ at 90 hours.
Figure 4.11 is an example of an 0+ /0 - clone which was apparently generated by 
asymmetric segregation of EGFP (and therefore 01ig2) at an early point in the
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end o f the experiment were both 01ig2+ and OHg2-negative. O f the Glig2-r 
cells, some retained strong EGFP fluorescence, some had weak EGFP fluor 
and some had no EGFP fluorescence. Given the lag in EGFP protein deg 
with respect to Qlig2 protein described in chapter 3, this is an unsurprising 
and could actually give an indication o f how recently the oHg2 ha 
down-regulated; EGFP+/01ig2- cells probably represent populations in whi< 
was recently down-regulated, but Glig2-negative cells in which EGFP fluor 
was also weak/absent probably represent an earlier down-regulation event, 
then the down-regulation o f oHg2 seemed to occur at multiple points wi 
lineage since there was a variety o f levels o f EGFP fluorescence at the en< 
experiments, indicating that it is first expressed and then down-regulated i 
cells to generate mixed G+/G- clones.
This data provides evidence for the idea that both initial asymmetric segreg 
oHg2 as well as later oHg2 up- or down-regulation can be responsible foi 
G+/G- clones.
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Figure 4.10 Stills from a time-lapse recording of a transgenic El 3.5 cortical NEP 
preparation in the presence of 10 ng/ml FGF-2 in which an 0+ clone was generated from a 
single cell in the starting culture. EGFP was up-regulated in the starting cell before the first 
division and was maintained in all daughter cells which all labelled for 01ig2 at the end. 
Note that the images of the stills from the experiment (18-68hrs) are cropped to show the 
cells more clearly and thus appear as though they are at a higher magnification.
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Figure 4.11 Stills from a time-lapse recording o f  a transgenic El 3.5 cortical NEP 
preparation in the presence o f  10 ng/ml FGF-2 in which an 0 + /0 -  clone was generated. The 
starting cell was EGFP-negative, but 2 o f  4 daughters were EGFP+ by 32 hours (white 
arrow). One o f  the EGFP-negative cells (black arrow 32h) divided once, and all were 
Qlig2-negative at 113 hours (black arrows). At 78 hours all the other daughter cells were 
EGFP+. Some down-regulated by 113 hours and were Glig2-negative (black, diamond- 
bottomed arrow). Others were EGFP+, but only weakly 01ig2+ (white dotted arrow) while 
other, strongly-EGFP+ cells were 01ig2+ at the end (white round-bottomed arrow).
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Figure 4.12 (above) Stills (A) and a lineage tree (B) from a time-lapse recording of a 
transgenic El 3.5 cortical NEP preparation in 10 ng/ml FGF-2 in which EGFP 
down-regulation was observed. At 58 hours, all daughter cells were EGFP+ (the two EGFP- 
cells at 58h were not part of the clone, and died by 78h). At 78 hours, one EGFP+ cell 
divided to give rise to two daughter cells with reduced EGFP fluorescence (white arrows), of 
which one was weakly 01ig2+ and the other was 01ig2- at 90 hours (white arrows). Brightly 
EGFP+ cells were strongly 01ig2+ at the end (diamond-bottomed arrows) whereas weaker 
EGFP correlated with weaker 01ig2 (round-bottomed arrows) indicating a possible 
correlation between strength of oHg2 and EGFP transcription. The downregulation of oUg2 
and EGFP appeared to occur at multiple branch points as can be seen from the lineage tree 
(B).
Figure 4.13 is an example o f a genuine asymmetric division since the first division 
gave rise to an EGFP+ and an EGFP- daughter cell. This was presumably a 
cell-intrinsic behaviour o f the starting NEP since the environment of the two 
daughter cells was identical. Although the EGFP-negative cells in this clone died, 
they did not divide again and had a neuronal morphology. They were therefore 
presumably neurons. The EGFP+ cells maintained EGFP fluorescence throughout 
the lineage, but not all were OHg2+ at 113 hours meaning that oHg2 down-regulation 
had occurred in some cells. Since, in vivo, oUg2+ precursors are known to give rise 
to neurons and oligodendrocytes and possibly also astrocytes, but is down-regulated 
as these cells differentiate, it is possible that these time-lapse movies are observing 
such differentiation events. While lineages were not filmed for more than 90 hours, 
some cultures were maintained over longer periods of time in order to account for the 
differentiation o f cells beyond 90 hours. OHg2 is maintained in oligodendroglial 
progeny and OLPs are seen to emerge over 4-5 days in FGF-2 according to the 
appearance o f early OLP markers such as NG2 and galactocerebrosidase (GC) which 
are co-expressed with Glig2 (Figure 4.14). Thus, despite oHg2 being subject to up- 
and down-regulation at early time points in FGF-2-treated lineages, continued 
expression for 4-5 days indieates commitment to the oligodendrocyte lineage.
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Figure 4.13 (above and previous page) Stills (A) and lineage tree (B) from a time-lapse 
recording o f  a transgenic El 3.5 cortical NEP preparation in the presence o f  10 ng/ml FGF-2 
in which an asymmetric division o f  the starting NEP gave rise to one EGFP+ and one 
EGFP-negative (white arrow) daughter cell by 28 hours. The EGFP- cell divided once to 
give two EGFP- daughters, neither o f  which divided further, but extended neurite-like 
processes and died by 95 hours (white arrows). These were presumed to be neurons as 
labelled in the lineage tree (B). O f the EGFP+ daughter cells some began to downregulate 
EGFP by 72 hours (black arrow) and these were Glig2-negative at 113 hours indicating 
complete oHg2 downregulation by this time. EGFP+/01ig2-negative cells (white dotted 
arrows) might indicate a more recent down-regulation o f oUg2 when EGFP protein 
degradation has not yet occurred. Strongly EGFP+ cells were Glig2+ at the end (black 
dotted arrows) indicating cells that they maintained oHg2 throughout the lineage. The 
retrospective lineage tree (B) indicated that oUg2 down-regulation could have occurred at 
multiple branch points within the clone.
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Figure 4.14 Sustained o/ig2 expression correlates with the acquisition of oligodendrocyte 
markers. After 4DIV in the time-lapse set-up, all 01ig2+ cells co-expressed NG2 (A,white 
arrows). At 7DIV, 01ig2 co-localised with GC (B). There were some persisting 01ig2- cells 
at this stage, and were probably neurons.
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4.2.7 FGF-2 increases cell division in the starting population independently of 
EGFP/Olig2 induction
Unpublished data from the Richardson laboratory has shown that oHg2 induction by 
FGF-2 in the cultures described here requires cell division since blocking the cell 
cycle with aphidicolin abolishes the effect. It is conceivable, therefore, that the 
expression of oHg2 in the presence o f FGF-2 was a by-product o f increased cell 
division rather than a direct induction by FGF-2 signalling. However, the increase in 
incidence o f 01ig2+ lineages in FGF-2 compared to controls far exceeded the relative 
increase in the number o f single cells that were induced to divide; 76.3% o f dividing 
cells in 10 ng/ml FGF-2 gave rise to EGFP-expressing cells compared to zero 
EGFP+ cells in control conditions, whereas there was only a ~ 1.5-fold increase in the 
proportion o f cells induced to divide by FGF-2 relative to controls. Furthermore, 
many EGFP-negative cells were observed to divide without up-regulating 
oUg2/EGFP^ and some dividing EGFP+ cells down-regulated oHg2/EGFP as they 
continued to divide. In order to investigate the relationship between cell division and 
oHg2 induction more quantitatively, time-lapse lineages were traced frame by frame 
to determine the number and duration of EGFP+ vs. EGFP-negative cell divisions 
that occurred in FGF-2-treated cultures. It was found that EGFP+ and 
EGFP-negative cells had comparable division times for the first four divisions 
observed (Figure 4.15). It is therefore very unlikely that FGF-2 induces simply 
by promoting division in a permissive environment or that rate o f division could 
influence the likelihood o f oUg2 expression. Many EGFP-negative cells died and 
none divided more than four times, whereas EGFP+ cells continued dividing for the 
entire 90 hours of filming. This demonstrated that EGFP+ cells were differentially 
responsive to the sustained mitogenic activity o f FGF-2.
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Figure 4.15 Comparison of division times of cells in EGFP+ vs EGFP- clones. There was 
no significant difference between division times for EGFP+ vs. EGFP-negative cells (P > 0.1 
for division times for EGFP+ vs. EGFP- cells for divisions 1 -4). However, EGFP-negative 
cells rarely underwent more than 4 divisions and most died before the end of the experiment. 
Therefore, divisions were not sustained in EGFP-negative clones. Note that the ‘first’ 
divisions indicate the time after the start of filming at which the first division was seen to 
occur. Subsequent divisions are quoted as absolute cell cycle time.
4.2.8 EGF does not induce oUg2 expression
Both FGF-2 and EGF have been implicated in the emergence of oligodendrocytes 
from neurospheres following mitogen withdrawal (Chandran et al., 2004;Kondo and 
Raff, 2000;Qian et al., 1998). Furthermore, Chandran et al showed that neurospheres 
from E l4 rat dorsal spinal cord cells cultured in EGF and FGF-2 were capable of 
generating oligodendrocytes. I therefore decided to compare the effects of EGF and 
FGF-2 on the cultures described here. When E l3.5 cortical NEPs were cultured on 
coverslips 1 found that EGF did not induce oHg2 even at concentrations up to 
20 ng/ml, unlike the strong inductive effect o f 10 ng/ml FGF-2. EGF-treated cultures 
were indistinguishable from controls with no apparent effect on cell division or 
expression of any differentiating cell markers (Figure 4.16). Therefore, even though 
these cells express EGF Receptor (EGFR) at this developmental stage (Tropepe et 
al., 1999), EGF does not elicit the same effect as FGF-2 with respect to oUg2 
induction. As a positive control, the same batch of EGF was used successfully in 
contemporaneous experiments by other lab members in a different culture paradigm. 
Thus, the absence of effect here must be attributed to an unresponsiveness of the 
cortical NEPs. The reason for this is unclear, but is most likely to be due to absence 
of necessary intracellular components or appropriate levels of EGFR.
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Figure 4.16 E13.5 cortical NEP cultures at 2 DIV in 10 ng/ml FGF2 (IOF), 5, 10 or 
20 ng/ml mouse EGF (5, 10, 20E) or 10 ng/ml human recombinant EGF (lOhE) versus 
control conditions. In all concentrations o f  EGF and in control conditions there was the 
occasional appearance o f  01ig2+ cells in doublets (lOE, lOhE), but most cells were /8-tubulin 
111+ neurons. In comparison, most cells were 01ig2+ (green) in 10 ng/ml FGF2. 
Furthermore, there was no significant difference in total cell number across any o f  the 
EGF-treated cultures or relative to controls.
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4.2.9 Dose-dependent response of cortical neuroepithelial precursors to FGF-2
Increasing concentrations o f FGF-2 generates significantly higher numbers o f OLPs 
(as determined by NG2 staining) in dense cortical NEP cultures assessed at a single 
time point (Kessaris et al., 2004). I therefore decided to investigate this effect at the 
level o f individual clones, using time-lapse microscopy.
E l3.5 cortical NEPs cultures were prepared and recorded by time-lapse microscopy 
in the presence o f 1-50 ng/ml FGF-2 over -90 hours. Both transgenic and wild type 
mice were used in different experiments according to availability and data were 
collated. The proportion o f single cells that divided over the recording period was 
comparable in all concentrations of FGF-2, but significantly higher than that in 
controls (Table 4.4);
Concentration 
of FGF-2 
(ng/ml)
0
(control)
1 10 15 25 50
% of single 
cells that 
divided
35  +/- 7 3 9  +/- 9 62  +/- 24 61 +/-18 62  +/-10 4 5  +/- 20
% of clones 
that survived
0 75  + /-14 63 +/-15 66 + / - 16 63 +/-10 0
Table 4.4 Comparison o f  percentage o f  single cells from E l3.5 NEP preparations that 
divided and clones that survived for immuocytochemical analysis in different concentrations 
o f  FGF-2. Data is shown as mean + /- standard deviation of triplicate experiments performed 
(data from 5 experim ents were assimilated for 10 ng/ml FGF-2 inputs). There was no 
significant difference between the figures for concentrations o f  10 ng/ml FGF-2 and above, 
but they ware all significantly different to the data collected for the 0 ng/ml and 1 ng/ml 
FGF-2 controls.
146
10 ng/ml 25 ng/ml ^  
1m u '
Figure 4.17 Two typical clones from a single experiment in which individual NEPs from the 
same preparation were cultured in either 10 or 25 ng/ml FGF-2. After 90 hours in culture, 
clones in 25 ng/ml FGF-2 were considerably larger than those derived in 10 ng/ml FGF-2, 
reflecting their shorter cell cycle time (Figure 4.18).
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Figure 4,18 D ivision times o f  cells in E l 3.5 cortical NEP cultures over 90 hours in different 
concentrations o f  FGF-2. Cell cycle time got progressively and significantly longer in 
10 ng/ml FGF-2 with a maximum o f  6 divisions occurring in 90 hours (A). Convereely, 
there was no significant difference in division time over 7 divisions in higher concentrations 
o f  FGF-2 and up to 8 divisions occurred in the culture period (A). There was no significant 
difference in division times in concentrations o f  15 ng/ml FGF-2 and above (B). Note that 
the ‘first’ divisions indicate the time after the start o f  filming at which the first division was 
seen to occur. Subsequent divisions are quoted as absolute cell cycle time.
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Despite there being no difference in the number o f single cells that were seen to 
divide after 18 hours, it was clear that clones derived in 25 ng/ml FGF-2 were 
considerably larger than those in 10 ng/ml (Figure 4,17) suggesting that cell division 
was faster in higher concentrations o f FGF-2. This was quantified by recording the 
cell cycle time for successive divisions o f daughter cells within clones at 10, 15, 25 
and 50 ng/ml FGF-2. Although an insufficient number o f cells survived in 50 ng/ml 
FGF-2 for clonal analysis (Table 4.4), division times could still be recorded and were 
therefore included. In 10 ng/ml FGF-2, the cell cycle time was 12-15 hours for the 
first couple o f divisions, but became progressively longer with each additional 
division (Figure 4.18 A). Thus, in a 90 hour culture period the cells divided a 
maximum of 6 times in 10 ng/ml FGF-2. However, in 15 ng/ml FGF-2 and above, 
the cell cycle time was sustained at -12-15 hours all through the 90 hour filming 
period (Figure 4.18 A, B) and was similar at all these higher concentrations o f FGF-2 
(Figure 4.18 B). Thus, in response to concentrations o f FGF-2 o f 15 ng/ml and 
above, up to 7-8 divisions could be accomplished in a 90 hour culture period 
compared to a maximum o f 6 in 10 ng/ml FGF-2. These extra couple o f rounds of 
division within 90 hours could contribute to the larger numbers o f OLPs in higher 
concentrations o f FGF-2 observed by Kessaris et al (Kessaris et al,, 2004).
At all concentrations o f FGF-2 there were some cells that failed to divide. Most died 
before the end o f the filming period and were therefore not identified by 
immunolabelling. Non-dividing cells in transgenic cultures were EGFP-negative and 
therefore presumably o//g2-negative, however, and although they were not formally 
identified many were presumed to be post-mitotic neurons by their morphology 
(Figure 4.19). There were other non-dividing cells which maintained a rounded 
appearance, some o f  which looked as though they were trying to divide 
(Figure 4.20). It is possible that these cells may have been apoptotic precursor cells 
unable to respond to FGF-2, but this was not addressed in these experiments.
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Figure 4.19 Putative neurons. Some had neutrite-like processes (white arrows) and others had large cell bodies 
with many processes (black arrows) which resembled the morphology of some /3-tubulin III+ neurons identified 
in other clones.
Figure 4.20 M orphologies o f  rounded cells seen in cultures that did not divide, but died 
before the end o f  the culture. Some looked as though they were trying to divide (white 
arrow), but never underwent cytokinesis. It is possible that these were apoptotic NEPs.
4.2.9 Higher concentrations of FGF-2 induce more NEPs in the starting culture 
to express and sustain oUg2
Immunolabelling of surviving clones demonstrated that there was a clear increase in 
the proportion of 0 +  clones generated in the presence of higher levels of FGF-2, the 
percentage o f 0 +  clones in 25 ng/ml being twice that generated in 10 ng/ml FGF-2 
(Table 4.5). Correspondingly, the proportion of O- and 0+/- clones decreased 
significantly with the most striking difference being that there were no O- clones at 
all in 25 ng/ml FGF-2 compared to 21% O- clones in 10 ng/ml FGF-2 (Table 4.5; 
Figure 4.21). Examples o f clones generated in 15 ng/ml and 25 ng/ml FGF-2 are 
shown in Figures 4.22- 4.27.
%o+ %o+/o- %o-
1 ng/ml FGF-2 1 +/-2.1 17 +/- 8 83 +/- 8
10 ng/ml FGF-2 46 +/- 15 34 +/- 13 21 +/- 13
15 ng/ml FGF-2 64 +/- 6 26 +/-11 9 + 1-1
25 ng/ml FGF-2 89 +/-10 11 +/-10 0+/-0
Table 4.5 Comparison o f  the distribution o f  clone types generated in El 3.5 cortical NEP 
cultures in different concentrations o f  FGF-2. Data is presented as mean +/- standard 
deviation for triplicate experiments (5 experiments for 10 ng/ml FGF-2)
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Figure 4.21 Clones derived from E l3.5 cortical NEP preparations in the presence o f  
different concentrations o f  FGF-2. The trend is towards an increase in o//gi-containing  
clones as FGF-2 concentration increases. O- clones are absent in 25 ng/ml FGF-2 and mixed 
clones are reduced in favour o f  0 +  clones.
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Figure 4.22 Stills from a time-lapse recording o f  an E l3.5 cortical NEP preparation in 
15 ng/ml FGFG-2 in which an O- clone was generated from a single cell in the starting 
culture. In this example, one daughter cell was a jS-tubulin III+ neuron, one looked as though 
it may have started to express /3-tubulin III (arrow) and the other was immunocytochemically 
unidentified.
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Figure 4.23 Stills from a time-lapse recording o f  an El 3.5 cortical NEP preparation in 
15 ng/ml FGF-2 in which an O- clone was generated. None o f  the cells were identifiable by 
01ig2 or /3-tubulin III labelling.
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Figure 4.24 Stills from a time-lapse recording of transgenic El 3.5 cortical NEPs in 
15 ng/ml FGF-2. After two divisions, four j3-tubulin III+ cells were generated (starred cells). 
At 70 hours, an EGFP+/01ig2+ cell and an unidentified cell moved into the field of view 
from a nearby clone (white and black arrows respectively). These should not be confused 
with the dividing cell that generated green /3-tubulin 111+ neurons (starred cells).
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Figure 4.25 Stills from a time-lapse recording of an El 3.5 cortical NEP preparation in 
15 ng/ml FGF-2 in which an 0+/0- clone was generated from a single cell in the starting 
culture. There were only a few 01ig2-negative cells in the final clone (some are indicated 
with white arrows). It was not possible to follow the lineage of this complex clone.
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Figure 4.26 Stills from a time-lapse recording of an E l3.5 cortical NEP preparation in 
15 ng/ml FGF-2 in which an 0+ clone was generated. The cells became too numerous and 
crowded to allow the lineage to be determined.
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Figure 4.27 Stills from a time-lapse recording of a transgenic El 3.5 cortical culture in the presence of 25 ng/ml FGF-2 in which an 0+ clone was 
generated. EGFP was appeared after the first division, just before the second division occurred at 29 hours. Thereafter, all daughter cells were brightly 
EGFP+, resulting in a large clone of EGFP+ cells by 113 hours. Counter-staining with anti01ig2 (red) determined that all of these cells were 
additionally 01ig2+. This was therefore a 0+ clone.
The dose-dependent decrease in proportion of O- clones and increase in proportion 
of 0 +  clones suggested that there was not only an increase in the induction of oUg2 
expression, but that maintenance o f oHg2 expression in cells was also increased at 
higher concentrations o f FGF-2. Indeed, there was little evidence for 
down-regulation o f EGFP fluorescence at all in transgenic cultures in 25 ng/ml 
FGF-2. However, clone sizes were large in concentrations o f 15 ng/ml FGF-2 and 
above, so individual cell behaviour was very difficult to trace. Examples of 
transgenic clones including the few clones in which down-regulation of EGFP was 
observed are shown in Figures 4.27- 4.30.
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Figure 4.28 Stills from a time-lapse recording of a transgenic E l3.5 cortical NEP 
preparation in the presence of 25 ng/ml FGF-2. In this clone, EGFP fluorescence was 
detected at the time of the first division at 23 hours and appeared to be maintained in all 
daughter cells thereafter. Counter-staining for 01ig2 at 98 hours determined that all cells 
were 01ig2+, although one cell (arrow) had weak 01ig2 and EGFP fluorescence. This 
appeared to be an 0+ clone, but if the single arrowed cell was genuinely 01ig2- this could 
indicate oUg2 down-regulation
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F ig u r e  4 .2 9  Stills and lineage tree from a time-lapse recording of a transgenic El 3.5 cortical 
NEP preparation in 15 ng/ml FGF-2. An asymmetric lineage was derived with an O- and an 
0+/0- branch. Although the EGFP and jS-tubulin III staining were the same fluorescent 
bandwidth, the two were separable by performing sequential immunolabelling such that the 
EGFP image was captured before )3-tubulin III staining was performed. Thus the three 
neurons (white arrows on the stills, black arrows on the lineage tree) could be identified. In 
the 0+/0- branch, EGFP was upregulated by the second division and was maintained in all 
daughter cells. All but two of the daughter cells were strongly 01ig2+ (black teardrops). 
The other two (cream teardrops) were weakly 01ig2+ at 90 hours indicating oUg2 
down-regulation.
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Figure 4.30 Stills and lineage tree from a time-lapse recording of a transgenic El 3.5 cortical 
NEP preparation in 15 ng/ml FGF-2 in which an asymmetric 0+/0- clone was generated. 
EGFP was up-regulated in one daughter cell after the first division and maintained in all 
daughter cells thereafter (green circles in the lineage tree). Two migrated out of the field of 
view, but the remaining two EGFP+ daughters were 01ig2+ at 90 hours (red). The other, 
EGFP-negative daughter cells (white arrows) were /3-tubulin III+ neurons (green at t90).
No EGFP+/01ig2- cells were identified in any transgenic clones in concentrations of 
FGF-2 above 10 ng/ml, suggesting that oUg2 down-regulation was infrequent. 
Anecdotally, in dividing cells, EGFP fluorescence was brighter in the presence of 
25 ng/ml FGF-2 than in lower concentrations, indicating higher levels of oUg2 
transcription. Thus, the observed effects o f FGF-2 were two-fold; a mitogenic effect 
that saturated at concentrations of FGF-2 above 10 ng/ml and an inductive effect on 
oUg2 which continued to increase at concentrations of FGF-2 above 10 ng/ml.
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4.2.10 Changes in fate potential of cortical NEPs during development
Cells acutely dissected from ElO -  El 7 embryonic cortices stain principally for 
neuronal markers (Barolo and Posakony, 2002;Qian et al., 2000) corresponding to 
the fact that neurogenesis in the cortex occurs mainly between the ages o f El 2.5 and 
E l7 in the mouse. When cultured over 7 days however, while most E l0.5 NEPs 
generate only neurons, some give rise to mixed clones containing both neurons and 
glia in unmodified culture medium (Davis and Temple, 1994;Qian et al., 2000;Qian 
et al., 1997). These data indicate an intrinsic tendency for neurogenesis at early ages 
followed by gliogenesis, corresponding to the ‘neurons first, glia second’ dogma o f 
CNS development. The addition o f FGF-2 increased the number o f glia in a mixed 
clone and Davis and Temple further demonstrated that the mixed clones generated 
from NEPs dissected from progressively older embryos contained a progressively 
higher glia : neuron ratio of daughter cells in the presence o f 10 ng/ml FGF-2 (Davis 
and Temple, 1994;Qian et al., 2000). This indicated that the multipotent NEPs 
become progressively more gliogenic with age. However, since only mixed clones 
were analysed in these studies, there was no indication o f how the ratio o f dedicated 
neuroblast : neuroglial progenitor within the initial cell preparation changed with 
developmental age. I therefore decided to re-address the question o f whether NEP 
preparations from different developmental ages had differential responses to FGF-2 
and whether they were therefore intrinsically different in their responses to FGf-2. 
This was addressed using time-lapse microscopy. The majority o f the cultures were 
prepared from wild type mice. Some cultures were prepared from 01ig2-EGFP 
transgenic mice to compare the dynamics o f oUg2 expression in younger embryonic 
ages with the data acquired from E l3.5 preparations described above.
4.2.11 E10.5 NEP cultures generate only neurons
Clones derived from E l0.5 NEPs were difficult to trace as the cells clumped together 
if  they divided and mostly died when they were plated at clonal density. The rate o f 
cell division was slow in these cultures however, meaning that clones were small; 
this had the benefit that mixing of neighbouring clones was unlikely. It was 
therefore possible to plate single cells at a higher density and to include some lumps 
o f less-dissociated tissue without compromising clonal analysis o f the single cells 
that were present. The higher plating-density encouraged better cell survival, likely 
due to localised self-conditioning of the medium. Divisions remained difficult to
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trace within an expanding clone and few clones could be characterised accurately 
since most single cells died and many cells within expanding clones also died even 
with the enhanced survival observed upon plating at higher densities. However, it 
was possible to ascertain that there were no 01ig2+ cells, even in large clusters of 
cells over 3 DIV. Moreover, immunocytochemical analysis identified only 
/3-tubulin III+ neurons throughout the cultures (Figures 4.31 -  4.33). Some of the 
single cells that produced a traceable lineage proved to be dedicated neuroblasts 
(N-clones), giving rise only to neuronal progeny (Figure 4.34). This was not 
quantified however, since there was not sufficient survival to make valid clone 
classifications in most cases although qualitatively speaking, it could be said that 
100% o f clones were 0 -. To ascertain whether the immunocytochemically 
unidentified cells could be induced to express glial markers with increased FGF-2 
signalling, the experiments were repeated in the presence o f 25 ng/ml FGF-2. 
However, this level o f FGF-2 seemed to be toxic since none o f the cells survived.
In order to investigate the differences in response to FGF-2 for cortical NEPs of 
different embryonic ages, cultures were also prepared and filmed from El 1.5 and 
£12.5 embryos as described in the next section. None of these cultures were filmed 
for more than 90 hours in order to make the data comparable to that collected from 
El 3.5 cultures. The limitations o f this are that the full potential o f these NEPs is not 
described. Thus, while no 01ig2+ cells were observed in time-lapse from El 0.5 
cultures over 3 DIV, 01ig2+ cells are seen to emerge over 7-10 DIV (data not shown) 
indicating that these NEPs have the potential to generate OLPs, but not over the time 
frame observed. Nevertheless, the 90 hour data collected indicates a difference in 
responsiveness to FGF-2 even if  it does not reveal the full potential o f the NEPs.
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Figure 4.31 Stills from a time-lapse recording of an El 0.5 cortical NEP culture. Even in large groups of cells there were no 01ig2+ cells and 
possibly only one Glast+ cell (black arrow) at 89 hours. Most cells were /3-tubulin III+ neurons.
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Figure 4.32 Stills from a time-lapse recording of an El 0.5 cortical NEP preparation. There were 4 starting cells in this recording, and 
although their individual lineages could not be distinguished, there were no 01ig2+ cells at 91 hours and roughly half of the daughter 
cells were (3-tubulinIII+ neurons. This distribution of cells could arise by N-clones mixing with clones that generate both neurons and 
unidentified cells or all of the starting cells may have generated a mixed population of daughter cells
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Figure 4.33 Stills from a time-lapse recording of an E10.5 NEP preparation. Over 89 hours in culture, a clone of 12 cells was derived. The 
focus drifted during the filming so the lineage could not be accurately traced, but a mixture of /3-tubulin III+ neurons and 
immunocytochemically unidentified cells was generated.
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Figure 4.34 Stills and a lineage tree from a time-lapse recording of an El 0.5 cortical NEP 
preparation which gave rise to 12 ^-tubulin III+ neurons and two cells that died. Since all 
identifiable cells were neurons and the two that died had the same morphology as the others, 
it was presumed that the starting cell was a dedicated neuroblast and this was classified as an 
N-clone.
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4.2.11 NEPs become more gliogenic with age
Preparations from El 1.5, E l2.5 and E l3.5 embryos had good enough survival over 
~90 hours (Table 4.6) for quantifiable clonal analysis (Table 4.7).
E11.5 E12.5 E13.5
% of single cells that 
divided
38 +/- 9 68  +/- 24 54 +/-13
% of clones that 
survived
78 +/- 20 83 +/- 9 69 +/- 8
Table 4.6 Percentage of single cells that divided and percentage of clones that survived for 
immunocytochemical analysis in 10 ng/ml FGF-2 in preparations derived from cortices of 
different embryonic ages (El 1.5, E l2.5, and E l3.5). Data is presented as mean +/- standard 
deviation for triplicate experiments (5 experiments for E l3.5). E10.5 data is not included 
since not enough single cells survived for valid quantitative analysis.
E10.5 E11.5 E12.5 E13.5
% o+ 0 1 +/- 0.8 30 +/-19 46 +/-15
% o+/o- 0 22 +/-15 4 4 + /-17 34 +/-13
% o- 100 77 +/-16 27 +/- 2 21 +/-13
%N ? 61 +/-23 10 +/- 3 0
Table 4.7 Distribution of clone types generated in preparations of cortical NEPs derived 
from different embryonic ages (E10.5, El 1.5, E12.5, E13.5) in the presence of 
10 ng/ml FGF-2.
In contrast to E l0.5 cultures, the El 1,5-derived NEPs gave rise to some, although not 
many 01ig2+ cells; -1%  0+ , 22% 0 + /0 -  and 77% 0-. The total percentage o f O- 
clones was made up o f 61% N-clones and 16% contained both /3-tubulin III+ and 
immunocytochemically unidentified cells (Table 4.7). There were many cells that 
did not divide, and those that survived were found to be ^-tubulin III+ neurons. 
Examples of the different clone types derived from these El 1.5 cultures in 10 ng/ml 
FGF-2 are shown in Figures 4.35 -  4.38.
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Figure 4J5  Stills from a time-lapse recording of an El 1.5 cortical NEP preparation in 
10 ng/ml FGF-2 in which both a dedicated neuroblast (white star) and 2 post-mitotic neurons 
(black and white arrows) were present. Only one cell divided (starred cell at 18h) and it 
gave rise to 2 /3-tubulin III+ neurons and was therefore classified as an N-clone. The starting 
cell indicated by a white arrow at 18 hours could have been a sister cell to the starred 
neuroblast since it looked like cytokinesis was just completing at this time. However, 
because the division itself was not observed, it was not classified as part of the same clone.
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Figure 4.36 Stills and a lineage from a time-lapse recording of an El 1.5 preparation 
in 10 ng/ml FGF-2 which included both a mixed neuronal clone (lineage drawn) and 
an N-clone. The N-clone derived from what was presumably a dedicated neuroblast 
(black arrows). The mixed clone (derived from the circled cell) also generated two 
neurons (white arrows). The remaining cells were unidentified.
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Figure 4.37 Stills from a time-lapse recording of an El 1.5 NEP preparation in 10 ng/ml FGF-2 which included an N-clone and an 
0+/0- clone. The N-clone was derived from the cell indicated by a white arrow at 18 hours which divided once and generated two 
neurons (white arrows). The other starting cell (white star) divided many times to yield an 0+/0- clone with many 01ig2+ cells (black 
arrows), jS-tubulin III+ neurons (white dashed arrows) and immunocytochemically unidentified cells (white dotted arrows)
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Figure 4.38 Stills from a time-lapse recording of an El 1.5 cortical NEP preparation in 10 ng/ml FGF-2. Two cells did not divide 
and were /3-tubulin III+ neurons (white arrows). One cell (starred cell at 18h) divided several times to yield an 0+ clone (black 
arrows). The cells that have been blacked out are cells that entered the field of view from a nearby clone. This is an example of 
one of the few 0+ clones derived from El 1.5 cultures. The other starting cell (boxed) at 18 hours underwent several divisions, but 
mostly outside of this field of view.
In cultures from E l2.5 embryos, there was a dramatic increase in the production of 
01ig2+ cells and a decrease in neurons compared to El 1.5 data since 30% of 
surviving clones were 0 +  and the total O- clones was 27% with only 10% being 
N-clones (Table 4.7). Examples of E12.5-derived clones are shown in 
Figures 4.39 - 4,41.
18h 70h
EGFP
%
jâi^ubulin 111
Figure 4.39 Stills from a time-lapse recording of an E l2.5 cortical NEP preparation in 
10 ng/ml FGF-2. This is an example of an N-clone in which the starting cell divided twice to 
yield four jS-tubulin III+ neurons. The only 01ig2 staining here (in red) corresponded to 
EGFP+/Oilg2-t- cells that migrated into the field of view from a nearby clone.
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Figure 4.40 Stills from a time-lapse recording of an El 2.5 cortical NEP preparation in 10 ng/ml FGF-2 in which one cell gave rise to a mixed 
clone of 01ig2+ and /3-tubulin IIH- cells as well as some cells which were immunocytochemically unidentified (white arrows). These had 
elongated processes and might be radial glial cells although they did not stain for the ROC marker Glast. Since all cells were EGFP+ at 55 hours, 
some down-regulation must have occurred to generate the jS-tubulin 111+ cells and those which were unidentified. This is another example of the 
dynamic nature of oUg2 expression in these cultures.
Figure 4.41 Stills from a time-lapse recording of a transgenic E l2.5 cortical NEP 
preparation in 10 ng/ml FGF-2 in which an 0+ clone was derived. One starting cell (black 
arrow) divided and expressed EGFP by 51h. All daughter cells maintained EGFP 
fluorescence and all counter-stained for Qlig2 at 80h. Other cells in the starting field of view 
died or divided once and died by 68h.
In E l3.5 cultures, 46% were 0+ , 34 % were 0 + /0 - and 21% were O- and all 
O- clones contained a mixture o f /3-tubulin 111+ neuron and unidentified cells 
meaning there were no dedicated neuroblasts (Table 4.7). Other than the absence o f 
N-clones in E l3.5 cultures, the clone distribution was not dissimilar to that produced 
in E l2.5 cultures. There was therefore clearly a switch Ifom neurogenic to gliogenic 
potential of NEPs in the presence of 10 ng/ml FGF-2 between the ages o f El 1.5 and 
E l2.5 (Figure 4.42). Since the percentage of surviving clones was similar in the 
different cultures (Figure 4.43; Table 4.6; 78% survival for El 1.5, 83% for E12.5 
and 69% for E l3.5), the distributions o f clone types derived from cultures prepared 
from the different embryonic ages were probably a consequence of the genuine 
emergence o f different lineages in response to FGF-2, rather than differential 
survival of clone types at different ages. Fewer starting cells in El 1.5 preparations 
divided relative to those in E l2.5 or El 3.5 cultures (Table 4.6), further suggesting 
that FGF-2 also had a less potent effect with respect to cell division as well as for 
induction of oUg2 at El 1.5.
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Figure 4.42 A) Distribution o f  clone types derived from cortical NEP preparations from 
embryos o f  different ages. B) Relative appearance o f  01ig2+ cells in clones derived from 
cultures from m ice o f  different embryonic ages. 0 +  clones here indicate the sum o f  0 +  and 
0 + /0 -  clones. All cell preparations were in 10 ng/ml FGF-2. Data is shown as mean +/- 
standard deviations. Quantitative analysis could not be done for clones from E l0.5 cultures 
since few survived.
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Figure 4.43 Comparison across cortical preparations from mice o f  different embryonic ages 
o f  the percentage o f  single cells in the starting population that divided at least once (blue) 
and the percentage o f  these dividing cells that went on to generate a larger clone which 
survived the filming period for immunocytochemical analysis (purple). Clones were filmed 
in 10 ng/ml FGF-2 over 72 hours. Data is presented as mean +/- standard deviation.
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4.2.12 Younger NEPs are less susceptible to oligl Induction even at high 
concentrations of FGF-2
The dose-dependent increase in oHg2 expression with increasing FGF-2 in E l3.5 
preparations was not replicated to the same extent in younger NEPs. Anomolously, 
El 1.5 cultures grown in basic medium without FGF-2 as controls survived unlike for 
E l2.5 or E l3.5 preparations and were therefore also analysed. In these El 1.5 
controls without FGF-2, 100% of surviving clones were O- compared to 77% O- in 
10 ng/ml FGF-2 and 81% O- in 25 ng/ml FGF-2 (Table 4.8; Figure 4.44). On closer 
inspection, the nature o f the O- clones were classified as being either derived from 
dedicated neuroblasts (N-clones) or mixed neuronal (containing neurons and 
unidentified cells). 100% of clones were N-clones in controls whereas in 10 and 
25 ng/ml FGF-2, 61% and 56% were N-clones respectively (Table 4.8). This 
indicated a decrease in neurogenesis relative to controls in response to FGF-2, 
although the effect was not enhanced with increasing levels o f FGF-2. 3% of the 
clones generated in the presence o f 25 ng/ml FGF-2 were 0 +  compared to 1% in 
10 ng/ml FGF-2. Although this was only a small increase, it was significant 
(Table 4.8; P = 0.02) while the percentage o f O- and 0 + /0 -  clones did not change 
significantly (Table 4.8; 22% 0 + /0 -  in 10 ng/ml FGF-2, 16% 0 + /0 -  in 25 ng/ml 
FGF-2 P>0.5; 77% O- in 10 ng/ml FGF-2, 81 % in 25 ng/ml FGF-2 P>0.5).
%o+ %o+/o- %o- %N
10 ng/ml FGF-2 1 +/- 0.8 2 2  + /-1 5 77 +/-16 61 +Z-23
25 ng/ml FGF-2 3 +/. 0.5 16 +/- 12 8 1 +/-11 56 +/-19
control 0 0 100 100
Table 4.8 Distribution of clone types derived from El 1.5 cortical NEP cultures in the 
presence of 0 (control), 10 or 25 ng/ml FGF-2. Data is presented as mean +/- standard 
deviation.
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Figure 4.44 Differences in clone types derived from El 1.5 cortical NEP cultures in 10 vs. 
25 ng/ml FGF-2. The proportion of O- clones did not decrease significantly with increasing 
FGF-2 (P>0.5), but the proportion of 0+ clones increased significantly from 1% to 3% 
(P = 0.02). Data is presented as mean +/- standard deviation.
Thus, it appears that increased  FG F-2 sign a llin g  increased the in c id en ce o f  oHg2 
exp ression  in E l 1.5 N E P  preparations, p ossib ly  at the ex p en se  o f  n eurogenesis, since  
the proportion o f  0 +  c lo n es  increased  w h ile  the proportion N -c lo n es  decreased  
(T able 4 .8 ). A  se lec tio n  o f  c lo n e  typ es derived from  E l 1.5 cultures in  25 ng/m l 
F G F-2 are sh ow n  in F igures 4 .4 5  -  4 .4 8 .
174
18h 37h
78h
Figure 4.45 Stills from a time-lapse recording o f  an E l 1.5 cortical NEP preparation in 
25 ng/ml FGF-2. This recording is an example o f  an N-clone in which two jS-tubulin III+ 
neurons were generated from the division o f  one starting cell (starred at 18h). The other 
starting cell (black arrow) did not divide, but was jS-tubulin III+ at 78 hours. 56% o f  clones 
were neuroblasts in 25 ng/ml FGF-2 as compared to 73% in 10 ng/ml FGF-2 and 100% in 
controls.
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Figure 4.46 Stills and a lineage from an E l 1.5 cortical NEP preparation in 25 ng/ml FGF-2 
in which a mixed neuronal clone was generated. Only one neuron was generated after the 
first division and all other cells were unidentified. There were no Glig2+ cells, thus 
classifying this as an O- clone.
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Figure 4.47 Stills and a lineage tree from a time-lapse recording o f an E l 1.5 cortical NEP preparation in 25 ng/ml FGF-2 in which an 
0 + /0 -  clone consisting o f  7 01ig2+ cells and 3 unidentified cells was derived. It seems from the lineage that the induction o f oHg2 likely 
occurred late in the lineage. Compared to E l3.5 cultures, these clones generated small numbers o f cells. The other starting cell at 18 
hours (black arrows) did not divide and died.
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Figure 4.48 Stills from a time-lapse recording o f  an El 1.5 cortical NEP culture in 25 ng/ml FGF-2 in which an 0 +  clone was 
generated. The starting cell indicated with a white arrow divided several times to yield 14 01ig2+ daughter cells. The other starting 
cell (black arrow) divided once and both o f  these daughter cells (arrows) died.
E 12.5-derived  cultures a lso  show ed  o n ly  a sm all increase in 0 +  o n ly  c lon es with  
increased FG F-2; from  30%  in 10 n g/m l FG F-2 to 40%  in 25 ng/m l FGF-2  
(T able 4 .9 ). T he proportion o f  N -c lo n es  how ever, doubled (from  10% to 21%  in 10 
vs. 25 n g/m l F G F -2) w h ilst the proportion o f  0 + /0 - c lo n e s  decreased  slightly  
(T able 4 .9 ; F igure 4 .49 ; 44%  in 10 ng/m l FG F-2 and 32%  in 25  ng/m l FG F-2).
%o+ %o+/o- % o- % N
10 ng/ml FGF-2 30  +/-19 4 4  +/-17 27  +/- 2 10 +/-3
25 ng/ml FGF-2 4 0  +/- 1 32  +/- 2 29  +/- 3 21 +/- 3
Table 4.9 Distribution o f  clone types derived from El 2.5 cortical NEP cultures in the 
presence o f  10 or 25 ng/ml FGF-2.
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Figure 4.49 Differences in clone types derived from El 2.5 cortical NEP cultures in 10 vs. 
25 ng/ml FGF-2. The proportion o f  0 +  clones increased marginally, but not significantly 
(P = 0.62 lOF vs. 25F), as did the proportion o f  neuroblasts (P = 0.55 lOF vs. 25F), and the 
proportion o f  0 + /0 -  clones decreased marginally, but not significantly (P =  0.52 10 vs. 25F). 
In 25 ng/ml FGF-2 however, the proportion o f  0 +  clones was significantly larger than in 
El 1.5 preparations (P =  0.0085 E l 1.5 0 +  clones vs. E12.5 0 +  clones in 25 ng/ml FGF-2). 
Furthermore, O- clones were significantly fewer in E12.5 than in El 1.5 cultures in 
10 ng/ml FGF-2 (P = 0.027 El 1.5 O- clones vs. E12.5 O- clones in 10 ng/ml FGF-2). E12.5 
cultures in control conditions without FGF-2 did not survive the culture period.
T he increase in the proportion o f  neuron-only  c lon es (N -c lon es) w ith increasing  
FG F-2 concentration seem s to be an anom alous result and w as on ly  just significant 
(P =  0 .05  for %N clon es in 10 vs. 25  ng/m l FG F-2). This anom aly could not be  
attributed to d ifferences in the percentage o f  d ivid ing or surviving ce lls  since this
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was not significantly different in 10 or 25 ng/ml FGF-2 (Table 4.10; Figure 4.50). It 
was clear however, that induction of oHg2 was far greater in E l2.5 cultures than in 
preparations from earlier embryonic ages. Examples o f the clones generated from 
E l2.5 cultures in 25 ng/ml FGF-2 are shown in Figures 4.51 and 4.52.
E 11 .5
IGF
E 1 1 .5
2 5 F
E 12 .5
IGF
E 12.5
25F
E 13 .5
IGF
E 13 .5
2 5 F
% of single 
cells that 
divided
38 +/- 9 36  +/-10 68 +/- 24 78 +/- 6 62  +/- 24 62 +/-10
% of clones 
that 
survived
78 +/- 20 78 +/-1 83 +/- 9 79  +/- 6 63 +/-15 63 +/-10
Table 4.10 Percentage o f  single cells in the starting culture that divided and percentage o f  
clones that survived for analysis in cultures prepared from different embryonic ages (E l 1.5, 
E12.5 and E13.5) in either 10 or 25 ng/ml FGF-2 (IGF or 25F respectively).
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Figure 4.50 Summary o f  the percentage o f  starting cells that divided at least once, and the 
percentage o f  the dividing cells that gave rise to clones that survived until the end o f  the 
experiment in El 1.5 and E l2.5 cultures in both 10 and 25 ng/ml FGF-2. There was no 
significant difference in the number o f  starting cells that divided nor the clone survival at 
different concentrations o f  FGF-2.
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Figure 4.51 Stills from a time-lapse recording of a transgenic El 2.5 cortical NEP 
preparation in 25 ng/ml FGF-2 in which an 0+/0- mixed clone was generated. At 54 hours, 
some cells from a nearby clone entered the field of view (demarcated by dotted line), but the 
majority of daughter cells from each clone were separable. Note that 2 cells (black arrows) 
from the original clone were seen to down-regulate EOF? and were 01ig2/EGFP-negative at 
90h. They were also jS-tubulin Ill-negative and were thus unidentified. A few other cells 
also seemed to down-regulate EGFP and 01ig2 (dotted black arrows). All other cells were 
01ig24 meaning the original clone was mixed. A few cells died (white arrows), but the 
divisions weren’t traceable so no lineage tree was drawn.
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F ig u r e  4 .5 2  Stills from a time-lapse recording of a transgenic El 2.5 cortical NEP 
preparation in 25 ng/ml FGF-2 in which an 0+ clone was generated from the starting cell 
indicated with a black arrow. EGFP was visualized after the first division, but only in one 
daughter cell. The EGFP-negative daughter was EGFP+ before its second division however, 
and all daughter cells thereafter were also EGFP+. All daughter cells were EGFP+/01ig2+ at 
85h. The other starting cell divided once and both daughter cells died by 54h (white arrows).
Overall responsiveness to FGF-2-induced oHg2 expression increased in cells derived 
from older embryonic ages. Furthermore, the clone sizes generated in preparations 
from older embryos were much larger, indicating that cells within clones were 
responding more to the mitotic effects of FGF-2. This was not quantified since 
divisions were frequently too difficult to trace, but the sizes of the clones and the 
anecdotal impression that cells were dividing faster in recordings of older cultures 
indicate that the older NEPs divided faster in response to FGF-2 relative to younger 
NEPs. Furthermore, NEPs derived from embryos younger than El 1.5 were 
unresponsive to FGF-2 with respect to oligl induction even at high concentrations.
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4.2,13 OHg2 up- and down-regulation can account for mixed clones in younger 
NEP preparations
As seen in E13.5 cultures, E12.5 and E11.5-derived cultures also showed 
down-regulation o f oUg2 after induction in some instances meaning that, at all 
developmental ages, olig l expression is a plastic event. An example of EGFP/01ig2 
down-regulation is shown in the earlier Figure 4.40, which is a lineage derived from 
E l2.5 NEPs in 10 ng/ml FGF-2. In this example all cells were EGFP+ by 43 hours, 
but by 75 hours two cells had completely down-regulated EGFP and had radial glial 
cell morphology although they were Glast-negative. At least 6 other cells were 
EGFP+, but 01ig2-negative, indicative o f more recent olig l down-regulation. Most 
01ig2-negative cells were also negative for all other markers, although two cells were 
j8-tubulin 111+ neurons (Figure 4.40). This demonstrates that EGFP+/01ig2+ 
precursors can become both neurons and other cell types with an unknown 
immunocytochemical profile. Another example can be seen by revisiting Figure 
4.51, which shows a clone derived from an E l2.5 NEP in 25 ng/ml FGF-2. Even at 
this responsive age, in high FGF-2, there was some EGFP and olig l down-regulation 
since two EGFP+ cells were EGFP/01ig2-negative at 90 hours and were also 
negative for any other markers. EGFP down-regulation was not observed in high 
concentrations o f FGF-2 in E l3.5 cultures however, indicating that the tendency to 
maintain o lig l expression might also increase with developmental age. Figures 4.52 
and 4.53 show lineages in which EGFP (and therefore oligl) up-regulation was 
recorded. In Figure 4.52, one cell was EGFP-negative at 33 hours, but they were all 
EGFP+ by 54 hours, going on to generate an 0 +  clone. Figure 4.53 shows a lineage 
from an E l l .5 NEP culture in 10 ng/ml FGF-2 in which EGFP was activated in a 
selection o f daughter cells by 48 hours and by 67 hours almost all cells were EGFP+. 
There was down-regulation o f EGFP thereafter however; yielding an 0 + /0 -  clone, 
including some /3-tubulin 111+ neurons, by 93 hours. In this example, the brightness 
of EGFP fluorescence matched that o f 01ig2 with weakly EGFP+ cells having weak 
01ig2 immunolabelling and vice versa. Thus, as was seen in the experiments 
described for E l3.5 cultures, oligl up- and down-regulation can occur in cultures 
from younger embryonic cortices as well, but also in high concentrations of FGF-2 
which was not seen for E l3.5 cultures.
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Figure 4.53 Stills from a time-lapse recording of an El 1.5 cortical NEP preparation in 10 ng/ml FGF-2 in which a starting cell 
divided at 18h and yielded a large clone of both EGFP/01ig2+ cells and |8-tubulin III+ neurons. The cells were too close together to 
draw an accurate lineage, but most cells expressed EGFP at some point and many down-regulated it (matched with weak/absent 
01ig2 staining). Others remained EGFP-negative and of these, some gave rise to neurons.
4.2.14 Effects of Sonic Hedgehog on clonal density cortical neuroepithelial 
precursor cells
Since Sonic Hedgehog is the principle signalling molecule required for 
oligodendrogenesis in the CNS, I decided to assess how SHH affected the dynamics 
of oligl expression in cortical NEPs in comparison to the responses to FGF-2. A 
small-molecule SHH agonist from Curis Inc (Cur-0188168/SHH-Agl.2, named SAg; 
(Frank-Kamenetsky et al., 2002)) was used at a working concentration o f 100 nM, 
added to the basic culture medium (Bottenstein and Sato’s defined medium, 
conditioned as described previously). At this concentration, SAg induces oligl in 
dense E l3.5 cortical NEP cultures within 20 hours, and NG2+ cells within 72 hours 
(Kessaris et al., 2004). Furthermore, the numbers o f 01ig2+ and NG2+ cells 
generated in 100 nM SAg are comparable to those in 10 ng/ml FGF-2 in dense 
cultures (6x10^ cells/ml). Thus, 100 nM SAg was deemed an appropriate 
concentration for the time-lapse experiments described here to enable direct 
comparison to the effects o f  FGF-2. Unlike FGF-2-treated cultures, however, I 
found that cells did not survive well at clonal density in 100 nM SAg and basic 
medium alone. Survival improved when 1 ng/ml FGF-2 was also added to the 
medium. This level o f FGF-2 did not induce olig l in many cells although the 
occasional 0 + /0 -  clone was identified (Table 4.5; Figure 4.54). Furthermore, 
addition o f 1 ng/ml FGF-2 to 100 nM SAg-treated cultures did not affect the 
percentage o f single cells that divided as compared to NEPs grown in 100 nM SAg 
alone (Table 4.11). However, the survival effect of this level o f FGF-2 enabled the 
SAg-treated cultures to be recorded over 90 hours.
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% of single NEPs that 
divided
% of clones that 
survived over 90 hours
Control (0 nM SAg) 40 +/-18 0
1 ng/ml FGF-2 39 +/- 7 75 +/-14
100 oM SAg 42 +/-16 0
100 nM SAg + 1 ng/ml FGF-2 42 +/-9 79 +/-15
50 nM SAg + 1 ng/ml FGF-2 42 +/- 6 76 +/- 7
200 nM SAg + 1 ng/ml FGF-2 51 +/-18 75 +/-10
Table 4.11 Percentage of single cells in the starting culture that divided and the percentage 
of clones that survived for immunolabelling compared between different concentrations of 
SAg with and without 1 ng/ml FGF-2, 1 ng/ml FGF-2 alone and controls.
% o + % o + /o - % o -
1 ng/ml FGF-2 1 +/-2.1 17 +/- 8 83 +/- 8
50 nM SAg 
+1 ng/ml FGF-2
52 +/- 35 31 +Z-24 18 +/- 14
lOOnM SAg + 
1 ng/ml FGF-2
37 +/-19 44 +/-16 20 +/-10
200 nM SAg + 
1 ng/ml FGF-2
49 +/- 32 44 +/- 27 8 +/- 7
Table 4.12 Comparison of distribution of clone types in different concentrations of SAg in 
the presence of 1 ng/ml FGF-2 and in 1 ng/ml FGF-2 alone.
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Figure 4.54 Stills from a time-lapse recording of an E l3.5 cortical NEP preparation in the 
presence of 1 ng/ml FGF-2 in which an 0+/0- clone was formed. Although oUg2 expression 
was induced at 1 ng/ml FGF-2, the number of 01ig2+ cells was small. The other cells were 
/3-tubulin 111+ neurons or remained immunocytochemically unidentified. This sort of lineage 
with 01ig2+ cells was a very rare occurrence as mostly only neurons were generated under 
these conditions.
4.2.15 Sonic agonist induces oUg2 over a range of concentrations
El 3.5 embryonic cortical NEPs were cultured and filmed in the presence of SAg at 
50, 100 and 200 nM along with 1 ng/ml FGF-2. The lineages were consistently 
difficult to trace however, since the cells frequently clumped together making 
individual divisions difficult to observe. The percentage of single cells that divided 
within the recording period could be counted however and was similar at all 
concentrations o f SAg (Table 4.11). The proportion of clones that survived for 
immunocytochemical analysis was also similar across the SAg concentration range 
analysed (Table 4.11) and were elassified as 0+, 0+ /0 - or O- clones as previously 
defined. The ratio of 0 +  : 0 + /0 - : O- clone types was roughly 2:2:1 in all
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concentrations o f SAg (Table 4.12, Figure 4.55). Examples of clones generated in 
the different concentrations o f SAg are shown in Figures 4.56 -  4.58.
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Figure 4.55 Distribution of clone types in different concentrations of SAg in the presence of 
1 ng/ml FGF-2 (IF). There was no general trend in the distribution of 0+, 0+/0- and O- 
clones across the different culture conditions and standard deviations were large enough to 
deem any differences as insignificant.
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Figure 4.56 Stills from a time-lapse recording of a cortical NEP preparation in the presence of 50 nM SAg + 1 ng/ml FGF-2 in which 
an 0+/0- clone was generated. One cell (black star) divided once and died. The other starting cell (red star) divided several times 
and gave rise to 8 Qlig2+ cells, 3 weakly-expressing Glig2+ cells and 4 unidentified cells that were negative for |3-tubulin III and 
Glast and GFAP. The |3-tubulin III staining shown here was for a neuronal process extending fi"om a cell in a nearby clone.
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Figure 4.57 Stills from a time-lapse recording of an E l3.5 cortical NEP preparation in the 
presence of 50 nM SAg + 1 ng/ml FGF-2 in which an 0+ clone was generated although one 
of the daughter cells aws only weakly 01ig2+ at 78 hours (arrow).
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Figure 4.58 Stills from a time-lapse recording of an E l3.5 cortical NEP preparation in the 
presence of 100 nM SAg + 1 ng/ml FGF-2 in which an 0+/0- clone was generated with an 
apparently asymmetric lineage. After two divisions at 32 hours, the four daughter cells had 
distinct morphologies and two did not divide again and were /3-tubulin III+ neurons while the 
other two continued to divide and generated only 01ig2+ cells.
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The classification o f clones was difficult in many instances however, since many 
cells died within the lineages. Thus, for example, while the only surviving cells may 
have been 01ig2+, 01ig2-negative cells may have been present but died before the 
termination o f the experiment. Thus, the distinction between clones was ambiguous 
in many instances and classification was therefore variable as indicated by the large 
standard deviations (Table 4.12, Figure 4.57). It was decided, therefore, to simplify 
the clone classification as either being either Olig2-containing or 01ig2-negative 
(Table 4.13, Figure 4.59). This classification system reduced variability and showed 
that clones were statistically similar between the concentrations o f SAg tested. The 
difficulties in clone discrimination are likely a side effect o f poor survival. Higher 
concentrations o f FGF-2 in the medium could afford better cell survival, but were not 
feasible for use since higher concentrations of FGF-2 would also induce the 
appearance o f oUg2 on its own and would thus compromise the effects of SAg. 
Other cell survival agents were used such as the anti-caspase agent Q-VD-OPH 
(TCS Cellworks), but no improvement in survival was noted.
% Olig2-containing 
clones
% 01ig2-negative 
clones
1 ng/ml FGF-2 18 +/- 8 83 +/- 8
50 nM SAg 
+1 ng/ml FGF-2
82 +/-14 18 +/- 14
lOOnM SAg + 
1 ng/ml FGF-2
80 +/-10 20 +/-10
200 nM SAg + 
1 ng/ml FGF-2
92 +/- 7 8 + /-7
Table 4.13 Comparison of distribution of clone types in different concentrations of SAg in 
the presence of 1 ng/ml FGF-2 and 1 ng/ml FGF-2 alone for the simplified classification of 
clones being either Glig2-containing or Glig2-negative.
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Figure 4.59 Distribution of Oligl-containing vs. Oligl-negative clones generated in 
different concentrations of SAg in the presence of 1 ng/ml FGF-2 (IF). There was no 
statistically significant difference in clone type frequencies over the range of SAg 
concentrations studied (P = 0.28 for Oligl-negative clones and P = 0.29 for Oligl-containing 
clones).
4.2.16 Oligl up- and down-regulation was observed in SAg-treated cultures
When transgenic mice were used as a source of ceils, both oHg2 up- and 
down-regulation could be assessed. Figure 4.60 shows a lineage in which the 
starting cell was EGFP+ at 18 hours and all daughter cells were EGFP+ at 44 hours. 
There followed complete down-regulation of EGFP in all daughter cells so they were 
all EGFP/Oligl-negative at 90 hours. Two were /3-tubulin 111+ neurons, but the other 
remaining cell was unidentified. It was generally not possible to trace lineages and 
observe changes in EGFP fluorescence in SAg-treated cultures, so the frequency of 
oHg2 up- or down-regulation occurring was not ascertainable.
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Figure 4.60 Stills from a time-lapse recording of an El 3.5 cortical NEP preparation in the presence of 100 nM SAg + 1 
ng/ml FGF-2. The starting cell was EGFP+ and EGFP fluorescence was maintained in all cells until 44 hours, but after 
this time there was complete down-regulation and all remaining daughter cells were EGFP/01ig2-negative at 90 hours. 
The other daughter cell that survived at 90 hours was unidentified (01ig2, Glast negative, white arrow). Another cell 
migrated into the field of view at 38 hours (black arrow), but died by 44 hours. At 90 hours there were three EGFP+ cells 
that migrated into the field of view from a neighbouring clone (black stars).
4.2.17 Cell division times do not vary across the different concentrations of SAg
Over the course of several experiments, sufficient divisions were observed for 
statistical analysis and it was found that there was no significant difference in 
division times at different concentrations of SAg (Table 4.14; Figure 4.61). 
Furthermore, division times did not increase during the course of the filming period, 
but kept constant over 90 hours. This is in contrast to the effects seen when cells 
were grown in 10 ng/ml FGF-2 when cell cycle time increased with successive 
divisions.
r*
division
2"d
division
3 rd
division
4‘"
division
5‘"
division
6*"
division
50 nM 
SAg + IF
8 +/-1 14+/-1 13 +/- 3 14 +/-3 14 +/-6 15+/-7
100 nM 
SAg + IF
7 +/-1 13 +/- 2 13+/-2 15 +/- 2 15 +/-1 14 +/-2
200 nM 
SAg + IF
7+/-2 13 +/-1 15 +/- 3 16 +/- 4 10 +/- 0 -
Table 4.14 Cell cycle times across a 90 hour filming period for cells in expanding clones in 
the presence o f  50, 100 or 200 nM SAg + 1 ng/ml FGF-2. Division times were not 
significantly different for cells in different concentrations o f  SAg, nor did division times 
change across the 90 hours observed. A maximum o f  6 divisions were observed, similar to 
clones in the presence o f  10 ng/ml FGF-2.
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Figure 4.61 Division times for successive divisions o f  cells within expanding clones in the 
presence o f  50, 100 or 200 nM SAg + 1 ng/ml FGF-2. Division times were similar at all 
concentrations o f  SAg analysed and, furthermore, were similar all through the 90 hour 
filming period. Note that the ‘first’ divisions indicate the time after the start o f  filming at 
which the first division was seen to occur. Subsequent divisions are quoted as absolute cell 
cycle time.
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4.3 DISCUSSION
4.3.1 Summary of Results
With the mounting evidence that FGF-2 is involved in regulating cell fate 
specification in the developing CNS, I examined how it influenced the generation of 
01ig2+ cells from NEPs derived from the embryonic dorsal telencephalon. It has 
previously been shown that FGF-2 can induce the expression o f oUg2 and the 
subsequent generation o f OLPs both in culture (Chandran et al., 2003;Kessaris et al., 
20041;Qian et al., 1997) and more recently in vivo (Naruse et al., 2006), but whether 
this was a secondary effect to mitosis or an independent effect had not been clarified. 
The data I acquired demonstrated that the extent o f  oUg2 induction by FGF-2 far 
exceeded the FGF-2-mediated increase in mitosis suggesting that these two activities 
are independent. Moreover, the proliferative effect was saturating at concentrations 
o f FGF-2 above 10 ng/ml while the induction of oHg2 continued to increase up to 
25 ng/ml FGF-2 in E l3.5 preparations. The induction o f oUg2 was greatly reduced in 
preparations from younger animals, however, even in the presence o f high FGF-2. 
This indicated a relative insensitivity to FGF-2 at E10.5 and E l l .5. In comparison, 
the response o f El 3,5 NEPs to SAg was less pronounced relative to the response to 
FGF-2, although oUg2 induction was observed at a significant level relative to 
controls. In contrast, no response to EGF was observed at all. I further showed that 
oHg2 induction can occur at various points within a lineage and is not necessarily 
maintained in the cells that are induced to express it. This means that there is a 
window o f plasticity during early oUg2 expression during which oHg2+ cells may 
still diverge from an oligodendroglial fate in vitro, much like in vivo.
4.3.2 FGF-2-induced proliferation is not sufficient for oUg2 induction
The data from this chapter show that FGF-2 not only increases the total number o f 
dividing cells in culture, but that the rate o f division also increases. This effect was 
true for both EGFP+ and EGFP-negative cells, since they divided at the same rate, 
but EGFP-negative cells rarely underwent more than 4 successive divisions. Thus, 
although the induction of oUg2 might be independent o f cell division, its expression 
correlates with a more proliferative cell type, meaning that 01ig2+ clones are 
expanded more than 01ig2-negative ones. Unpublished data from our lab has shown
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that induction o f oUg2 by FGF-2 is abolished by the application of aphidicolin, 
which arrests the cell cycle at the G l/S phase interface or within S phase itself This 
data together with my observations suggest that, while progression through the cell 
cycle is necessary, it is not sufficient for oHg2 induction.
The indication that proliferation and oHg2 induction might be independent responses 
to FGF-2 should be investigated further. The identification o f differential 
components involved in cell division vs. induction of transcription could give 
valuable insights into the possible role o f FGF-2 in CNS patterning and development, 
which has its roots in the balance between cell division and cell specification. In 
support o f the idea that the two responses are separable, FGF-2 has been shown 
previously to be capable o f eliciting a variety o f cellular responses independently 
(Boilly et a f, 2000). In NIH-3T3 cells, a mutant variation o f FGF-2 (FGF-2 SI 17 A) 
continues to be able to stimulate differentiation, but not proliferation (Bailly et al., 
2000). Similarly, a 6-amino acid deletion mutant of FGF-2 can induce proliferation 
as normal while migratory responses are considerably reduced in foetal bovine aortic 
endothelial cells and in NIH-3T3 cells (Isacchi et al., 1991). The dissociation of 
responses to FGF-2 has also been achieved pharmacologically; inhibition of protein 
kinase C (PKC) (a downstream effector o f FGF-2 signalling) in NIH-3T3 cells 
prevents FGF-2-induced migration, but not proliferation (Besser et al., 1995;Isacchi 
et al., 1991;Presta et al., 1989).
4.3.3 FGF-2 increases the generation of OIig2+ cells over 3DIV by a 
combination of proliferation and induction of oUg2
95% o f cells acutely dissected from E l3.5 embryos expressed Dcx+ (a neuroblast 
marker) in the absence o f FGF-2. Furthermore, all clones that were generated in 
control cultures without FGF-2 contained only neurons over 3DIV, indicating that 
most NEPs at E l3.5 were neurogenic. Thus, the finding that 79% of clones 
contained 01ig2+ cells in the presence o f 10 ng/ml FGF-2 means at least some early 
NEPs were re-programmed to a more gliogenic fate. Furthermore, the finding that, 
at 48 hours, O- clones contained only /3-tubulin III+ neurons, but at 90 hours they 
contained a mixture o f /3-tubulin III+ neurons and unidentified cells implies that 
neurons themselves may be able to de differentiate under FGF-2 signalling. This 
could however, be a misleading result since there were very few O- clones counted at
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all at 48 hours and, moreover, the occasional cell within O- clones died leaving it 
unidentified. Although these consistently had the morphology o f a neuronal cell, 
their identity was unconfirmed and it is therefore possible that, in these neuronal 
O- clones (N-clones) there may have been multipotent cells that died before 
immunocytochemical analysis. This will have to be investigated further to be 
confident of this idea.
The induction o f oUg2 in response to FGF-2 increased as concentration of FGF-2 
increased in E l3.5 cultures, reminiscent of the dose-dependent effect seen by 
Kessaris et al in dense cultures (Kessaris et al., 2004). Although the proliferative 
response to FGF-2 was saturated at concentrations o f FGF-2 above 15 ng/ml, 
increased proliferation no doubt also contributed to the increase in NG2+ cells 
observed in dense cultures. The data I described in fact indicate that it is a 
combination o f responses to FGF-2 that could account for the increase in NG2+ cells 
in a dense population o f cortical NEPs with increasing FGF-2:
* recruitment of more starting cells to generate oUg2+ clones
* maintenance o f oUg2 in expressing cells
* sustained rapid cell division, enabling the exponential growth o f o/ig2-expressing 
clones
It would be o f interest to investigate what down stream signalling components are 
involved in the induction of oUg2 and proliferation in response to FGF-2 at different 
concentrations. Maher et al (1999) determined that p38MAPK, but not Erk 
(extracellular regulated kinase) activity was involved in FGF-2-stimulated 
proliferation o f NIH-3T3 fibroblasts via FGFRl signalling at 25 ng/ml FGF-2 
(Maher, 1999). Garcia-Maya et al, however, demonstrated that both high 
(>10 ng/ml) and low (0.1 ng/ml) concentrations of FGF-2 were associated with cell 
survival and differentiation in fibroblast NIH3T3 cell line cultures while 
intermediate concentration ranges (1-10 ng/ml) induced proliferation along with 
inhibition of cell differentiation (Garcia-Maya et al., 2006). These differential 
responses related to changes in profiles o f the intracellular components FRS-2 (a 
downstream effector of FGF signalling, chapter 1), Erk and p38MAPK. For 
example, p38MAPK and FRS-2 were rapidly down-regulated in higher
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concentrations o f FGF-2 (Garcia-Maya et al., 2006). Despite differences in 
proliferative response at high concentrations o f FGF-2 identified by these two 
groups, p38MAPK was universally identified as being involved in a proliferative 
response. Components that are uniquely required for FGF-2-induced differentiation 
have not been confirmed.
FRS2 is a pivotal component o f the docking protein complex that associates with 
FGFRs upon activation and is itself a central molecule for the recruitment of 
signalling molecules (Schlessinger, 2004). FGF-2 could feasibly have differential 
cellular effects according to its concentration via the recruitment and activation of 
more downstream components such as FRS2. Since different FGFR isoforms bind 
FGF-2 with differing affinities (Omitz et al., 1996) it is also a possibility that the 
differential responses seen at higher concentrations o f FGF-2 could be via 
recruitment o f lower affinity receptors.
4.3.4 NEPs from embryonic cortices younger than E12.5 are unresponsive to 
FGF-2-induced expression of oligl
Induction o f olig l did not occur significantly at embryonic ages younger than El 2.5. 
This is complementary to the in vivo period o f neurogenesis in the embryonic cortex, 
which occurs in earnest before the onset o f neurogenesis. Not only is there an 
intrinsic tendency for neurons first, glia second therefore, but there is also a change 
in responsiveness o f these embryonic NEPs to FGF-2 over the course of 
development. How the increase in responsiveness to FGF-2 occurs is not addressed 
here. Future experiments could be designed to ascertain whether this change in 
responsiveness is intrinsic by determining whether daughter cells derived from El 1.5 
preparations cultured over 2-3 DIV in the absence of FGF-2 have the same 
responsiveness to FGF-2 as freshly-dissected E l3.5 cells. A great deal o f work 
would need to be done to establish a suitable experimental design to enable this in 
vitro analysis. Molecular characterisation o f the intracellular components that might 
be involved at different ages should be assessed in order to ascertain the reason for 
the differential response to FGF-2 at different embryonic ages. This could be 
achieved by immunolabelling for the presence of PLCy, PI3-K and PKC as these are 
different signalling components that are recruitable by FGF-2 signalling. Western 
blot could also be used to identify the presence of activated components of the
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FGFR-associated docking complex (FRS2, Grb, SHC) to determine whether 
differential transduction o f FGF-2 signalling enables differential responses of NEPs 
from different embryonic ages. FGF-2 signalling has been implicated in the direct 
regulation o f gene transcription following translocation to the nucleus (Bailly et al., 
2000;Besser et al., 1995;Isacchi et al., 1991) and it is therefore possible that 
epigenetic effects within a cell may influence its responsiveness to FGF-2 signalling 
and this is also something that should be investigated. Whatever the mechanism, the 
data presented here indicate that neurogenesis is ‘protected’ at earlier stages of 
development and that gliogenesis can possibly only be precociously induced later in 
development, consistent with the idea that a neural network should be established 
before supporting cells are generated.
The fact that neurons are bom before glia and that they may derive from a common 
precursor in the CNS is well described, as discussed in Chapter 1. The elonal 
analysis I have described also categorically demonstrates that both neurons and glia 
can be derived from single progenitors from ages as early as El 1.5 (Figures 4.8, 
4.37, 4.38 and 4.41). This has previously been demonstrated by Davis and Temple 
and Qian et al (Davis and Temple, 1994;Qian et al., 1997) where E l0.5 preparations 
were cultured for up to 7 days, over which time glia and neurons were seen to 
emerge. With the use of transgenic cultures I have also specifically shown that 
o//g2-expressing cortical NEPs can give rise to both neurons and glia. The means by 
which a common precursor changes from being neurogenic to gliogenic are not yet 
known, although interplay between transcription factors promoting gliogenesis vs. 
those that promote neurogenesis will certainly be central to this mechanism. An 
example o f this is the co-expression o f the neurogenic bHLH factor Neurogenin-2 
(ngn-2) and oHg2 required for the generation of motor neuron precursors in the pMN 
domain in the spinal cord (Mizuguchi et al., 2001;Novitch et al., 2001;Scardigli et 
al., 2001) and the later exclusion of ngn-2 from oHg2+ cells that is necessary for the 
onset o f oligodendrogenesis thereafter (Sun et al., 2001;Zhou and Anderson, 2002). 
The data I have presented indicate that oHg2+ NEPs can also be a common precursor 
to both neurons and glia in the developing cortex.
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4.3.5 01ig2 expression is dynamic
A significant finding o f the work described here is that oUg2 can be down-regulated 
subsequent to its induction, indicating induced oHg2 expression by FGF-2 does not 
irreversibly commit E l3.5 cortical NEPs to an oligodendrocyte fate in vitro. In 
combination with the possibility that neuronal cells may de-differentiate as described 
above, these data suggest that cell specification is a dynamic process and that 
developmental/differentiation programmes can be reversed or modified. It is known 
that in the spinal cord, motor neuron precursors express oHg2 which is rapidly 
down-regulated in post-mitotic, terminally differentiating motor neurons. Furusho et 
al (Furusho et al., 2006) directly described the generation of neurons from 
o/zg2-expressing precursors in mouse spinal cords. Using tamoxifen-induced cre~lox 
mediated recombination to permanently activate a reporter gene in o/zg2-expressing 
cells at E l2.5 in mice, they found derivative reporter-gene labelled cells in the E l8 
spinal cord that expressed neuronal markers including ChAT. This is consistent with 
the in vitro data 1 described here where 01ig2+ precursors gave rise to neurons in 
which oUg2 had down-regulated. There is evidence that oHg2 might also be involved 
in early specification o f a pan-glial progenitor in preference to a neuronal one 
(Marshall et al., 2005), raising the possibility that some o f the cells that 
down-regulated oUg2 in my experiments, yet did not express jS-tubulin 111, might be 
astrocytes or astrocyte precursors. Although no GFAP expression was observed in 
the cultures analysed here, GFAP is a late astrocyte marker and would not 
necessarily mark immature astrocytes. Some of the 01ig2-negative cells were seen to 
express Glast, although labelling was usually very weak. The population of cells that 
remained unidentified is o f great interest and their identification is pressing. Markers 
such as Nestin and SlOO-jS should be used to ascertain whether they express other 
stem cell or astrocyte-related proteins respectively given that they were negative for 
Glast, RC2 and GFAP.
The up- and down-regulation of oUg2 observed indicates that there may be a window 
o f opportunity within which cell fate may be plastic even in the presence of an 
inductive ligand. However, the co-expression of 01ig2 with other OLP markers by 
120 hours in culture implies that these Glig2+ cells are likely to be firmly committed 
to the oligodendrocyte lineage. I observed anecdotally that the more intense the 
initial EGFP fluorescence, the more likely it was that the descendants o f that cell
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would maintain oHg2 expression. Thus, the initial strength/level of oHg2 expression 
might influence commitment to the oligodendrocyte lineage. This hypothesis is 
supported by recent evidence from Liu et al, demonstrating a delayed expression of 
mature oligodendrocyte markers in heterozygous oUg2 mutants as compared with 
wild type controls (Liu et al., 2006). They also noted reduced numbers of 
MBP+/PLP+ mature oligodendrocytes in older spinal cords which was not 
accountable for by an increase in cell death. Furthermore, prolonged expression of 
oHg2 in the dorsal chick spinal cord caused mature oligodendrocytes to emerge from 
dorsal NEPs within 4 days whereas a more transient expression o f oUg2 induced 
oligodendrocytes later and in reduced numbers. This led to the conclusion that dose 
as well as duration o f oHg2 expression is important in oligodendrocyte specification 
and supports the observations I have made.
4.3.6 Responses to other signalling molecules:
EGF
Comparison o f the effects o f EGF with those o f FGF-2 signalling was important to 
analyse given their complementary roles in neurosphere formation from cortical stem 
cells. Furthermore, an asymmetric distribution o f EGFR has been demonstrated in 
subventricular zone cells in the embryonic murine forebrain both in vitro and in vivo 
(Sun et al., 2005). This asymmetrical distribution o f EGFR is thought to underlie 
functional differences in daughter cells; High EGFR denotes an astrocytic fate and 
low EGFR determines that cells that could go on to pursue the oligodendrocyte 
lineage (Sun et al., 2005). Thus, it was possible that EGF might have had an effect 
on the induction o f oUg2 and astrocyte markers and/or on cell proliferation. 
However, I found no observable effect of EGF signalling on E l3.5 NEP. 
Furthermore, the addition o f EGF in combination with FGF-2 at lOng/ml had no 
effect on the inductive effects o f FGF-2 alone. However, while Tropepe et al 
determined that there is EGFR expression in NEPs at E l3.5, this was not confirmed 
in my experiments and it is therefore possible that there was no EGFR expression in 
the cultured NEPs that I observed. Even if  there was a baseline o f EGFR expression, 
since FGF-2 signalling is known to induce EGFR upregulation, it is possible that in 
the absence o f FGF-2, EGFR expression was not sufficient for an observable 
response to EGF. Unfortunately, the lack o f both available markers and time meant 
that this question could not be answered. As a possible alternative explanation, the
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fact that the NEPs cultured here were at clonal density may have affected their 
responsiveness to EGF signalling. Tropepe et al determined that the proliferative 
response to EGF o f NEPs derived from E14.5 mouse embryonic brains depended 
upon cell density; at low density (10 cells/jul), EGF induced a proliferative effect half 
the magnitude o f that o f FGF-2, but at high densities (50 cells//d) EGF induced a 
proliferative response -1 0  times greater than that to FGF-2 (Tropepe et al., 1999). 
Since the ‘low density’ in the experiments described by Tropepe et al was equivalent 
to the clonal density at which cells were plated in my experiments, it is possible and 
likely that the absence o f EGF-induced proliferation or induction could be related to 
the need for cell-cell contact for this to occur. The suggested importance of cell-cell 
contact and paracrine signalling between neighbouring cells is an inherent caveat to 
the data acquired here although it means that the responses observed in these clonal 
time-lapse experiments reveal a more cell-intrinsic capacity to respond to exogenous 
signalling.
Sonic Hedgehog
SHH has a well-defined role as a dorso-ventral patterning morphogen in the spinal 
cord, but its role in the developing brain is less clear. Like in the spinal cord, SHH is 
involved in both neurogenesis and oligodendrogenesis in the brain, being important 
in the induction o f dopamine-releasing neurons in the midbrain (Hynes et al., 1995) 
and serotinergic neurons in the ventral forebrain (Ericson et al., 1995;Fedtsova and 
Turner, 2001;Hynes et al., 1995;Kohtz et al., 2001;Ye et al., 1998) early in 
development (E9-E12) and important in oligodendrogenesis thereafter. The 
experiments described in this chapter investigated the effects o f SHH signalling on 
dorsal cortical NEPs from E l3.5 mice from a region in which neurogenesis is still 
ongoing and endogenous oligodendrogenesis has not begun (Ericson et al., 
1995;Kessaris et al., 2006). Given that FGF-2 induced oUg2 expression in a 
dose-dependent fashion in these cultures (Kessaris et al., 2004) and that SHH is a 
classified morphogen in the CNS (Echelard et al., 1993), it was expected that a 
dose-dependent induction of oHg2 within a bandwidth o f SAg concentrations should 
be seen. In dense E l3.5 cortical NEP cultures this is indeed the case; SAg induces 
large numbers o f OLPs at concentrations between 250 and 500 nM, but above or 
below these concentrations the numbers o f NG2+ cells generated declines 
significantly (Kessaris et al., 2004). Contrary to this, the data presented in this
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chapter indicate that SHH does not act as a morphogen in the same E l3.5 cortical 
NEPs when they are cultured at clonal density. No significant difference in the 
expression o f olig l was observed across a range of SAg concentration of 50-200 nM. 
Furthermore, SAg alone did not enable sufficient cell survival for any level of oUg2 
induction to be observed and there was an obligate requirement for the presence of at 
least 1 ng/ml FGF-2 for sufficient cell survival for analysis. It is known that FGF-2 
signalling is required in vitro at least for SHH-induced oUg2 expression via the 
activation of MARK since blocking FGF-2 signalling with an FGFRl inhibitor in 
dense cultures blocks SAg-induced oHg2 expression (Kessaris et al., 2004). This 
indicates that there is endogenous FGF-2 signalling in dense cultures since SAg was 
able to induce oUg2 without the exogenous addition o f FGF-2, but this is not the case 
in the clonal cultures recorded here. It could be assumed that in clonal cultures, the 
benefits of proximal production o f FGF-2 by neighbouring cells are removed and it is 
therefore feasible and likely that the addition o f FGF-2 in these experiments 
facilitated an obligate requirement for FGF-2 signalling in SAg-induced oUg2 
expression in addition to a role as a survival factor. Unfortunately, given the poor 
survival and difficulty in analysing the clones in these cultures, the data was variable. 
This meant that quantification of the distribution o f clone types did not reveal a clear 
trend across the different concentrations o f SAg. Qualitatively, the clones generated 
in all concentrations were similar although there seemed to be more cell division in 
the higher doses o f SAg. It was also still possible to determine that oUg2 up-and 
down-regulation occurred in the presence o f SAg as it did in FGF-2 meaning that 
SAg does not induce the irreversible expression o f oUg2 and manipulation of 
differentiation programmes might still be possible. More work will need to be done 
in order to analyse this more thoroughly.
The absence o f morphogenetic activity of SAg on the clonal cultures o f E l3.5 
cortical NEPs described here could be due to expression o f downstream effectors in 
these cells being different to those in spinal cord domain NEPs. If SHH signalling is 
strong enough it can induce the generation o f a weak Gli3 activator isoform (Bai et 
al., 2004;Wang et al., 2000), while it normally regulates Gli3 post-translationally to 
alter Gli3R availability. If SHH additionally encouraged the generation o f Gli3 A in 
preference to GH3R in dorsal cells in the brain, SHH signalling may have a more 
direct activating effect here than in the dorsal spinal cord. To assess this possibility.
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the quantification o f GH3A vs. Gli3R should be performed by both Western blot 
analysis on dorsal cortical NEP cultures both in the presence and absence of SAg. 
Furthermore, the expression of other downstream components should be analysed in 
comparison to ventrally-derived NEPs to determine whether the differential effects 
of SHH could be attributed to availability o f intracellular signalling molecules as 
well as differential regulation o f Gli3 isoform modification. If there is the 
availability o f suitable antibodies, the detection of the different Gli3 isoforms may 
also be detected in real time by in situ immunolabelling and visualization of NEPs 
using time-lapse. This could give a better idea of the dynamics o f Gli3 regulation 
upon SHH signalling.
The fact that not a huge proliferative or cell survival effect was observed with the 
addition of SAg indicates that these cells behave differently in low density than in 
high density cultures. What causes this difference is yet to be ascertained although 
evidence suggests that is might be related to FGF-2 signalling or, at least, MAPK 
activation (Kessaris et al., 2004). In vivo, FGF-2 is widely available so the effects of 
SHH are likely to be supported by FGF-2 activation o f intracellular events if  they are 
indeed physiologically required. This could potentially be assessed by regionalized 
blocking o f FGF-2 signalling by topical application o f FGFRl inhibitors in 
oligodendrogenic domains. Whether the sonic agonist has different effects to 
endogenous SHH is also a contentious issue. Previous experiments have indicated 
that they induce equivalent effects in dense cultures (Kessaris et al., 2004), however, 
this should also be quantified for clonal preparations to confirm the observations 
described here. Certainly, the differences in responses of NEPs cultured in high vs. 
clonal density should be studied further to help determine what physiological 
implications data obtained from experiments like these might have.
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Chapter 5 
Final Discussion
5.1 Summary of results
The aim of this work was to use time-lapse microscopy to observe, in detail, the 
behaviour of individual neuroepithelial precursor cells (NEPs) cultured at clonal density. 
In particular, the responses of embryonic cortical NEPs to FGF-2 and a Sonic Hedgehog 
agonist (SAg) were analysed since these are two factors that play important roles 
throughout CNS patterning and development and in glial development in particular. 
FGF-2 has been shown to induce both the expression of oUg2 and the generation of OLPs 
in culture (Kessaris et al., 2004) and can also induce the generation of ectopic OLPs in 
vivo (Naruse et al., 2006). My experiments examined the induction of oHg2 in cultured 
NEPs using time-lapse microscopy. NEPs cultured from the dorsal cortex of E l3.5 
mouse embryos do not express oUg2 over 3 days in vitro when cultured in basic medium 
without added FGF-2. However, oUg2 expression is observed within 24 hours in the 
presence of FGF-2. Time-lapse analysis of olig2 expression within the clones generated 
from dividing NEPs was facilitated by the use of the transgenic mouse line that I 
generated, which expressed enhanced green fluorescent protein (EGFP) under the same 
transcriptional control as oUg2, The main findings were that FGF-2 induced oUg2 
expression in a dose-dependent manner over 90 hours in NEPs from E l3.5 embryos, but 
not in NEPs from E l0.5 or El 1.5 embryos. Filming over only 90 hours meant that the 
analysis of cell potential was limited to this time frame. Indeed, over longer culture 
periods, E l0.5 NEPs eventually gave rise to 01ig2+ cells. However, it was clear that 
over 90 hours there was a marked difference in response to FGF-2 in NEPs from different 
embryonic ages; E l3.5 NEPs being highly sensitive to oUg2 induction and increased rates 
of proliferation and younger NEPs being more refractory to FGF-2 signalling.
Furthermore, in E l3.5 cultures, higher concentrations of FGF-2 resulted in the 
maintenance of oUg2 expression in oUg2+ cells. Consequently, more cells in the final
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clones were Oüg2+. Since OLP specification seems to require sustained oUg2 
expression, it is likely that increasing FGF-2 signalling would increase the number of 
OLPs that are generated as more cells would maintain oHg2 expression. FGF-2 also had 
a pronounced effect on cell division and caused E13.5-derived NEPs to divide at an 
accelerated rate that was sustained over 90 hours in higher concentrations of FGF-2. 
These data indicate that FGF-2 acts pleiotropically on these NEPs sine both oUg2 
expression and proliferation were affected. The combination of maintained oUg2 
expression with increased cell division clearly accounts for the dramatic increase in OLPs 
seen in increasing concentrations of FGF-2 described by Kessaris et al (Kessaris et al., 
2004). Since such effects were not observed over 90 hours for NEPs derived from 
younger embryos, something must change in NEPs between El 1.5 and E l3.5 making 
them responsive to FGF-2 and permissive of gliogenesis. Furthermore, since E l0.5 
NEPs do have the potential to generate OLPs over time, it is possible that the E l3.5 NEPs 
are lineal descendents of the El 0.5 NEPs,
The Sonic Hedgehog agonist (SAg) also induced oUg2 in the NEPs, but not in an obvious 
dose-dependent manner, at least over the concentration range that I used. This was 
unexpected since, in the dense cultures described by Kessaris et al, SAg induced oHg2 in 
a dose-dependent way, peaking between 200 and 500 nM (Kessaris et al., 2004). This 
response to SAg required a basal level of FGF signalling since it was blocked by FGFR 
inhibitors. It was also blocked in the absence of MAPK activation and an obligate 
requirement for MAPK activation for OLP generation could be satisfied through FGF-2 
signalling (Kessaris et al., 2004). In clonal density cultures there is perhaps insufficient 
production of FGF-2 by neighbouring cells to meet the requirement for FGF; this might 
explain the different responses to SAg in clonal density versus high-density cultures.
There still remain several questions that are unanswered. First, through what signalling 
pathways does FGF-2 elicit proliferation and induction of oHg2 in NEPs and are they 
genuinely separable responses? Second, what is the basis of the differential effects to 
FGF-2 at different embryonic ages and are E l3.5 NEPs lineal descendents of E l0.5 
NEPs? Third, what is the difference, if any, in the response of NEPs to SAg (or SHH)
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and FGF? These questions could be approached by microarray analysis of the NEPs of 
different ages and in different conditions in order to establish what signalling components 
are involved in different scenarios. The use of specific inhibitors may also be useful in 
determining the signalling pathways which are involved. Finally, the question of identity 
of the cells that did not immunolabel for any of the markers used here should also be 
addressed. In order to do this, a good understanding of mechanisms involved in OLP, 
neuron and astrocyte precursor specification must be established.
5.2 A question of density
The difference in response to SAg in high- versus clonal-density cultures could be 
attributed to the availability or absence of FGF-2 given the findings of Kessaris et al 
(Kessaris et al., 2004). Plating density is important with respect to signalling via cell-cell 
contact and/or paracrine signalling events. This implies that the responses seen in clonal 
density cultures may not reflect what happens in a high density population of cells. 
Tropepe et al determined that differential plating density of E14.5 NEPs dramatically 
affected their mitogenic and neurosphere-forming response to EGF (relative to FGF-2); 
in low-density cultures, the mitogenic response to EGF was half that seen in response to 
FGF-2, however, the two mitogens induced comparable mitogenic responses in 
higher-density cultures, with EGF actually having a slightly stronger effect than FGF-2 
(Tropepe et al., 1999). These findings, that cell density influences the potency of cell 
responses to EGF, might explain the lack of response to EGF in the cortical cultures 
described here. Moreover, if cell density influences responsiveness to exogenous 
signalling, then the responses of daughter cells within expanding clones may be different 
to the original isolated founder cells. Thus, the sustained divisions and maintained 
expression of oUg2 in the larger clones that were generated in higher concentrations of 
FGF-2 could possibly be attributed to paracrine signalling events occurring within the 
clone. This could be assessed by subcloning cells from expanding clones to assess 
whether they behave in isolation as they do within a clone in response to FGF-2. This 
process could itself affect cell behaviour however. There is no simple solution to this 
potential problem, except to observe cells in vivo, although the extracellular environment
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cannot be easily manipulated in vivo. Thus, further progress will probably require a 
combination of both high- and clonal-density culture and in vivo observation.
5.3 OUg2 in gliogenesis vs. neurogenesis
OUg2 is expressed in the precursors of both neurons and glia; it is subsequently 
down-regulated in neurons and astrocytes and maintained in the oligodendrocyte lineage 
(Marshall et al., 2005;Zhou et al., 2001). My data suggest that early expression of oHg2 is 
plastic and that both up-and down-regulation of oHg2 can occur within clones and that 
FGF-2 significantly increases the generation of oUg2+ cells. This was at the expense of 
neurons and, while no astrocytes were identified, this does not mean they weren’t 
generated since they may not have expressed differentiated markere within the culture 
period analysed. The maintenance of oUg2 expression in my experiments was associated 
with oligodendrocyte lineage development. The observation that both 01ig2+ cells and 
01ig2-negative neurons can derive from a single oHg2+ precursor is reminiscent of the 
results of in vivo fate mapping of the oHg2 lineage which demonstrates that neurons, 
oligodendrocytes and astrocytes derive from oUg2+ precursors in the brain and spinal 
cord (Furusho et al., 2006;Masahira et al., 2006), indicating that in vivo events can be 
recapitulated in these cultures.
In the spinal cord, the onset of motor neuron production is associated with up-regulation 
of the bHLH factors ngn 1 and 2 in the pMN domain, resulting in their co-expression 
with oUg2. This is followed by rapid down-regulation of oUg2 in differentiating motor 
neurons (MNs) as MN-specific genes such as hb9 are activated (Novitch et al., 2001). 
Although down-regulation of oUg2 accompanies MN differentiation, its early expression 
is necessary for MN specification since there are no MNs (or OLPs) in olig2-f- mice. 
The onset of oligodendrogenesis in the pMN domain is coincident with down-regulation 
of ngn~2 and up-regulation of sox9, after MN production is over (Lee et al., 2005; S toit et 
al., 2003;Sugimori et al., 2007). It is clear that the combination of oUg2 with other bHLH 
and HD transcription factors is central to cell type specification, but the details are 
unclear. Sox9 is first expressed weakly at around ElO in the pMN domain (Stolt et al.,
2003) with increasing levels to a peak at El 2/13, around the time of OLP specification. It
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might be speculated therefore, that sox9 could be involved in the neuron/glia switch. 
However, sox9-/- mutants have no major phenotype with respect to spinal cord patterning 
and, although oligodendrocyte generation is slightly delayed and reduced at around 
E l4.5, by E l7.5 it is almost normal, indicating that sox9 is not absolutely necessary for 
their generation (Stolt et al., 2003). Sox9 also has a proven role in astrocyte specification 
(Kordes et al., 2005;Stolt et al., 2003;Wegner and Stolt, 2005). It is possible therefore, 
that sox9 is important in the initiation of gliogenesis and whether the resultant progeny 
are OLPs or astrocytes is dependent upon the presence or absence of oUg2, The 
unidentified cells present in the mixed cell clones described here could feasibly be 
astrocyte precursors which have down-regulated oUg2^ but have not yet up-regulated 
differentiated astrocyte markers such as GFAP; this will need further investigation. In 
order to determine which transcription factors might be causally involved in the initiation 
of the neuron/glia switch, forced expression of transcription factors such as sox9, mashl 
or ngn2 could be activated via viral transfection and the effects on the generation of 
neurons and glia analysed by time-lapse microscopy.
5.4 Signalling in gliogenesis and neurogenesis
The combination of oUg2 expression with other bHLH and homeodomain transcription 
factors is a central component of the specification of neurons versus glia. Sonic 
Hedgehog and Notch are two important signalling factors that are likely to be involved in 
co-ordinating the expression of different combinations of transcription factors. Motor 
neuron precursors are sensitive to SHH early on in their specification, but become 
independent of SHH signalling post-mitotically (Ericson et al., 1996), whereas sustained 
SHH signalling is required for OLP specification (Bertrand and Dahmane, 2006;0rentas 
et al., 1999;Park et al., 2004). This mimics the temporal requirements of oUg2 expression 
in motor neuron versus oligodendrocyte precursor cells and is also mimicked in the 
experiments I describe here. In my time-lapse experiments, sustained oIig2 expression 
was induced by increased FGF-2 signalling, indicating that prolonged FGF-2 signalling 
could, in principle, produce similar results as prolonged SHH signalling i.e. neurons first 
and then OLPs.
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Notch signalling is also thought to be important in the specification of neurons and glia 
and might possibly have a role in the neuron/glia switch; over-expression of Notch 
produces excess OLPs at the expense of motor neurons in the pMN domain and vice 
versa (Park and Appel, 2003;Yoon and Gaiano, 2005). Furthermore, some cells in the 
neuroepithelium express Notch 1 asymmetrically at their basal pole and the 
Notch-expressing daughter cell becomes a migrating neuron (Chenn and McConnell, 
1995;Park et al., 2004). Time-lapse could potentially be utilised in combination with 
Notch stimulation of NEPs to determine how the lineal relationships of cells within 
clones are affected. This could also, in principle, be done using explants and might 
indicate what qualitative influence Notch signalling has on the ability of NEPs to 
generate neurons versus glia in a more physiologically relevant context. Lateral 
inhibition by Notch signalling means that once neuronal fate is induced, neighbours are 
prevented fi*om following the same fate. This suggests that Notch signalling might be 
important in regulating numbers or the balance of neurons and glia as well as, or rather 
than, determining the switch from neurogenic to gliogenic activity. The data I have 
presented suggests that there might possibly be a cell-intrinsic mechanism governing the 
neuron/glia switch since I identified asymmetric divisions in the absence of obvious 
asymmetric stimuli. This suggests that the segregation of transcription factors during cell 
division could be an important component of the neuron/glia switch although this does 
not negate the idea that exogenous signalling and lateral inhibition play a part.
5.5 SHH and FGFs -  working together?
SHH has a predominantly ventralising role in CNS development, its actions being largely 
interpreted by Gli proteins as outlined in chapter 1. In culture, the induction of oHg2 in 
response to SHH seems to be dependent on the activation of MAPK which can be 
initiated by FGF-2 signalling (Kessaris et al., 2004). Whether this has physiological 
relevance is another question, although the availability of FGFs and SHH are known to 
overlap at several stages in CNS development. For example, FGFs and SHH are 
expressed in the node (early signalling centre during mouse and chick gastrulation) and in 
the ventral neural tube during spinal cord and telencephalic patterning.
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FGF-2 is expressed widely throughout the CNS during development (Ford-Perriss et al., 
2001) implying that cell responsiveness is likely to govern whether or not FGF signalling 
will have an effect. My data show that responsiveness to FGF-2 increases with 
embryonic age above ~E11.5 meaning that dorsal NEPs may be immune to ventralising 
signals early on in development, but that oligodendrogenesis in the cortex could be 
facilitated by FGF-2 thereafter if the signal is strong enough. Sensitivity to FGFs might 
even be partly dependent on Gli3 expression since Gli3 -/- mutants show expansion of 
FGF-8 expression with a concomitant decrease in the expression of Wnts, resulting in 
ventralisation of the dorsal forebrain (Aoto et al., 2002;Gunhaga et al., 2003;Gunhaga et 
al., 2003;Theil et al., 2002;Theil et al., 1999;Tole et al., 2000), FGFs are known to be 
ventralising (Crossley et al., 2001) and the repression of FGF-8 expression by Gli3 
repressor activity in the dorsal brain may enable dorsalisation at least partly by excluding 
FGF signalling from these regions. Neurons are known to produce FGF-2 and thus a 
peak in FGF-2 signalling could feasibly arise at the peak neurogenesis which just 
precedes the onset of gliogenesis in vivo. Although my data indicates that timing of 
FGF-2 availability is unlikely to provoke oligodendrogenesis in vivo, if  increased cell 
responsiveness is accompanied by an increase in neuron-derived FGF-2, this could 
possibly facilitate the onset of oligodendrogenesis. What causes the observed increase in 
responsiveness at ~E 12.5-El3.5 is not known. However, FGFRl is up-regulated just 
prior to gliogenesis in the rat dorsal cortex. Although this should relate to an increase in 
FGF-2 responsiveness at this time, an induced FGFRl-/- knock out (Kessaris et al 
unpublished) is phenotypically normal other than having no corpus callosum. Thus, 
FGFRl is unlikely to be necessary for normal oligodendrocyte development, although 
there may be redundancy between FGFRl and other FGFR isoforms which could 
compensate for its absence. The physiological role of FGF-2 therefore requires a great 
deal more investigation as its in vivo function is not yet clear.
5.6 Proliferation and cell specification
CNS patterning is a combination of cell specification and directed cell division. FGF-2 is 
classically a mitogen, but has recently also been shown to be important in cell 
specification and SHH is classically a morphogen, but also plays a role in cell division.
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being highly mitogenic in the cerebellum (Kenney and Rowitch, 2000). Notch activity is 
also important in determining cell number in a directed fashion, since increased Notch 
signalling results the generation of more glia at the expense of neurons, while reduced 
notch signalling causes the emergence of more post-mitotic neurons and fewer glia as 
outlined in the introduction (Park and Appel, 2003). Notch activity probably regulates 
cell number by determining the timing of cells exiting the cell cycle and thus facilitating 
differentiation. Increased activation of CDK inhibitors is observed when Notch 
signalling is reduced (Park et al., 2005;Park and Appel, 2003), indicating that Notch 
might act by inhibiting CDK inhibitors normally to keep cells cycling, although the 
relationship is not necessarily causal. This is unlike FGF-2 which accelerates the cell 
cycle by increasing the rate of progression form G1 to S phase (Li and Cicco-Bloom,
2004). The mechanisms of SHH-induced cell proliferation are unknown, but it is clear 
that most signalling factors that are involved in determination of cell fate are also 
involved in cell division. In combination, they can therefore potentially regulate both the 
number and distribution of different cell types in the CNS.
5.7 Combinatorial codes in development
There is extensive spatiotemporal overlap of ligand availability during CNS development 
meaning that CNS development involves the activation of combinatorial signalling 
pathways. It is also likely that there is a significant degree of redundancy among 
signalling molecules and transcription factors in order to ensure that small alterations in 
availability of a single component don’t lead to massive failings in developmental 
programmes. Redundancy amongst the Gli proteins is a good example since, despite 
their apparently polarised roles in CNS patterning, GU3 and GH2 can compensate for the 
absence of one another. For example, gH3, expressed from gU2 promoter, can reduce the 
gH2-/- phenotype (Bai et al., 2004). Since the activator functions of the different Glis are 
effectively interchangeable, their expression profiles in combination with 
post-translational processing must largely determine their developmental role as this 
governs activator versus repressor functions at different times and places. Signalling 
molecules themselves might also be able to compensate for the loss of one another. Since 
FGF-2 can generate OLPs independently of SHH signalling, perhaps is could compensate
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for reduced SHH signalling in vivo provided the cells were appropriately responsive. 
Given the ventralising role for FGFs in CNS development, it is feasible that they may 
facilitate SHH-dependent oligodendrogenesis. There are no OLPs in shh-/- mutants, 
however, meaning that it is unlikely that an SHH-independent mechanism (via FGF 
signalling or otherwise) is sufficient for ventral oligodendrogenesis.
The data I collected indicates that there is plasticity in the cell types that can be derived 
from embryonic cortical NEPs according to their exposure to ligands (FGF-2 and SAg 
described here). Precursor cells throughout the neuroepithelium have the capacity to 
generate specific glial and neuronal subtypes given the right cues. If the appropriate 
signalling pathways can be harnessed, there is feasibly, therefore, potential for the 
manipulation of cell specification during CNS development. This has important 
implications for intervention in developmental CNS pathologies.
5.8 Unidentified cells in FGF-2-generated cortical clones
A level of plasticity with respect to cell specification is maintained in the adult thanks to 
resident neural stem cells (NSCs) in the SVZ (Weiss et al., 1996). The lineal relationship 
between different embryonic NEP populations and postnatal NSCs is currently under 
investigation. Using Cre-lox fate-mapping in transgenic mice. Young et al (Young et al., 
2007) have shown that precursors from throughout the telencephalic neuroepithelium 
contribute to NSCs in the adult SVZ. It is feasible, therefore, that some of the 
unidentified cells in the clones described in my experiments could potentially be such 
stem cells, although this will need further analysis. This could be done by subcloning 
cells from expanding clones after 90 hours and assaying for stem-cell potential i.e. 
neurosphere-forming potential with properties of self-renewal and multipotentiality. In 
order to target the unidentified cells for subcloning, fluorescence assisted cell sorting 
(FACS) analysis could first be performed in order to isolate the EGFP-negative cells, thus 
eliminating a large proportion of the identified cells. It is now well documented that 
there are neural stem cells and glial progenitor cells in many regions of the adult brain. 
Young et al (Young et al., 2007) demonstrated that embryonic NEPs contribute to these 
adult populations and there is now also a great deal of interest around whether the
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pathways that are involved in cell specification in the embryo are recapitulated in these 
adult NSCs and glial progenitors.
The distinction between stem cells and restricted precursors and the signals involved in 
tightly regulated cell difîerentiation is an area of much current interest. Investigation into 
fate mapping and linking differentiated cells to particular stem cell or precursor cell 
populations is vast. The importance of understanding these processes is critical for 
understanding the biology of development, but also enables insight into the processes 
that, when disrupted, can result in serious pathologies, such as cancer. Pathways 
involved in normal progenitor cell proliferation are often the same pathways that are 
involved in tumour cell proliferation and survival (Garraway and Sellers, 2006). Neural 
stem cell populations in the subventricular zone of the adult brain are thought to be a 
significant source of gliomas. The idea that gliomas arise from NSCs could account for 
the heterogeneity that is characteristic of these tumours; if the tumour derives from a 
multipotent precursor cell then not only might its progeny be capable of self renewal, but 
also of differentiation into different glial subtypes. Of particular interest here is the link 
between oUg2 expression and gliomas since all gliomas have at least a proportion of 
oHg2+ cells.
OUg2 is known to be involved in the maintenance of replication competence in glial 
progenitor cells in development (Lee et al., 2005) and is also required for 
oligodendrocyte specification. In the adult, subpopulations of NSCs also express oHg2 
(Bachoo et al., 2002; Menn et al., 2006) including type B and type C cells which are the 
adult neural stem cells and rapidly dividing transit amplifying cells respectively (type B 
cells are thought to give rise to type C cells). Stimulation of oUg2+ type C cell 
proliferation can result in glioma formation. Furthermore, Ligon et al (Ligon et al., 2007) 
demonstrated that oUg2 function is actually required for glioma formation and for tumour 
growth. The majority of the rapidly dividing tumour stem cells in gliomas are oHg2+ and 
cells derived from oHg2/oligl null mice do not generate gliomas in animal models of the 
disease (Ligon et al., 2007). Given that oUg2 is involved in proliferation and glial 
differentiation in the developing animal, it is hardly surprising that it could also have a
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role in glioma pathology, but this example illustrates quite how closely linked the 
signalling pathways for development can be to those involved in pathology.
In vitro systems can give an idea of the fate potential of cells given the activation of 
different signalling pathways, even if this potential isn’t realised in vivo. Nevertheless, 
the identification of pathways and mechanisms that could be involved in normal 
developmental cell specification is an important start in understanding the potential 
means of intervention in conditions where normal developmental programmes are 
defective. I am excited to see what the future holds for in vivo manipulation of the NEPs 
that are the precursors of the CNS.
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